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The homeobox gene Pitx3 has been implicated as a key regulator for lens 
development because homozygous mutant aphakia mice, which are hypomorph for 
Pitx3, fail to develop lenses. One aim of my thesis is to investigate the underlying 
cellular and molecular mechanism of Pitx3 mediated lens defect by studying 
knockout mice lacking Pitx3. Chimeric embryos, generated by aggregating the wild 
type embryos with Pitx3 heterozygous or Pitx3 homozygous mutant ES cells, have 
been used to analyse lens development. Pitx3 null cells failed to colonise the lens 
epithelium in Pitx3 null ↔ wild type chimeric lens, suggesting that Pitx3 is 
cell-autonomously required for lens epithelial cells. Further study of Pitx3 null mice 
revealed an earlier downregulation of the lens epithelial markers PDGFRα and 
E-cadherin in E11.5 lens epithelium, suggesting the loss of lens epithelial identity in 
Pitx3 deficient mice. Furthermore, cell cycle inhibitors p27KIP1 and p57KIP2 were 
ectopically expressed throughout the morphologically normal Pitx3 mutant lens 
vesicle, suggesting that inactivation of Pitx3 leads to cell cycle exit of epithelial lens 
cells. 
In addition, precocious activation of the fibre cell-specific proteins β- and 
γ-crystallins was observed in Pitx3 null lens. β-crystallin expression could be 
observed as early as E10.5 throughout the entire Pitx3 null lens vesicle and 
γ-crystallin was detected in the malformed Pitx3 deficient lens at E11.5. RNA in situ 
hybridisation study revealed that the expression of the transcription factor Foxe3 was 
lost in Pitx3 null lens at E10.5, suggesting that Pitx3 maintains the lens epithelial 
cells partly via the regulation of transcription factor Foxe3 during lens development. 
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Accordingly, this study provides the cellular and molecular basis for the lens defect 
observed in Pitx3 null and Pitx3 hypomorph aphakia mice. Pitx3 is a key 
transcription factor for the maintenance of lens epithelium and its absence leads to 
premature activation of fibre cell differentiation programme of lens epithelial cells. 
In the other part of my PhD, I have further developed the Pitx3-GFP knockin ES cell 
system with a goal to use this tool for the identification of determinants of midbrain 
dopaminergic (mDA) neurons, the type of cells lost in Parkinson’s disease (PD) 
patients. Experimental cell therapy and clinical trials have shown that foetal midbrain 
tissues, but not tissues from other DA neuron containing regions, can functionally 
restore the lost mDA neurons when transplanted in Parkinson’s disease patients. 
Therefore, it is essential to coax mDA properties on stem cell-derived neurons when 
considering therapeutic development. 
Within the central nervous system, Pitx3 is expressed exclusively in mDA neurons. 
Using a Pitx3-GFP knockin mouse line previously generated in the laboratory I have 
derived heterozygous and homozygous Pitx3-GFP ES cells from mouse blastocysts. 
In keeping with previous findings in our laboratory, the heterozygous Pitx3-GFP 
(Pitx3GFP/+) ES cell-derived GFP positive cells of neuronal morphology can be 
detected after in vitro differentiation using the PA6 coculture system. Furthermore, I 
have shown that these cells express tyrosine hydroxylase and midbrain markers 
Engrailed-1 and Nurr-1, demonstrating their midbrain characteristics. I have also 
generated supertransfectable Pitx3GFP/+ ES cells to offer a rapid and efficient way to 
express a transgene episomally. The Cre-mediated inducible system of Pitx3-GFP 
reporter ES cells has also been developed in our laboratory and I have shown that 
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they have high induction efficiency thus allows transgene activation in a temporally 
controlled manner. The Pitx3 null ES cells showed impaired potential to differentiate 
into mDA neurons thus they may be used to evaluate candidate Pitx3 downstream 
target by gain-of-function test. In summary, I have developed a Pitx3-GFP reporter 
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1.1 Introduction for the transcription factor Pitx3 
The homeodomain transcription factor Pitx3 belongs to the family of the newly 
identified homeobox gene Pitx, which has 3 members (Gage et al., 1999). The Pitx3 
gene consists of 4 exons of 121, 130, 203 and 918 bp each (Figure 1-1 A) (Rieger et 
al., 2001; Semina et al., 1997). The coding region starts within exon 2, while the 
homeodomain region of the gene is located at exon 3 and exon 4, interrupted by an 
intron located in the same position as Pitx1 and Pitx2.  
Pitx3 was identified by two groups at approximately the same time. Semina et al. 
screened mouse cDNA libraries with a probe comprising the homeodomain region of 
Pitx2 and identified the third member, Pitx3 (Smidt et al., 1997). Their in situ 
hybridisation data revealed Pitx3 expression in the developing lens beginning on E11. 
Almost at the same time, Smidt et al. screened rat brain cDNA based on brain 
expressed homeobox genes and isolated this cDNA encoding the bicoid-related 
homeobox gene Pitx3 (Smidt et al., 1997). They found that Pitx3 has highly 
restricted brain expression in the midbrain SN and VTA and is superimposed with 
TH expression, thus Pitx3 could be used as a unique transcription factor marking the 
mDA neurons at the exclusion of other DA neurons. As well as the developing lens 
and the midbrain, Pitx3 expression is also reported in the tongue, incisor primordial, 
mesenchyme around sternum and vertebrae and in the head muscles (Semina et al., 
1998). 
The Pitx proteins all belong to the bicoid-related subclass of homeodomain proteins 
because they encode the defining lysine at residue 50 within the homeodomain. This 
residue, at the position 9 within the recognition helix of the homeodomain, is the 
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major determinant of DNA binding specificity. The Pitx3 protein consists of 302 
amino acids, while there are 217 and 317 amino acid isoforms generated by 
alternative splicing of Pitx2 and Pitx1 is a 315 amino acid protein. These 3 members 
are highly conserved at the amino acid level. Pitx2 and Pitx3 homeodomain are 
identical while Pitx1 differs by only 2 amino acids. The C-terminal domains of Pitx1, 
Pitx2 are around 50% conserved relative to Pitx3; however Pitx1 and Pitx2 isoforms 
have 70% amino acid identity. 
It has been confirmed that Pitx3 mutation is responsible for the spontaneous mouse 
mutation aphakia phenotype (Rieger et al., 2001; Semina et al., 2000). More recent 
genomic research on aphakia mice has identified two deletion mutations close to and 
within the mouse Pitx3 gene; the first one is a 652 bp deletion at 2.5 kb upstream of the 
transcription start site and the second is a 1423 bp deletion that encompasses the 
presumed promoter region, the transcription start site, the noncoding exon 1 and a 
portion of intron 1 (Rieger et al., 2001; Semina et al., 2000)(Figure 1-1 B). This 
suggests that Pitx3 mutation is responsible for the aphakia phenotype. Therefore, 
aphakia mice are used as a model to investigate Pitx3 deficiency for mDA 
development (Hwang et al., 2003; Nunes et al., 2003; Smidt et al., 2004; van den 
Munckhof et al., 2003). The functional requirement of Pitx3 in the development of 
lens and midbrain will be further discussed in section 1.2.4 and 1.3.1, respectively. 
It is worth noting that about 5% of wild type levels of Pitx3 transcripts are still present 
in aphakia mice (Rieger et al., 2001), suggesting that the aphakia mutation is a Pitx3 
hypomorph instead of Pitx3 null. Most studies about Pitx3 hypomorphic aphakia mice 
are concentrating on the functional roles of Pitx3 in mDA development. The 
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underlying cellular and molecular mechanism leading to aphakia lens defects remains 
elusive. 
In humans, mutation of PITX3 has been reported with inherited forms of cataracts 
and ASMD (Addison et al., 2005; Berry et al., 2004; Bidinost et al., 2006; Burdon et 
al., 2006; Rieger et al., 2001; Semina et al., 1998). This will be further discussed in 
Chapter 3. 
1.2 Introduction for lens 
Lens development is an excellent model for developmental biology since the process 
involves intercellular signalling between different cell layers, invagination in 
association with morphological changes in cell shape and terminal cell differentiation. 
It also involves a precisely coordinated development of the anterior neural plate, 
mesenchyme, and adjacent surface ectoderm (Kondoh, 1999; Lang, 2004; Lovicu 
and McAvoy, 2005). The fully formed lens consists of post-mitotic differentiated 
fibre cells that are covered anteriorly by a layer of proliferative immature epithelial 
cells. Differentiation of epithelial and fibre cells involves acquisition of distinctive 
morphological and molecular characteristics that are required for the different 
structures and functions of cells in the two different lens compartments. 
1.2.1 Lens development 
Lens morphogenesis begins with ectoderm. The optical vesicle, which is an 
outgrowth from the ventral forebrain that later forms the retina, induces the surface 
ectoderm to gain the lens competence (Figure 1-2 A). The head surface ectoderm 
facing the approaching optic vesicle thickens to form the lens placode which 
subsequently invaginates to forms the lens pit and later the lens cup (Figure 1-2 B). 
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The lens cup deepens and finally breaks away from the surface ectoderm to form the 
lens vesicle (Figure 1-2 C). At the same time the optic vesicle invaginates to produce 
the optic cup with an inner layer, which forms the neural retina and an outer layer, 
which forms the retinal pigmented epithelium. 
Proper lens development requires the mutual inductions between the optic vesicle 
and the lens placode. The transcription factor Pax6 appears to lie at the top of a 
regulatory hierarchy (Collinson et al., 2003; Lang, 2004; Ogino and Yasuda, 2000; 
Reza and Yasuda, 2004a). Mutant mouse studies suggest that FGF (Faber et al., 2001) 
and BMP7 (Wawersik et al., 1999) receptor signalling are required for lens induction 
and that they cooperate to promote Pax6 expression (Faber et al., 2001). BMP4 is 
also required for the optic vesicle to manifest a lens inducing capacity (Furuta and 
Hogan, 1998).  
After lens vesicle formation lens development involves the differentiation of two 
types of lens cells. A polarity soon develops in the primitive lens. Cells in the 
posterior segment of the lens vesicle differentiate into elongated, crystallin 
expressing, primary lens fibres that gradually fill the vesicle, whereas the anterior 
surface retains a layer of proliferating lens epithelial cells (Figure 1-2 D). Continued 
elongation of the fibre cells leads to occlusion of the cavity of the lens vesicle 
(Figure 1-2 E). From this stage onwards, the anterior lens epithelial cells continue to 
divide throughout life. Most of the proliferation occurs in the epithelial region 
anterior to the lens equator located between the anterior lens epithelial cells and the 
posterior lens fibre mass. As the lens epithelial cells migrate posteriorly below the 
equatorial region, they start to differentiate into secondary lens fibre cells and are 
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added to the fibre mass throughout life. 
When the elongating lens fibre cells reach the midpoint of the lens (Bassnett and 
Winzenburger, 2003) and meet fibres from the other side, the posterior ends of these 
cells began to detach from the lens capsule. The continued formation of successive 
waves of fibre cells causes these elongated cells to be buried deeper within the lens 
and then degrade all intracellular organelles including the nucleus. The programmed 
removal of organelles from lens fibre cells is of fundamental importance to the 
function of the mature lens since it leads to the formation of a transparent region at 
the centre, which has been termed the organelle-free zone. Disturbances in the 
programmed removal of organelles during lens development can lead to cataracts. 
The programmed disappearance of the nucleus in lens fibre cells resembles apoptosis 
in various ways, including chromatin condensation and DNA fragmentation, which 
can be visualised using the TUNEL technique, and involvement of the caspases. 
However, there is a difference between apoptosis, which results in cell death, and the 
programmed organelle loss, after which lens fibre cells persist throughout the 
lifetime of the organism. The existence of biochemical similarities to classical 
apoptosis makes lens fibre cell organelle loss an interesting system for researchers to 
dissect the molecular events of apoptosis (Wride, 2000). On the other hand, the 
interpretation of tests about apoptosis, such as caspase expression or TUNEL assay, 
should be very careful in the context of lens. 
The lens and the anterior segment of the eyes are linked in development with a 
commonality of origin in surface ectoderm components, a necessity for separation of 
these components for anterior chamber formation and a requirement for signalling 
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from the lens for anterior segment organisation (Beebe and Coats, 2000). The 
interaction of the lens vesicle with the overlaying ectoderm results in the induction of 
the cornea. At the same time, it has been suggested that the anterior segment of the 
embryonic eye may contain mitogens, which are responsible for maintaining the cell 
division in the lens epithelium. Some anterior segment disorders arise due to 
abnormalities in lens development, including mutations in PAX6 (Hanson et al., 1994; 
Ton et al., 1991), MAF (Jamieson et al., 2002; Lyon et al., 2003), PITX3 (Semina et 
al., 1998), and FOXE3 (Semina et al., 2001). 
1.2.2 Transcription factors involved in lens development 
 Pax6 
Pax6 is a member of the Pax family, the paired-type homeobox-containing 
transcription factors. In Drosophila, there are two Pax6 homologues called eyeless 
and twin-of-eyeless. Gain-of-function experiments have shown that Pax6 is sufficient 
for eye formation. Misexpression of Pax6 in Xenopus embryos leads to the formation 
of ectopic eyes with fully differentiated lenses and retina tissues (Chow et al., 1999). 
In mice, Pax6 is expressed broadly in the head ectoderm from E8.0 which becomes 
progressively restricted to the developing lens placode and nasal placode at E10. It is 
also expressed later in the optic vesicle, but its expression in surface ectoderm is 
earlier than in the optic vesicle apposition (Li et al., 1994). Heterozygous Pax6 
mutation results in the phenotype of Small eye (Sey) (Hill et al., 1991). Mouse 
embryos homozygous for the Sey mutations do not develop lens and nasal placodes, 
resulting in a lack of eyes and nose, and die perinatally due to an inability to breathe 
(Hill et al., 1991; Hogan et al., 1986). In these Sey/Sey mice, there is no lens 
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induction and no sign of thickening of the ectoderm to form lens placodes in spite of 
the apposition of optic vesicles, suggesting that Pax6 activity in the presumptive lens 
ectoderm but not in the optic vesicle is required for the initiation of lens induction. 
Assessment of Pax6 mRNA expression patterns in wild type and homozygous 
Pax6Sey-1Neu/Sey-1Neu mutant mice shows that Pax6 expression in the surface ectoderm 
can be divided into at least two stages (Grindley et al., 1995; Grindley et al., 1997; 
Gumbiner, 2000). The first stage corresponds to Pax6 in the surface ectoderm, before 
close contact with the optic vesicle occurs (defined as Pax6pre-placode). The second 
stage occurs after contact, and correlates with the formation of the lens placode 
(defined as Pax6placode). Functional Pax6 in the first stage is required for continued 
placodal Pax6 expression and subsequent lens development. 
Tissue recombination studies in rats indicate that the ectoderm from homozygous  
(rSey/rSey) never differentiates into lens tissue even if it is cultured with normal 
optic vesicle tissue from wild type embryos, whereas lens differentiation occurs 
when wild type or heterozygous ectoderm is cultured with homozygous Pax6 mutant 
optic vesicles (Fujiwara et al., 1994). It suggests that Pax6 is required by the head 
ectoderm for responding to the inductive effect of the optic cup, thus Pax6 expression 
confers lens competence to the head ectoderm. Aggregation of wild type and Sey/Sey 
embryos results in chimeric mice in which Sey/Sey mutant cells are excluded from 
the lens placode (Collinson et al., 2000) and the maturing lens at E12.5 (Quinn et al., 
1996), respectively. The chimera studies also revealed that Pax6 is required for the 
maintenance of contact between the lens placode and the optic vesicle (Collinson et 
al., 2000). Deletion of Pax6 in the prospective lens ectoderm by Cre-loxP 
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tissue-specific gene targeting results in the absence of the lens placode formation, 
which supports the cell-autonomous requirement for Pax6 in placode initiation 
(Ashery-Padan et al., 2000). 
An ectoderm enhancer (EE) of Pax6 has been deleted by gene targeting (Dimanlig et 
al., 2001). The homozygous mutant mice (Pax6∆EE/∆EE) have a reduction in lens 
placode thickness and proliferation rate, a smaller lens, delayed primary fibre cell 
differentiation, a persistent connection between the lens and surface ectoderm, and 
loss of expression of Foxe3, which is another transcription factor required for lens 
development. 
At later stages, Pax6 continues to be expressed in the entire lens vesicle and, when 
the lens matures, Pax6 expression is confined to the lens epithelium (Grindley et al., 
1995). βB1-crystallin promoter analysis shows that Pax6 represses the expression of 
the lens fibre cell-specific marker β-crystallin, which is first expressed after Pax6 
expression has ceased (Cui et al., 2004; Duncan et al., 1998). Taking these data 
together, it has been suggested that the function of Pax6 at later stages is to maintain 
the lens epithelium state by inhibiting fibre cell-specific genes, and that the 
downregulation of Pax6 in differentiated lens fibre cells during development allows 
β-crystallin activation by other positive regulators such as Prox1 and c-Maf. 
Since Pax6 homozygous null embryos are completely lens-less, the Pax6 
heterozygous lens, which shows haploinsufficient phenotype, serves as another 
model system to study the functional role of Pax6 and to identify genes regulated by 
Pax6. Pax6+/- chimera data demonstrates a cell autonomous deficiency in lens 
placode formation as well as in lens epithelium after closure of the lens pit 
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(Collinson et al., 2001). Reduced levels of expression of Pitx3 in Pax6 heterozygous 
lens by microarray and RT-PCR analysis have also been shown (Chauhan et al., 
2002a; Chauhan et al., 2002b). Furthermore, two conserved Pax6 binding sites are 
found in the 5’-flanking sequences of the human and mouse PITX3/Pitx3 genes. 
These data suggest that Pax6 may directly regulate Pitx3. 
In humans, one case of a stillborn foetus of homozygous Aniridia, which is 
associated with the PAX6 mutation, has been reported with severe craniofacial 
abnormalities, including a total absence of the eyes and nose. The phenotype is 
similar to homozygous Pax6 mutation in mice. Heterozygous loss of function of 
PAX6 is responsible for anterior segment disorder of eyes, including ASMD and 
Peters’ anomaly (Hanson et al., 1994; Ton et al., 1991). 
 Sox1 and Sox2 
Sox1, Sox2 and Sox3 belong to the B group of Sox proteins which have previously 
been described as δEF2 that can activate δ-crystallin enhancer and γ-crystallin 
promoter (Kamachi et al., 1998). In mice, Sox2 expression starts in Pax6 expressing 
head ectoderm just before the lens placode is formed and its activation defines the 
lens fate of the ectoderm. Subsequently Sox2 is highly expressed in the lens pit and 
lens vesicle. Later on, Sox2 expression is downregulated and taken over by Sox1, 
which is the major Sox protein expressed throughout the lens, and the expression is 
significantly higher in the fibre compartment. Sox3 is also expressed in the 
vesicle-facing ectoderm in chick embryos, but its expression is not detectable in 
mouse embryos. Optic vesicle ablation experiments in the chick have shown that 
induction of Sox2/3 activation depends on the effect of the apposing optic vesicle.  
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Sox2 homozygous null embryos die soon after implantation, reflecting the unique 
expression of Sox2 in the inner cell mass and epiblasts (Avilion et al., 2003). 
Recently, Sox2 hypomorphic and conditional knockout mice have been generated. 
These mice showed a reduced eye size caused by impaired proliferation of retinal 
neural progenitors, but no lens phenotype was observed (Taranova et al., 2006). Sox1 
knockout mice are viable and their major phenotype is the defect in lens fibre 
development (Nishiguchi et al., 1998). Lens fibre formation is initiated normally 
upon withdrawal from the cell cycle, but is prematurely arrested before cell 
elongation, thus the lens cavity remains empty and gives rise to a hollow lens. All 
γ-crystallin genes are severely affected but the expression of α- and β-crystallin 
occurs normally. This suggests that Sox1 is required for γ-crystallin expression 
and/or differentiation of lens fibre cells. 
 Six3 
Six3 was originally cloned as the vertebrate homologue of Drosophila’s Sine oculis 
(so) homeobox-containing gene (Oliver et al., 1995). In mice, Six3 is progressively 
expressed in the optic stalk, lens pit, optic vesicle and is later restricted to the 
neuroretina and lens epithelium. Misexpression of mouse Six3 in medaka fish can 
direct ectopic lens formation in a cell non-autonomous manner, suggesting that it 
may induce a soluble factor that changes the bias of the optic placode toward a lens 
type fate (Oliver et al., 1996). Six3 can significantly repress the promoter activity of 
the γF-crystallin gene crygf in a promoter assay (Lengler et al., 2001) and suppress 
lens fibre differentiation when overexpressed in the chick lens primordium (Zhu et 
al., 2002). Together with the fact that Six3 and γ-crystallin expression is inversely 
related during lens development, it has been suggested that Six3 may prevent 
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γ-crystallin expression in the lens epithelium whilst its downregulation in 
differentiated lens fibre cells allows γ-crystallin genes to be activated by other 
positive regulators such as Prox1 and c-Maf. Thus the primary function of Six3 may 
be to maintain the proliferative state of lens epithelium (Reza and Yasuda, 2004a). 
Six3 is also essential for the establishment and maintenance of the anterior 
neuroectodermal identity including the presumptive forebrain and developing retina. 
Six3 expression can be detected as early as E7.0 in the prospective anterior 
neuroectodermal region including the area which later on gives rise to the optic 
vesicle and retina primordium. The set of regulatory molecules that control this 
expression may be different from the set that regulates the expression of head 
ectoderm that includes the area which later on and after thickening gives rise to the 
lens placode (Lagutin et al., 2001). Overexpression of Six3 results in expanded and 
ectopic retinal primordial in medaka fish (Loosli et al., 1998; Loosli et al., 1999) and 
Xenopus (Bernier et al., 2001), and promotes the formation of ectopic optic 
vesicle-like structures in the midbrain-hindbrain region of developing mouse 
embryos (Lagutin et al., 2001). Inactivation of Six3 leads to the complete absence of 
the forebrain and eyes (Carl et al., 2002). It has been reported that Six3 regulates the 
proliferation of retina precursor cells by antagonising the cell cycle inhibitor geminin 
(Del Bene et al., 2004). 
In humans, SIX3 expression has been detected in the retina (Granadino et al., 1999). 
Mutation of human SIX3 is associated with human holoprosencephaly type 2 (HPE2), 
of which the manifestation includes severe malformation of the brain, 
microphthalmia and craniofacial defects. This suggests that SIX3 is essential for the 
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development of anterior neural plate (Granadino et al., 1999; Wallis et al., 1999). 
 Prox1 
Prox1 is a homeodomain protein related to Drosophila prospero. During mouse 
development, Prox1 is expressed in the lens placode and lens vesicle but the 
expression level is highest in the lens equator in differentiating lens (Duncan et al., 
2002; Wigle et al., 1999). Indeed, loss-of-function study of Prox1 in mice has 
demonstrated an involvement of Prox1 in the transition of the proliferative lens 
epithelium to the post-mitotic lens fibre cells. 
Histological analysis of Prox1 homozygous mutant eyes has revealed that the initial 
induction of the lens vesicle is unaffected. However, the mutant lens cells failed to 
polarise and elongate properly, resulting in a hollow lens. Prox1 inactivation causes 
downregulated expression of the cell cycle inhibitors p27KIP1 (also known as cdkn1b) 
and p57KIP2 (also known as cdkn1c), suggesting that Prox1 activity is necessary for 
cell cycle withdrawal of the lens epithelial cells. At E14.5 the Prox1 mutant lens cells 
uniformly express the epithelial marker E-cadherin. RT-PCR analysis of the mutant 
lens shows slightly downregulated but detectable expression of the genes encoding 
α-, β- and most of the γ- crystallins. However, expression of the genes encoding γB- 
and γD- crystallin are not detected in mutant lens. The expression of most genes 
encoding crystallins suggests that fibre cell differentiation is initiated but then 
arrested in Prox1 null lens despite of the loss of cell cycle inhibitors p27KIP1 and 
p57KIP2. 
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 Foxe3 
The forkhead gene Foxe3 starts to be expressed in the prospective lens surface 
ectoderm, where later, the lens placode is formed (Blixt et al., 2000; Brownell et al., 
2000). Subsequently, Foxe3 expression is confined to the lens vesicle as it is 
detached from the surface ectoderm. Initially it is evenly distributed throughout the 
lens vesicle, and then the expression is switched off in the posterior cells of the lens 
vesicle as these cells start to differentiate into lens fibres, but remains high in lens 
epithelial cells. By E14.5 the Foxe3 expression is restricted to anterior lens 
epithelium, where it persists into adulthood. 
Foxe3 is mutated in the spontaneous mouse mutation dysgenetic lens (dyl) (Brownell 
et al., 2000). The phenotype of dyl is manifested as a persistent connection between 
the lens and the corneal epithelium, which results from failure of the lens vesicle to 
close and separate from the ectoderm. The lens structure is irregular in shape and 
reduced in size. It has been suggested that the primary defect of dyl mouse lens 
morphology is due to failure of the lens epithelium to proliferate, which subsequently 
leads to a reduction in the number of secondary lens fibres.  
In the dyl mutants the expression of cell cycle exit marker p27KIP1 extends anteriorly 
into the epithelium, the pdgfra expression is diminished compared to the wild type, 
and the epithelial cells express a higher level of the crya1 gene, which encodes 
α1-crystallin (Blixt et al., 2000). There is also inappropriate upregulation of 
β-crystallin in the lens epithelial cells (Brownell et al., 2000). This suggests that the 
functional role of Foxe3 may be to maintain the border separating the dividing cells 
of the epithelium from the posterior differentiating cells, by preventing the 
expression in epithelial cells of genes involved in growth inhibition and 
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differentiation (Blixt et al., 2000). The expanded expression pattern of Prox1 in the 
lens epithelium of dyl mice indicates that Foxe3 may be a suppressor of Prox1 in this 
location. Foxe3 expression is absent in Pax6 mutant embryos (Brownell et al., 2000; 
Dimanlig et al., 2001), showing that Foxe3 is located downstream of the placodal 
phase of Pax6 expression in a genetic pathway regulating lens development. Foxe3 
knockout mice have recently been generated by targeted deletion (Medina-Martinez 
et al., 2005). The morphological and molecular changes observed in the lenses of 
Foxe3 null embryos are similar to those observed in the dyl mouse strain. 
In a recent zebrafish experiment, foxe3 knockdown resulted in a smaller lens with 
increased numbers of nucleated cells and disordered fibre cell arrangements. The 
most interesting finding is that the knockdown pitx3 protein in zebrafish results in 
the elimination of foxe3 expression, suggesting that foxe3 lies genetically 
downstream of pitx3 in a zebrafish lens development pathway (Shi et al., 2006a). 
In humans, FOXE3 is expressed in the lens epithelium (Semina et al., 2001). 
Mutations in FOXE3 have been identified in several families with ASMD and 
cataracts characteristic of Peters’ anomaly, similar to those of the individuals with 
PITX3 mutation (Ormestad et al., 2002; Semina et al., 2001). 
 Maf 
The Maf oncogenic family originally emerged with the isolation of the v-maf gene 
from the genome of acute transforming retrovirus AS42, which causes avian 
musculoaponeurotic fibrosarcoma (Nishizawa et al., 1989). All the proteins in this 
family share a highly conserved basic region of a leucine zipper domain (bZIP) at 
their C-terminals, which allows them to bind to the target DNA, the Maf-responsive 
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element (MARE), either as homodimers or as heterodimers with other transcription 
factors. Maf family transcription factors are subdivided into two major groups based 
on their molecular size: small Mafs or large Mafs. Large Mafs identified in human 
and mouse include c-Maf, MafB, MafA and NRL (neural retina leucine zipper), 
whereas c-Maf, MafB and L-Maf have been identified in chicks and Xenopus (Reza 
and Yasuda, 2004b). Maf genes are expressed in a highly regulated temporospatial 
manner, suggesting different Mafs have distinct roles in lens development. 
L-Maf is the first chick Maf protein to be expressed in developing lens cells. When 
the invaginating optic vesicle approaches, L-Maf is expressed in the overlying head 
surface ectoderm, regulated by Pax6 (Reza et al., 2002). Ectopic expression of L-Maf 
in different parts of the head ectoderm induces Prox1 and crystallin genes expression 
(Reza et al., 2002). After the lens vesicle stage, L-Maf essentially regulates the 
expression of crystallin and fibre-specific genes. 
Mouse c-Maf and chick L-Maf have similar functions. In mice, c-Maf expression is 
first evident in the presumptive lens ectoderm before its invagination. At E11.5 the 
expression is preferably higher in the fibre cells and less in epithelial cells (Kawauchi 
et al., 1999). However, mouse c-Maf does not play as an important role in lens 
placode formation as chick L-Maf does because lens development is not impaired 
until the lens vesicle stage in c-Maf mutant mice. c-Maf function is crucial for lens 
fibre differentiation and crystallin expression in mice. In the c-Maf knockout mice, 
the initial stages of primary fibre cell function are normal but fibre cell 
differentiation and elongation cease by E12.5, giving rise to the persistence of a 
hollow lens structure. This phenotype partially overlaps with those reported for gene 
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targeting of Prox1 and Sox1. However, RNA in situ hybridisation at E13.5 shows no 
difference between the c-Maf homozygous mutant and the heterozygous controls for 
the expression of Prox1 or Sox1 (Ring et al., 2000). In c-Maf mutant mice, weak 
expression of α- and β-crystallin has been observed but γ-crystallin is almost absent, 
demonstrating that γ-crystallin gene transcription is under strict c-Maf regulatory 
control (Kawauchi et al., 1999; Ring et al., 2000).  
Mouse MafB mRNA is apparent in the lens epithelial cells at E10.5 but not in the 
lens fibre cells, while NRL is absent in early lens lineage during development 
(Kawauchi et al., 1999). Since MafB expression in mice is exclusively detected in 
the lens epithelium, it has been suggested that it is involved in the maintenance of 
lens epithelial cells (Reza and Yasuda, 2004b) but further investigation is required. 
In humans, inherited cataract of the lens along with other ocular abnormalities has 
been identified due to MAF mutation (Jamieson et al., 2002; Lyon et al., 2003).  
1.2.3 Signal pathways for lens development 
Lens polarity and growth pattern are maintained throughout life by growth factors 
that are present in the ocular environment. It is well known that growth factors 
modulate each other’s bioactivity and bioavailability. The complex process of fibre 
differentiation depends on the synchronised and integrated action of a number of 
distinct growth factor-induced pathways. 
 BMP pathway 
Members of the TGFβ superfamily appear to have a prominent role in regulating 
aspects of lens induction and differentiation. BMP proteins form soluble dimers 
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which are involved in autocrine and paracrine signalling during development. 
Binding of BMPs induces the formation of complexes of type I and type II receptors. 
Activated type II receptors transphosphorylate type I receptors, which propagate the 
signal to the nucleus via a family of structurally related proteins known as SMADs. 
BMPs, TGFβs and their respective receptors are expressed in the lens (de Iongh et al., 
2001; Faber et al., 2002). BMP4 and BMP7 are crucial for the early steps of the lens 
induction process. In mice, BMP4 is highly expressed in the dorsal region of the 
optic vesicle, but weakly expressed in the overlying surface ectoderm, whereas 
BMP7 is expressed in the head ectoderm where later on, the lens placode forms 
(Furuta and Hogan, 1998; Wawersik et al., 1999). In BMP7 mutant mice, neither 
Pax6 expression nor lens placode formation is observed, suggesting that BMP7 
functions upstream of Pax6 expression in the presumptive lens ectoderm (Wawersik 
et al., 1999). On the other hand, BMP4 null mutant embryos show no lens placode 
induction associated with the lack of Sox2 expression in the head ectoderm. Lens 
formation from presumptive lens ectoderm of BMP4 null mutants can be rescued by 
recombining them with wild type optic vesicle in explant culture. Explantation of eye 
rudiments from BMP4 null mice in the presence of exogenous BMP4 supply rescues 
the Sox2 expression, suggesting a functional role of BMP4 for Sox2 induction and 
lens development (Furuta and Hogan, 1998). In contrast, applying BMP4 beads 
without optic vesicles does not induce lens formation. These observations indicate 
that BMP4 and some unknown signals from the optic vesicle are required to form 
lens placode from the ectoderm.  
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In addition to their important roles in lens induction, BMPs are also important for 
lens fibre cell elongation and differentiation (Faber et al., 2002). Phosphorylated 
SMAD1 (pSMAD1), a target of BMP signalling, localises to the nucleus of 
elongating lens fibre cells (Belecky-Adams et al., 2002). In mice, in vitro 
experiments have shown that primary lens fibre cell elongation can be suppressed in 
the presence of Noggin, which is a BMP ligand inhibitor (Faber et al., 2002). Primary 
fibre cell elongation is also inhibited when a dominant-negative form of BMP 
receptor type I (BMPR1B, Alk6) is overexpressed in the lens (Faber et al., 2002). 
Targeted deletion of Alk3 (BMPR1B), the most abundant type 1 BMP receptor, by 
the Pax6 P0 promoter, results in a smaller lens with thin epithelial layers (Beebe et 
al., 2004). Alk3 null lens fibre cells become vacuolated and begin to degenerate by 
the first postnatal week. These studies show that BMP signalling also contributes to 
the later development of lens epithelial and fibre cells. 
Other members of TGFβ superfamily are also important for lens fibre differentiation. 
Follistatin, a binding protein that binds to the members of the TGFβ superfamily, 
cooperates with Noggin to block the elongation of cultured chick lens epithelial cells 
(Beebe et al., 2004). Overexpression of dominant-negative type II and type I TGFβ 
receptors shows disrupted fibre cell differentiation including attenuated fibre cell 
elongation (de Iongh et al., 2001). However, targeted deletion of the type II TGFβ 
receptor does not result in abnormalities in lens growth and differentiation (Beebe et 
al., 2004). Careful evaluation by further experiments is needed to have a clearer 
picture about the regulation of these signalling pathways. 
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 Wnt pathway 
Wnts function as ligands for members of the Frizzled (Fz) family of 
seven-transmembrane receptors. The presence of Fz receptors and LDL (low density 
lipoprotein)-related protein co-receptors (LRPs), 5 or 6 are required to activate the  
Wnt/β-catenin pathway (Cong et al., 2004; Tamai et al., 2000), which is commonly 
referred to as the Wnt canonical pathway. In situ hybridisation shows that Wnt5a, 
Wnt5b, Wnt7a, Wnt7b, Wnt8a and Wnt8b gene, and frizzled receptors Fz1-Fz8, are 
expressed throughout the embryonic lens up to E12.5 but then become 
predominantly restricted to the lens epithelium and the equatorial region (Chen et al., 
2004). The negative regulators of Wnt signalling, Dickkopfs (Dkks) 1, 2 and 3, are 
strongly expressed in the lens epithelial cells and elongating primary lens fibres but 
downregulated in mature fibre cells (Ang et al., 2004). It has been shown that LRP6 
is expressed, and active β-catenin is present in the lens epithelium during 
development (Stump et al., 2003). Mice with a null mutation of LRP6, which is a 
Wnt co-receptor, have small eyes and an aberrant lens characterised by an 
incompletely formed anterior lens epithelium. Therefore it has been suggested that 
the Wnt/β-catenin pathway may have a role in maintenance of anterior epithelial 
cells or in preventing aspects of fibre differentiation. Further investigation is needed 
to confirm the functional requirement of the Wnt signalling pathway in the lens 
epithelium. 
 FGF pathway 
Members of the FGF family play key roles in mammalian lens biology. The picture 
that is emerging so far is that FGF appears to be a key initiator for lens development. 
The expression of Pax6 and Sox2 in the lens placode is significantly decreased when 
the FGF receptor is inactivated in the presumptive lens ectoderm, suggesting that 
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Pax6 and Sox2 lie downstream of the FGF signalling in the lens induction pathway 
(Faber et al., 2001). 
At later stages, FGF1, FGF2 and high affinity FGF receptors are shown to be 
expressed throughout the eyes, in particular in the lens (de Iongh et al., 1997; de 
Iongh et al., 1996). In a rat lens epithelial explant culture system, FGF is shown to 
induce proliferation or differentiation responses in lens epithelial cells in a 
concentration-dependent manner. A low concentration of FGF induces lens epithelial 
cell proliferation, whereas subsequent higher doses induce lens epithelial cell 
migration and fibre cell differentiation, which includes morphological change 
accompanied by the accumulation of fibre cell-specific β- and γ-crystallins (McAvoy 
and Chamberlain, 1989). Since more FGF can be recovered from the vitreous than 
aqueous humour, these dose-response characteristics of lens cells to FGF lead to the 
development of the FGF gradient hypothesis, which proposes that the anteroposterior 
patterns of lens cell behaviour are determined by an anteroposterior gradient of FGF 
stimulation (McAvoy et al., 2000). It is possible that low concentrations of FGF in 
the anterior chamber of the eye maintains the proliferation of lens epithelial cells, 
and in the equatorial region cells are exposed to higher levels of FGF which leads to 
the definite process of terminal differentiation. 
Overexpression of a truncated FGF receptor that acts in a dominant-negative manner 
(Stolen and Griep, 2000) and overexpression of a specific secreted FGF receptor 
SFGFR3 (Govindarajan and Overbeek, 2001) lead to inhibition of fibre cell 
differentiation in vivo. These experiments indicate that FGF ligand and the FGF 
receptor signalling is essential for lens fibre cell differentiation. However, many 
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FGFs have overlapping effects in the lens (Lovicu and Overbeek, 1998) and mice 
null for a number of different FGFs have no abnormal lens phenotype (Zhao et al., 
2002). Additionally, no single fgfr gene is essential for lens fibre cell differentiation. 
However, the triple knockout of Fgfr1, Fgfr2 and Fgfr3 shows no fibre 
differentiation and confirms that different FGFRs play an essential but redundant role 
in fibre differentiation (Zhao et al., 2003). To date it is still poorly understood which 
of the currently known FGF family members are involved in the regulation of lens 
fibre cell differentiation in vivo. 
The intrinsic signalling pathway associated with FGF receptor induces 
mitogen-activated protein kinases (MAPK), of which the sequential phosphorylation 
of its components are then translocated from the cytoplasm to the cell nucleus where 
it activates nuclear transcription factors leading to changes in gene expression. To 
date several distinct mammalian MAPKs have been characterised and among them, 
the extracellular-regulated kinases (ERKs), are the most abundant MAPK in the lens. 
Rat immunohistochemistry experiment reveals that phosphorylated ERK (pERK) is 
observed throughout the lens epithelial cells including the equatorial region, and 
downregulated in differentiated lens fibre cells (Lovicu and McAvoy, 2001). In rat 
lens explant experiments, high differentiation-inducing doses of FGF induce a 
greater level of ERK phosphorylation than a lower proliferation-inducing dose 
(Lovicu and McAvoy, 2001). Additionally, FGF-induced lens fibre cell 
differentiation, including elongation and expression of the fibre cell-specific marker 
filensin, is also dependent on ERK activation. However, FGF-induced β-crystallin 
accumulation in rats is independent of the ERK pathway (Lovicu and McAvoy, 2001), 
in keeping with the chick experiment which shows that FGF-induced δ-crystallin 
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expression does not require ERK activation (Le and Musil, 2001). Thus FGF-induced 
lens fibre cell differentiation may involve other yet to be identified signalling 
pathways regulating the expression of the fibre cell-specific crystallin. These studies 
demonstrate the uncoupling of the fibre cell differentiation process in the lens and 
highlight that multiple signalling pathways are involved in the regulations. 
1.2.4 The Pitx3 hypomorphic aphakia mice 
The spontaneous mouse mutation aphakia (ak) was first observed in a colony of strain 
129/Sv-S1j mice in 1968 (Varnum and Stevens, 1968). Because of difficulties in 
maintaining the aphakia line, mutants were outcrossed to C57BL/Ks animals. The 
aphakia mice appear to be small, emaciated, and have reduced fertility. They are 
characterised by small sized eyes with lack of lens and anterior segment structures. 
Morphologically aphakia and normal lens are grossly indistinguishable until E10, the 
lens vesicle stage. However, a significantly greater number of malorientated mitoses is 
found in the lens placode and the early lens cup in homozygous aphakia mice (ak/ak) 
(Zwaan and Kirkland, 1975). By E11, the lumen of the lens vesicle is filled with 
disorganised groups of rounded cells. Additionally, the extracellular matrix material 
that forms a firm attachment between the lens vesicle and optic vesicle during 
invagination of the lens vesicle is abnormal (Zwaan and Webster, 1984). The cells of 
the posterior wall never elongate to become lens fibres. Abnormal lens morphogenesis 
in the aphakia mutant results in a club-shaped elongated lens remnant that remains 
attached to the face surface epithelium by a persistent connecting stalk. Subsequently 
the disorganised rudimentary lens disappears during later development. The growth of 
the retina continues and the retina tissue eventually fills the space of the whole eye ball 
without formation of the vitreous body. The folding of the retina may be caused by the 
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absence of the lens and continued growth of the retinal layer, or by an alternation of a 
lens-derived signal. 
Since separation of the lens vesicle from the surface ectoderm is essential for 
formation of anterior segment, the anterior eye structures, including the cornea, iris, 
and pupillary opening, never differentiate properly in aphakia mice (Zwaan and 
Webster, 1984; Zwaan and Webster, 1985). It has been suggested that the persistent 
lens stalk, which does not detach from the surface ectoderm, is caused by the 
differences in the intercellular deposition and composition of the extracellular matrix 
between the aphakia and normal mice at the lens placode stage (Zwaan and Webster, 
1984). Furthermore, it has been reported that aphakia mutant lens remnants do not 
express crystallin protein, suggesting impairment in the function of lens differentiation 
(Zwaan, 1975). Previous work on chimeras showed that homozygous aphakia (ak/ak) 
cells did not contribute to the lens, indicating that the gene acts cell autonomously in 
the lens (Liegeois et al., 1996). 
 




Figure  1-1 The genomic structure of the Pitx3 wild type, aphakia and the 
Pitx3-GFP targeted locus  
(A) The four boxes represent Pitx3 exons. The filled blue regions indicate coding 
sequence, whilst the blank regions represent non-coding sequence. (B) The two 
deletions previously identified in aphakia are marked by triangles (drawing not to 
scale). (C) In the Pitx3-GFP targeted allele, the entire coding sequence of Pitx3 is 
replaced with eGFP cDNA, marked by filled green box. 
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Figure  1-2 Schematic diagrams of lens development 
The head surface ectoderm facing the approaching optic vesicle, which grows out 
from the developing forebrain, thickens to form the lens placode (A). Invagination of 
the placode with optic vesicle leads to the formation of the lens cup and the optic cup, 
respectively (B). The lens cup deepens and finally breaks away from the surface 
ectoderm to form the lens vesicle (C). Cells in the posterior part of the lens vesicle 
elongate to form primary lens fibre cells (D). Continued elongation of the fibre cells 
leads to occlusion of the cavity of the lens vesicle (E). 
Adapted from (Lovicu and McAvoy, 2005) 
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1.3 Introduction for embryonic stem cells and midbrain dopaminergic neuron 
differentiation 
With the mouse and human genome project well underway, the goal of understanding 
gene function in mammalian development appears a real possibility. It has 
revolutionised our ability to probe the role of a particular gene in development by 
current technological advances, among which the derivation of the embryonic stem 
(ES) cells from inner cell mass of blastocysts has opened up the possibilities for 
introducing designed genes into the mouse germ-line to produce transgenic animals. 
In addition to their use in gene targeting, ES cells can give rise to a variety of somatic 
cell types in culture. The combination of genetic manipulation of ES cells and their 
in vitro differentiation into somatic cell types lends a powerful system to identify key 
cell fate determinants and to model embryonic development. 
1.3.1 Development of mesencephalic dopaminergic neuron 
Dopaminergic (DA) neurons play crucial roles in motor and behaviour processes 
(Morris et al., 2006). They are usually identified by the presence of tyrosine 
hydroxylase (TH), the rate limiting enzyme in dopamine biosynthesis. They were 
originally grouped and numbered as if they were parts of the noradrenergic system 
because identification was based on histofluorescence, which does not distinguish 
dopamine from norepinephrine very well. In the dorsal hypothalamus, the A11 and 
A13 DA neurons send descending axons to autonomic areas of the lower brain stem 
and the spinal cord (Figure 1-3 A), regulating sympathetic preganglionic neurons. 
Along the wall of the third ventricle, the A12 and A14 DA neurons are components 
of the tuberoinfundibular hypothalamic neuroendocrine system. Some of them 
release dopamine as a prolactin releasing factor in the hypophyseal portal circulation. 
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There are also DA neurons in olfactory tubercle (A15), olfactory bulb (A16) and 
retina (A17) (Prakash and Wurst, 2006a).  
The largest group of DA neurons in CNS are the mesencephalic DA neurons in the 
ventral midbrain, located in the retrorubral field (A8), the substantia nigra (SN; A9), 
and ventral tegmental area (VTA; A10)(Figure 1-3 B). The VTA DA neurons project 
to limbic structures such as nucleus accumbens and olfactory tubercle, and are 
involved in emotional behaviour and mechanisms of reward. Dysfunction of this 
mesolimbocortical system has been implicated in drug addition, depression and 
psychotic disorders such as schizophrenia. The SN DA neurons project into the 
dorsolateral striatum, forming the nigrostriatal pathway mediating the control of 
voluntary movement (Simon et al., 2003; Wallen and Perlmann, 2003). Impairment 
of nigrostriatal pathway results in Parkinson’s disease (PD). 
The correct specification and development of mesencephalic dopaminergic (mDA) 
neurons depends upon the proper development of the ventral midbrain which 
involves a number of signalling/transcription factors. mDA neurons are generated at 
the ventral mesencephalon just rostral to the isthmic organiser (IsO), which is a 
signalling centre located at the border between the midbrain and the hindbrain and its 
position determines the location and size of the mDA neuron population (Brodski et 
al., 2003). At the end of gastrulation, embryonic day (E)7.5 in mouse, the future 
position of the IsO is identified by the opposing expression domains of two 
transcriptional repressors: Otx2 in the presumptive fore- and midbrain, and Gbx2 in 
the presumptive hindbrain and spinal cord (Li and Joyner, 2001). At E8, the 
transcription factor Pax2 is expressed across the Otx2/Gbx2 border and expression of 
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the secreted molecule Wnt1 is predominantly limited to the Otx2 domain (Wurst and 
Bally-Cuif, 2001). Following this, the transcription factors En1, En2 and Pax5 are 
expressed across the Otx2/Gbx2 border, and fibroblast growth factor (FGF8) is 
expressed on the Gbx2 positive side (Wurst and Bally-Cuif, 2001). By E9.5 the 
expression of Wnt1 and FGF8 domains have sharpened into rings on the rostral and 
caudal sides of the IsO, respectively (Wurst and Bally-Cuif, 2001). The intersection 
of the floor plate-derived signal Sonic hedgehog (Shh) with the isthmus-derived 
FGF8 creates an inductive centre for mDA neurons just rostral to the IsO. It has been 
shown that Shh is necessary and sufficient for the induction of mDA neurons along 
the dorso-ventral axis, whereas FGF8 is responsible for the position of mDA neurons 
along the anterior-posterior axis of the neural tube (Ye et al., 1998). However, recent 
studies have highlighted that the mDA-inducing effects of Shh and FGF8 are 
complex and that interactions with other factors are required for correct cell-type 
specification in the midbrain. 
The secreted glycoprotein Wnt1 is expressed around the IsO, predominantly on the 
midbrain side, and later refined to a narrow ring on the rostral site of the IsO. A key 
role for Wnt1 in midbrain development has been demonstrated by loss-of-function 
studies which reveal a failure by Wnt1 deficient embryos to develop any midbrain or 
anterior hindbrain structure (McMahon and Bradley, 1990; McMahon et al., 1992). 
In the Wnt1 null mice, few TH expressing cells are still generated, but they fail to 
initiate expression of Pitx3 (Prakash et al., 2006). In addition to Wnt1, Wnt5a is also 
expressed at a high level in the ventral midbrain, with a peak at E11.5 in rat 
(Castelo-Branco et al., 2003). Addition of Wnt5a to rat E14.5 ventral midbrain 
primary cultures has resulted in an increase in the number of TH expressing neurons. 
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Furthermore, there was an increase in the overall expression levels of Pitx3 in 
cultures treated with exogenous Wnt5a. From these studies the authors suggested that 
Wnt5a increases the total number of mDA neurons by promoting the acquisition of 
mDA phenotype, whilst Wnt1 acts as a general midbrain mitogen (Castelo-Branco et 
al., 2003). 
At E8 the mouse homeobox transcription factor Engrailed-1 (En1) and Engrailed-2 
(En2) are expressed across the IsO in the caudal midbrain and rostral hindbrain 
(Simon et al., 2001). In adulthood, En1 and En2 have a more limited expression 
pattern. En1 is highly expressed by essentially all DA neurons in SN and VTA, 
whereas En2 is expressed at lower levels and is restricted to a subset of the En1 
expressing cells. The striking deletion in the mid-hindbrain junction region from 
E9.5 in En1 mutants suggests that En1 is essential for generation and/or survival of 
mid-hindbrain precursor cells. Yet, mDA neurons are present in En1 null mice at P0, 
and En2 expression is up-regulated in these cells (Simon et al., 2001). In En1/En2 
double mutants, TH+ cells are generated in ventral midbrain at E11 but are smaller 
and lack of axonal outgrowth. By E14, when almost all wild type mDA neurons 
express En1, the TH+ DA neurons disappear in engrailed double mutants (Simon et 
al., 2001). Expression of other mDA markers has not been reported for these TH+ 
neurons which are present during E11 to E14, so it is still an open question whether 
Pitx3 is regulated by En1/En2. The continuous expression of En1/En2 of mDA 
neurons into adulthood suggests that they may be involved in maintenance of this 
neuronal population (Alberi et al., 2004; Simon et al., 2001). By using cell-mixing 
experiments and RNA interference on primary midbrain cell cultures, it has been 
reported that En1/En2 is required for the survival/maintenance of mDA neurons in a 
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cell-autonomous manner (Alberi et al., 2004). 
The LIM homeodomain transcription factor Lmx1a was shown to be expressed in the 
ventral midbrain in a spatiotemporal pattern correlating with the onset of mDA 
neurogenesis (Andersson et al., 2006b). The induction of ventral Lmx1a expression 
appears to be Shh dependent. Ectopic or overexpression of Lmx1a in the chick neural 
tube or in ES cells is sufficient to induce mDA neurons in the ventral midbrain or in 
the presence of Shh, respectively. On the other hand, RNA interference experiments 
have shown that Lmx1a is required for generation of mDA neurons. In chick, Lmx1a 
induces Msx1, which in turn suppresses floor-plate characteristics and induces 
proneural transcription factor neurogenin 2 (Ngn2) for pan-neural differentiation. 
The basic helix-loop-helix gene Ngn2 is expressed and required by the mDA 
progenitors for the acquisition of generic neuronal properties (Andersson et al., 
2006a; Kele et al., 2006). Ngn2 null mutation in mice attenuates the generation of 
mDA precursors, eventually resulting in a reduced number of mDA neurons. 
Lmx1b is expressed throughout the mesencephalon and diencephalons from E7.5 in 
mice and expression is restricted in the SN and VTA from E12.5 onwards (Nunes et 
al., 2003; Smidt et al., 2000). Studies on Lmx1b null mice have revealed that a loss of 
Lmx1b results in the failure of proper mDA neuron development. At E12.5 there is a 
reduction in the number of TH expressing cells and an absence of Pitx3 expression in 
the ventral midbrain of Lmx1b null mice. From E16 onwards, TH expression in not 
detected in the mutant ventral midbrain (Smidt et al., 2000). As Lmx1b is expressed 
early (E7.5 in mouse) during CNS patterning events, has a widespread expression 
pattern in the brain, and overexpression studies show that Lmx1b is not a potent 
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inducer of TH+ DA neurons (Andersson et al., 2006b), it is difficult to draw 
conclusions about a direct role for Lmx1b in mDA neurons. Further experiments are 
needed to address the cell-autonomous functions of Lmx1b in mDA neurons. 
However, the knockout study suggests that Nurr1 is not regulated by Lmx1b and that 
Pitx3 might be a target of Lmx1b. Since Lmx1b has been shown to be required for 
induction and/or maintenance of Wnt1 expression in the chick IsO, it has been 
suggested that the action of Lmx1b on Pitx3 may be mediated by the secreted factor 
Wnt1 (Prakash et al., 2006; Prakash and Wurst, 2006b). 
Nurr1 (also known as Nr4a2) is a member of the orphan nuclear receptor family of 
transcription factors and is strongly expressed in the ventral mesencephalic flexure 
from mouse E10.5 onwards (Zetterstrom et al., 1997). Nurr1 deficient mice lack TH 
expression in the ventral midbrain from E11.5 (Zetterstrom et al., 1997). A later 
study has revealed that Nurr1 deficient neuroepithelial cells undergo normal 
ventralisation and differentiate into Pitx3 expressing neurons (Saucedo-Cardenas et 
al., 1998). Further studies have demonstrated the expression of En1, En2, AHD2 and 
AADC in DA cells in Nurr1 mutant midbrains, although the expression of these 
markers is reduced or absent by E15.5 (Smits et al., 2003; Wallen et al., 1999). These 
Nurr1 deficient midbrain neurons do not express DA neuron markers such as TH, 
vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) 
(Smits et al., 2003) and subsequently die by apoptosis, resulting in a severe loss of 
SN and VTA cells by neonate stage. Thus, Nurr1 is required for the transcriptional 
activation of the genes encoding those proteins that confer DA neurotransmitter 
properties and is necessary for the survival of late dopaminergic neurons 
(Saucedo-Cardenas et al., 1998). 
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The first post-mitotic DA neurons are detected at E10.5 in the mouse, characterised 
by expression of Nurr1 followed by TH expression at E11.5. Terminal differentiation 
and maturation of an mDA neuron includes expression of all enzymes and 
transporters required for the proper synthesis, storage, release and reuptake of 
dopamine, as well as the proper innervation of their target field in the forebrain 
(Burbach et al., 2003; Wallen and Perlmann, 2003). 
 Parkinson’s disease 
PD is the second most common neurodegenerative disease and affects 1% of 
population over 50 years of age. The three cardinal clinical features are resting 
tremors, a slowness of movement (bradykinesia) and a difficulty in initiating 
movement (akinesia) (Samii et al., 2004). The pathological findings of PD show that 
mDA neurons in SN are greatly diminished. In some cases the remaining neurons 
contain intracytoplasmic inclusions known as Lewy bodies. Lewy bodies contain 
various proteins, including α-synuclein and ubiquitin that might have been defined 
for degradation but are not broken down. In the striatum there is a loss of dopamine, 
its metabolites and the dopamine transporters. Clinical signs of PD are evident when 
about 80% of striatal dopamine and 50% of nigral neurons are lost (Fearnley and 
Lees, 1991). The observation that massive DA denervation and depletion occurs 
before even the earliest features of PD appear has been explained by compensatory 
mechanisms both presynaptically and postsynaptically in the nigrostriatal DA 
system. 
The specific aetiology of PD is unknown and this has made it difficult to develop 
ideal methods for studying the disease. Age is the most important risk. Other 
aetiology is likely heterogeneous, with genetic factors predominating in some cases, 
- 47 - 
 
and environmental factor in others. For instance, some cases with PD are associated 
with exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is 
highly lipophilic and readily crosses the blood-brain barrier, concentrate selectively 
in mitochondria of mDA neurons and inhibits complex I of the electron transport 
chain. The single gene abnormalities identified thus far, including α-synuclein and 
parkin, cause very few cases. However, the discovery of these genes and their 
products has already expanded our understanding of the potential mechanisms of 
neurodegeneration in both familial and sporadic PD. 
Since loss of mDA neurons with a reduction of striatal dopamine is possibly the 
cause of abnormal motor control, pharmacologic dopamine replacement with L-dopa 
(L-3,4-dioxyphenylalamine), which is the precursor of dopamine, is the mainstay 
treatment of PD (Mercuri and Bernardi, 2005). Therapy with L-dopa is normally 
administered in combination with a peripheral decarboxylase inhibitor beserazide or 
carbidopa to prevent peripheral conversion to dopamine. Other treatment includes 
intake of dopamine agonists which have a direct action on post-mitotic DA receptors 
to improve PD symptoms (Thobois et al., 2005). Ablative surgical treatment includes 
pallidotomy, thalamotomy and, more recently, subthalamotomy. The other surgical 
alternative is deep brain stimulation of the subthalamic nuclei, thalamus, and internal 
globus pallidus (Nutt et al., 2003). These treatments are not ideal and sometimes give 
rise to side effects, such as abnormal movement (dyskinesia) by L-dopa or cognitive 
disturbance by deep brain stimulation. Therefore, new strategies need to be 
developed. 
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Neurotrophic factors, such as glial cell-derived neurotrophicc factor (GDNF), have 
been proved to increase survival of mDA neurons in cellular and animal models of 
PD. However, a multi-centre, double-blind, placebo-controlled trial of 
intraventricular infusion of GDNF failed to confirm clinical benefit at 8 months (Nutt 
et al., 2003). It has been suggested that the reason of the clinical failure is the method 
of trophic factor delivery. Another approach to introduce GDNF is by use of the 
strategy of gene therapy. Kordower et al. have shown neuroprotection by lentiviral 
vector deliver of GDNF in primate models of PD (Kordower, 2003; Kordower et al., 
2000). In addition to GDNF, Bankiewicz et al. have used recombinant 
adeno-associated virus to deliver aromatic L-amino acid decarboxylase (AADC) 
gene, which is an important enzyme that converts L-dopa to dopamine, thus reducing 
L-dopa requirement in animal models of PD and expending the duration during 
which clinical benefit of the medication is observed (Bankiewicz et al., 2000; 
Sanftner et al., 2005). During et al. have used adeno-associated viral vectors to 
deliver glutamic acid decarboxylase (GAD), which synthesises the major inhibitory 
neurotransmitter GABA, into excitatory glutamateric neurons of subthalamic nucleus. 
This changes these cells from excitatory to inhibitory and reduces the excessive 
output from subthalamic nucleus, which is associated with motor dysfunction in 
patients of PD (During et al., 2001; Luo et al., 2002). Another candidate target for 
gene therapy under investigation is to block the signalling pathway of apoptosis, thus 
forestalling neuronal death before irreversible cellular injury (Silva et al., 2005). 
However, long term gene expression and safety of the strategy of gene therapy need 
to be established before further clinical trials.  
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 Cell replacement therapy for PD 
The relative simplicity of the major pathology of PD, the loss of a unifocal and 
phenotypically homogeneous neuron population, have spurred cell-based 
replacement strategy for PD. Intrastriatal transplantation with human foetal 
mesencephalic tissue, rich in DA neurons, was started in 1987 with the idea to restore 
the loss of dopamine release by the impairment of nigrostriatal pathway (Mercuri and 
Bernardi, 2005). The mesencephalic tissue was taken from aborted human foetus, 
aged 6-9 weeks after conception. The clinical benefits after foetal mesencephalic 
transplantation were coupled with an increase in striatal fluorodopa uptake on 
positron emission tomography (PET) (Kordower et al., 1995). Postmortem studies 
have confirmed long-term survival of implanted DA neurons with extensive 
reinnervation of the striatum (Kordower et al., 1995; Kordower et al., 1997). 
However, two groups had performed prospective, randomised, double-blind, sham 
surgery-controlled trial of foetal mesencephalic transplantation and both failed to 
confirm significant clinical benefit despite increased striatal fluorodopa uptake on 
PET and evidence of surviving transplanted neurons at postmortem (Freed et al., 
2001; Olanow et al., 2003). 
From available experimental and clinical data, patient selection is a significant factor 
for determining the functional efficiency of intrastriatal human foetal mesencephalic 
grafts. Although selective degeneration of mDA neurons is believed to be a common 
pathology of most PD patients, clinically diagnosed PD patients show a wide range 
of neuropathology and even extrastriatal changes. In the double-blind, sham 
surgery-controlled study, Freed et al. have shown clinical benefit in patients younger 
than 60 years of age, but not in older ones (Freed et al., 2001). Animal studies have 
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supported that DA-depleted striatum of aged animals is an impoverished 
environment for survival, growth and function of DA grafts (Collier et al., 1999; 
Sortwell et al., 2001).  
Additionally, it has been suggested that immune rejection after discontinuation of 
immunosuppressive treatment limits the benefit of transplantation. Long-term 
immunosuppressive treatment is essential to prevent the development of a delayed 
immunologic response to the allogeneic graft tissue (Lindvall and Bjorklund, 2004). 
On the other hand, the successful experience with correct immunosuppression also 
implicates that therapeutic cloning to avoid graft rejection is not necessary in ES cell 
replacement therapy for PD. 
Furthermore, a critical issue for developing cell replacement therapy is the quantity 
and quality of transplanted tissue. Survival of embryonic DA neurons is only 3-5% 
after grafting with current available procedures (Kordower et al., 1995; Kordower et 
al., 1997), so it is very important to get the right cells with greater survival and better 
potential for integration into the host brain. 
Currently it seems likely that cell replacement therapy will be optimally effective and 
therapeutically valuable only in moderately advanced PD patients exhibiting a good 
and reliable response to L-dopa medication in combination with symptomatology 
and PET image, which suggest intrastriatal dysfunction as the leading cause of 
disability (Lindvall and Bjorklund, 2004). However, a clinically competitive cell 
replacement therapy has to provide advantages over current, rather effective 
treatment in PD patients. So far the improvement after intrastriatal transplant of 
foetal mDA neurons in PD patients has not exceeded those found with subthalamic 
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deep brain stimulation and there is no convincing evidence that drug-resistant 
symptoms are reversed by these grafts (Lindvall and Bjorklund, 2004). Although the 
results appear to provide proof-of-principle for cell replacement strategy in PD, it is 
also obvious that further developments are needed before cell-based approaches 
become clinical treatment. 
 The transcription factor Pitx3 in mDA development 
In developing mice Pitx3 mRNA expression in midbrain is first seen at E11.5 as a 
small layer at the ventral surface of the mesencephalic flexure. This layer 
corresponds to the first TH expressing cells in the mouse brain. Then the expression 
is maintained through adult life. In the unilaterally 6-OHDA treated mouse model, 
Pitx3 expression is no longer detected in the 6-OHDA injection side but is normally 
expressed contralaterally. In situ hybridisation studies on human brains reveals that 
PITX3 is expressed in the SN and there is a reduced density of PITX3 expressing 
neurons in the patients with PD (Semina et al., 1998; Smidt et al., 1997). 
Pitx3 expression is strongly hypomorphic in homozygous aphakia mice from E11 to 
newborn (only 5% of wild type level of Pitx3 transcript at E13.5) (Rieger et al., 
2001). Therefore aphakia mice are usually used to study midbrain development with 
loss of Pitx3 protein (Hwang et al., 2003; Nunes et al., 2003; Smidt et al., 2004; van 
den Munckhof et al., 2003). The adult aphakia mice display loss of TH+ cells in SN 
and VTA. Nissl-stained sections of aphakia mice have shown that loss of TH 
immunoreactivity is due to loss of TH+ cells. In the dorsal striatum where SN DA 
neurons project, there is also reduced TH immunoreactivity. High pressure liquid 
chromatography (HPLC) measurement of striatal DA levels is reduced, compared to 
wild type. Retrograde tracing experiments show that the absence of Fluoro-gold 
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labelling reflects loss of innervations in the striatum due to neuron loss in SN, rather 
than a defect in intracellular transport (Hwang et al., 2003; Nunes et al., 2003; van 
den Munckhof et al., 2003). These data have shown Pitx3 is not only a specific 
marker for mDA neurons, but also functionally required for their survival or 
maintenance. 
Reports on the motor function and behaviour phenotype of Pitx3 hypomorphic 
aphakia mice are inconsistent. In the report of van den Munckhof et al., aphakia 
mice have shown 50~70% reduction in ambulatory and stereotypic activities and 
spend more time resting compared to wild type (van den Munckhof et al., 2003). In 
contrast, Nunes et al. have shown that general locomotor behaviour appears to be 
higher in aphakia as compared to wild type (Nunes et al., 2003). Smidt et al. have 
compared behavioural characteristics of aphakia mice with wild type mice, which 
had been made blind on postnatal day 6-7. They did not find altered posture, walking 
pattern or tremor, but the mice have lower overall activity in an open field test and 
increased activity in a climbing test (Smidt et al., 2004). Hwang et al. have selected 
tests that do not require visual clues and found no deficits in neurological reflex and 
sensorimotor response (Hwang et al., 2003). It has been suggested that the lack of 
gross neurological deficits may be due to compensatory mechanism during 
development. 
 Pitx3-GFP reporter mice for developmental study of mDA neurons 
Prior to the start of this PhD thesis, our laboratory has created mice with an enhanced 
GFP (eGFP) reporter targeted to the Pitx3 locus via homologous recombination in ES 
cells (Zhao et al., 2004). The Pitx3 DNA sequence, including part of intron 1, exon 2, 3, 
and part of exon 4, has been replaced with an eGFPirespac cassette downstream of the 
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endogenous Pitx3 promoter (Figure 1-1 C). This removes the entire Pitx3 coding 
sequence, so there is no expression of Pitx3 from the mutated allele, while eGFP 
expression is under the control of the endogenous Pitx3 regulatory elements. Mice that 
are heterozygous and homozygous for the Pitx3-GFP allele have been generated from 
these ES cells and they are able to survive to adulthood, whilst the homozygous Pitx3 
null mice appear to be small and have reduced fertility. 
The heterozygous Pitx3GFP/+ mice have no apparent phenotypic abnormalities. It has 
been confirmed that in the transgenic embryos and adult mice heterozygous for the 
Pitx3-GFP allele the Pitx3-GFP is an accurate reporter of Pitx3 expression. In embryos 
Pitx3-GFP expression is observed in midbrain, eyes, somites, cranial facial muscles, 
and the tongue, which correlates with reported sites of Pitx3 mRNA expression 
(Semina et al., 2000; Semina et al., 1997; Smidt et al., 1997). Furthermore, in adult 
mice Pitx3-GFP is co-expressed with TH in virtually all mDA neurons of the SN and 
VTA (Maxwell et al., 2005). Therefore, Pitx3-GFP can be used as a lineage marker to 
track the fate of Pitx3 expressing cells in both Pitx3 heterozygous and Pitx3 null mice. 
In fact, the Pitx3-GFP reporter has been used successfully for identification of 
ontogenetically distinct subgroups of mDA neurons in early stage of development 
(Maxwell et al., 2005). Some mDA neurons in the midbrain at E12.5 express TH but 
not Pitx3, whilst another population of cells express Pitx3 but not TH and these two 
populations of cells partially overlap so that some cells express both TH and Pitx3. As 
development progress more midbrain cells express both TH and Pitx3 and by 
adulthood virtually all mDA cells of SN and VTA express both Pitx3-GFP and TH. 
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Mice homozygous for the Pitx3-GFP allele, Pitx3GFP/GFP, are true Pitx3 null mice 
which can be used to analyse the functional role of the transcription factor Pitx3 in 
midbrain and lens development. It has been shown that there is a progressive loss of 
mDA neurons in Pitx3 null mice which is restricted to the SN (Maxwell et al., 2005). 
By E14.5 there is around 60% loss of Pitx3-GFP+TH+ cells in the SN of Pitx3GFP/GFP 
mice. Eventually, by adulthood a complete loss of Pitx3-GFP+TH+ neurons is observed 
in the SN of Pitx3 null mice. The Pitx3GFP/GFP mouse model also provides biological 
evidence that Pitx3 is required for TH expression in mDA neurons. At E14.5 there is a 
loss of TH expression in Pitx3-GFP positive cells in Pitx3 null mice and this loss of TH 
expression is restricted to the SN. The data demonstrate that Pitx3 is not only required 
for the survival mDA neurons but it is also involved in the regulation of TH expression 
in a subset of mDA neurons (Maxwell et al., 2005). 
The Pitx3 null mice, as well as the Pitx3 hypomorphic aphakia mice, seem to be a 
favourable animal model of PD due to a selective and significant loss of SN mDA 
neurons. However, the rate of mDA neuron loss and the presumed behavioural 
phenotype of the Pitx3 null mice do not correlate well with PD. The lack of a severe 
behaviour phenotype in Pitx3 null mice can be due to a compensatory mechanism as 
a result of the early developmental loss of the SN mDA neurons. Therefore, a 
transgenic mouse, in which Pitx3 is conditionally knocked out at a later stage in life, 
may provide further information about the functional role of the transcription factor 
Pitx3 in the maintenance of mDA neurons and thus may represent a better model of 
PD. 
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1.3.2 Embryonic stem cells 
 Key features of ES cells 
Directly isolated from the inner cell mass of the blastocyst embryo, ES cells are 
unique stem cells as they retain the developmental potency of foetal founder cells 
even after extended propagation and manipulation in culture. When transferred to a 
pre-implantation mouse embryo, ES cells incorporate into the inner cell mass and 
generate mice that are chimeric both in somatic and germ tissues (Bradley et al., 
1984).  
ES cells were initially isolated and maintained by coculture on feeder layers of 
mitotically inactivated mouse fibroblasts (Evans and Kaufman, 1981; Martin, 1981). 
It was later identified that the fibroblast feeders express the stem cell regulator 
leukaemia inhibitory factor (LIF) which actively suppresses differentiation (Gearing 
et al., 1987; Smith et al., 1988). LIF is able to completely replace feeder layers, not 
only in the maintenance of previously established ES cell lines, but also in the de 
novo establishment of karyotypically normal and germ-line competent ES cell lines 
(Smith et al., 1988). This property has enabled the culture of a homogeneous 
population of pluripotent ES cells in the absence of contaminating fibroblasts. 
Recently, it has been discovered that bone morphogenetic proteins (BMPs) act in 
combination with LIF to sustain self-renewal and preserve multilineage 
differentiation of ES cells in serum-free condition (Ying et al., 2003b). This fully 
defined culture paradigm also supports the generation of germ-line competent ES cell 
lines. In the absence of LIF, however, BMP stimulates differentiation, suggesting that 
a very delicate balance of different signalling pathways regulate ES cell self-renewal 
versus differentiation.  
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The ES cell genome can be manipulated at will, either via introduction of new 
genetic information or the alteration of the host gene sequences. The capability of 
germ-line colonisation means that ES cells can be exploited as vehicles for 
transgenic manipulation of the mouse genome. Indeed the major use of ES cells in 
the last decade has been as a cellular tool for the production of mice carrying a 
predetermined genetic modification generated by homologous recombination or gene 
targeting. The planned alteration of a gene is first generated in the genome of ES 
cells in tissue culture. Genetically modified ES cells can then be injected into 
recipient blastocysts, where they contribute differentiated progeny to their host, 
resulting in the birth of genetically modified chimeric pups. Following germ-line 
transmission, mice that carry a defined mutation of a gene are generated. Genetic 
modifications can now be designed in a sophisticated manner such that the mutation 
can be temporally and spatially regulated (conditional knockout), by exploiting the 
Cre-loxP system and cell/tissue specific regulatory elements. Over the past decade, 
gene targeting by homologous recombination has revolutionised the field of mouse 
genetics and allowed the analysis of diverse aspects of gene function in vivo.  
However, as it will be discussed below, the application of ES cells is not limited to 
the generation of designer mouse mutations. With the combination of genetic 
manipulation in ES cells and in vitro differentiation into somatic cell types, ES cells 
can provide a powerful system to identify key cell fate determinants. ES cells can 
also serve as a research tool to model diseases and hence to screen for therapeutic 
drugs as well as to be used directly as future regenerative medicine in cell 
replacement therapies. 
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 Prospects for ES cells in modelling disease and drug development 
Screening therapeutic compounds with a cellular platform can significantly reduce 
cost and the usage of animals. There are several DA cell lines available for academic 
research and commercial drug development. However, these cells are of tumour 
origin (either derived directly from neuroblastomas or fusion of primary midbrain 
cells with a tumour cell line) and thus may not respond to drugs in a physiologically 
relevant manner. The ability of ES cells to produce biologically compatible DA 
neurons of midbrain phenotype suggests that they could serve as a good cellular 
system to screen for chemical compounds that support the function or survival of DA 
neurons. ES cell derivative could also be used for toxicity testing of substances 
potentially harmful to DA neurons. The feasibility of this approach has been 
demonstrated by several studies (Aubert et al., 2002; Aubert et al., 2003; Buesen et 
al., 2004; Ding et al., 2003; Seiler et al., 2004). 
Furthermore, genetic manipulation in ES cells provides opportunities to model 
aspects of human disease in an easily accessible cell culture system (Wilmut, 2004). 
For example, gene mutations implicated in PD can be engineered in ES cells, either 
via homologous recombination (gene targeting) or transgene expression. These 
‘disease’ ES cells can then be directed to neural stem cells and/or DA neurons in the 
laboratory and be used to identify compounds that target particular cellular activities 
or signalling pathways that are relevant to PD (Ho and Li, 2006). 
 ES cells as cell replacement therapy 
The relative simplicity of the major pathology of PD, the loss of a unifocal and 
phenotypically homogeneous neuron population, spurred research into a cell-based 
replacement strategy for PD. Despite challenges and controversies (Bjorklund et al., 
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2003; Dunnett et al., 2001; Freed et al., 2000; Freed et al., 2001; Olanow et al., 2003), 
foetal transplantation has alleviated symptoms in some PD patients for many years 
and the idea of further developing cell therapy to replace or rescue degenerated DA 
neurons has remained promising (Bjorklund et al., 2003; Lindvall and Bjorklund, 
2004). It is also evident in animal studies that neuroprotective or trophic molecules 
which are delivered either via cell grafting or viral vectors can prolong the life of the 
damaged DA neurons. A key issue is the development of a reliable cell source with 
well characterised properties. 
The ability to produce unlimited amounts of well-defined somatic cell types makes 
ES cells an obvious candidate for cell therapy. Furthermore, by exploiting genetic 
manipulation, ES cells can be used as a vehicle to deliver therapeutic genes while at 
the same time serving as donor cells for transplantation. To realise the potential of 
ES cells as regenerative medicine for PD, it is essential to establish the type and 
developmental/maturation stage of cells that are required for functional repair in 
Parkinsonian brains. Although ES cells might have greater developmental plasticity 
to respond to host environmental inductive cues that guide DA differentiation, the 
adult striatum is probably unlikely to retain all instructive signals for DA 
development from ES cells. Therefore, pre-differentiation of ES cells into neural 
cells of a certain maturation stage might be the answer (Kuhn and Svendsen, 1999). 
However, since it is not known which ventral midbrain cell population is specifically 
required for functional reconstitution in Parkinson’s disease brain, it remains an open 
question how far ES cells will have to be pushed along the neural differentiation 
pathway in vitro before transplantation. Systematic transplantation studies using 
purified, molecularly defined cell populations from the developing midbrain should 
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address this important question. Work in this direction is likely to benefit from 
developmental studies on normal development of the midbrain DA lineage and the 
molecular make up of cells at each step of DA lineage differentiation. 
Understanding the molecular identity of the desired ‘donor’ cells is essential as one 
could design a strategy for selecting these cells from heterogeneous populations of 
differentiated ES cell progeny, and to guide the development of novel approaches for 
producing the right kind of therapeutic cells. It should be noted however, that 
phenotypically and functionally satisfying therapeutic cell types may not necessarily 
need to be derived through normal developmental pathways (Collins et al., 2005). 
1.3.3 In vitro differentiation of ES cells to mDA neurons 
As an integral part of pluripotency, ES cell differentiation in vitro is heterogeneous in 
nature. Currently, our abilities to direct ES cells into specific pathways and then to 
support the viability and maturation of individual differentiated phenotypes in vitro 
remains limited. Consequently, the differentiated ES cell cultures constitute 
heterogeneous types of differentiated ES cell progeny with unknown phenotypes. In 
the absence of knowledge to instruct ES cells into a specific fate, strategies have 
been developed to enrich or isolate cell phenotypes of interest from the mixed cell 
population. This can be achieved through selective culture conditioning or 
fluorescence-activated cell sorting (FACS). In addition, drug resistance or cell sorting 
capacity conferred by genetic manipulation in ES cells provides another way of 
isolating a particular cell lineage or cell types (Li et al., 1998a). Using this approach, 
researchers can successfully label and isolate neural progenitors, neurons and 
oligodendrocytes from differentiating ES cell cultures. While neural progenitors and 
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neurons in general can be derived from ES cells with relatively high frequency, the 
production of a particular neuronal subtype is less efficient. 
 DA fate induction by Shh and FGF8 
Inspired by previous studies on DA fate induction of naive neuroepithelium by Shh 
and FGF8 (Ye et al., 1998), Lee et al. have developed a method to produce DA 
neurons from ES cells using these two factors (Kim et al., 2002; Lee et al., 2000). 
The protocol starts with a short period of embryoid body (EB) differentiation 
followed by medium-based enrichment for Nestin positive neural precursor cells 
(Okabe et al., 1996). The neural precursors are then expanded using FGF2 followed 
by induction to a DA fate by addition of Shh, FGF8 and ascorbic acid. The authors 
have reported a production of over 30% TH expressing cells within the neuronal 
population. These ES cell-derived DA neurons exhibit some electrophysiological 
properties and release dopamine upon polarisation (Lee et al., 2000). Using a similar 
approach, Rolletschek et al. have applied an array of survival-promoting factors in 
the production of DA neurons from ES cells (Rolletschek et al., 2001). They have 
found that a cocktail containing interleukin (IL)-1β, glial cell line-derived 
neurotrophic factor (GDNF), neurturin (NTN), transforming growth factor (TGF)-β3, 
and dibutyryl (db)-cAMP enhance RNA expression levels of En1, Mash1, dopamine 
receptor 2 (D2R), TH and Nurr1 and increase the proportion of TH positive and DAT 
positive neurons from ~20 to 40%. 
 Stromal coculture system 
Kawasaki et al. have identified a stromal cell-derived inducing activity (SDIA) that 
efficiently induces neural differentiation from ES cells, with a high proportion of TH 
positive neurons (Kawasaki et al., 2000). This method does not require EB formation 
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or retinoic acid treatment. They have screened for differentiation of ES cells after 
coculture with various cell lines and discovered PA6 cells (stromal cells derived from 
skull bone marrow) to be the best inducer of neuronal differentiation. The nature of 
SDIA is unclear as PA6 neural inducing activity remains when the cells are fixed thus 
unable to secrete soluble factors, or when the PA6 cells are separated from the ES 
cells by a filter. The authors suggest that SDIA may be a secreted factor that is 
secondarily tethered to the cell surface, as treatment with heparin removes the neural 
inducing activity. 
In the authors’ report, 92% of ES cell colonies became NCAM+ neurons. 92% of 
colonies contained TH+ neurons. At the cellular level, TH+ neurons occupied 30% of 
β-tubulin III+ neurons, which was 16% of total cell population. In their RT-PCR 
results, mDA markers Nurr1 and Pitx3 were induced in SDIA-treated ES cells. In 
culture, these ES cell-derived DA neurons can release dopamine in response to a 
depolarising stimulus. While they have demonstrated good survival following 
transplantation to 6-OHDA-lesioned rat Parkinsonian brains, their ability to generate 
functional repair has not been reported. 
 Monolayer neural differentiation method 
Ying et al. have reported that neither multi-cellular aggregation via EB formation nor 
coculture is necessary for ES cells to commit efficiently to a neural fate (Ying et al., 
2003b). For monolayer culture, undifferentiated ES cells are dissociated and plated 
onto gelatinised tissue culture plates in N2B27 medium. TH+ neurons can be induced 
with addition of FGF2, Shh and FGF8. However, the regional identity of these TH 
positive neurons needs to be further investigated (Parmar and Li, in preparation). 
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 DA neuron differentiation of primate and human ES cells 
Using stromal cell coculture system and/or via induction with Shh and FGF8, several 
groups have reported the production of DA neurons from primate and human ES 
(hES) cells (Kawasaki et al., 2002; Park et al., 2005; Perrier et al., 2004; 
Sanchez-Pernaute et al., 2005; Takagi et al., 2005; Yan et al., 2005; Zeng et al., 2004). 
Furthermore, neurotrophins such as GDNF and foetal midbrain astrocytes can also 
promote DA neuron production from hES cells (Buytaert-Hoefen et al., 2004; Park et 
al., 2004). Owing to differences in developmental timing between mice and humans, 
necessary adjustments and improvement of the differentiation protocols, for example 
the time window for Shh treatment, have been made to suit hES cells. 
Mouse ES cells, when grafted in small numbers, give rise to DA neurons very 
efficiently in adult rodent brains (Bjorklund et al., 2002; Deacon et al., 1998). 
Furthermore, transplantation of pre-differentiated mouse ES cells that contain DA 
neurons provide motor benefits in rodent models of PD (Tabar et al., 2005). It has 
been shown that hES cell-derived neural precursors can differentiate into neurons, 
astrocytes and oligodendrocytes following transplantation into normal or lesioned 
young adult rat brains (Park et al., 2005; Sanchez-Pernaute et al., 2005; Takagi et al., 
2005; Zeng et al., 2004). These hES cell progeny also exhibit region-specific 
differentiation and migration behaviour. However, studies focused on DA neuron 
differentiation and cell replacement therapy in animal models of PD have generally 
observed limited behavioural responses with poor cell survival, as compared with 
those obtained with mesencephalic grafts. These transplantation studies have been 
carried out using a mixed population of ES cell differentiated progeny which are 
likely to contain neural cells at different maturation stages, and have non-neural 
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lineage. The non-neural cells may have adverse effects on the differentiation, 
survival and migration of DA neurons in the recipient brain. It is also possible that 
the donor population does not provide the right category of cell types or insufficient 
numbers. In this respect it is important to identify what the desired cellular 
phenotype is for grafting in Parkinsonian brain. 
1.4 Aims 
Prior to the start of this PhD research, Pitx3-GFP reporter mice had been created and 
proved powerful for analysis of the essential roles of the transcription factor Pitx3 in 
mDA development. The homozygous Pitx3 mutant mouse is a true Pitx3 null, and 
also shows a phenotype characterised by small eyes and no lens. The hypothesis was 
formed that Pitx3 is essential for lens development. Therefore, the aim of this project 
was to investigate the functional role of Pitx3 during lens development using the 
Pitx3-GFP reporter mice. Firstly, the lens morphogenesis of heterozygous and 
homozygous Pitx3-GFP reporter mice will be examined. The heterozygous and 
homozygous Pitx3-GFP reporter ES cells which I have created will be used to 
generate chimeric animals for a fine scale analysis of the cellular change of Pitx3 
null cells during lens development. The Pitx3 null lens will also be characterised by 
comparing key molecules or markers associated with the developing lens. These 
studies lay the foundation for the elucidation of the molecular mechanisms and 
genetic pathways regulated by Pitx3 during lens development. 
Based on the restricted expression pattern of Pitx3 in mDA neurons combined with 
the finding that Pitx3-GFP reporter has proved to be a useful marker to track mDA 
development in vivo, Pitx3-GFP reporter ES cells may be a useful system to 
investigate mDA development in vitro. Therefore, the aim of the other part of the 
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project is to develop an ES cell system for functional identification of molecules 
governing mDA development using the Pitx3-GFP reporter. Firstly, the in vitro 
differentiated Pitx3-GFP expressing cells will be further characterised. Then the 
Pitx3-GFP reporter ES cells will be modified to be easy for transgene introduction, or 
to be able to express transgene in a temporally controlled manner. Homozygous Pitx3 
null ES cells will also be used in differentiation experiments to study mDA 
development with loss of Pitx3 and to test candidate Pitx3 downstream targets. The 
final goal is to identify candidate mDA regulators. Although the production of mDA 
neurons from ES cells draws attentions in the cell replacement therapy for PD 
patients, what is more important is to define how and when mDA development is 
regulated and how it extends and progress in the Parkinsonian brain. ES cell-based 
research may eventually provide necessary information for this insight or for the 
development of a more effective therapy. 




Figure  1-3 Dopaminergic neuron in the brain 
(A) Hypothalmic DA neurons in the A11 and A13 cell groups provide descending 
pathways to the lower brain stem and the spinal cord. Neurons in the A12 and A14 
groups are involved with endocrine control. There are also DA neurons in olfactory 
tubercle (A15), olfactory bulb (A16) and retina (A17). (B) Mesencephalic DA 
neurons in the ventral midbrain are located in the retrorubral field (A8), the 
substantia nigra (SN, A9) and ventral tegmental area (VTA). The VTA DA neurons 
project to limbic structure such as nucleus accumbens. The SN DA neurons project 
into dorsal striatum forming the nigrostriatal pathway. 
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Materials and methods 
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2.1 Materials 
Unless otherwise stated, analytical grade chemicals were obtained from either Sigma 
or BDH Laboratory Supplies. Stock solutions were prepared with reverse osmosis 
purified (ROP) water and filtered or autoclaved as necessary. Agarose for 
electrophoresis was supplied by Invitrogen. Synthetic oligonucleotides were 
synthesised by Eurogentic SA. 
2.1.1 Solutions 
Phosphate buffered saline (PBS): 
2.7mM KCl, 137mM NaCl, 4.3mM Na2HPO4.7H2O, 1.4mM KH2PO4 (pH 7.4) 
PBST: 
0.2% (v/v) Triton X-100 (BDH) and 1% (w/v) bovine serum albumin (BSA, Sigma) 
in PBS 
1X TAE 
0.04M Tris-acetate, 0.001M EDTA 
20X SSC (Standard sodium citrate) 
3M NaCl, 0.3M Na3Citrate 
Lysis buffer: 
10mM Tris (pH 8.0), 50mM EDTA, 100mM NaCl, 0.5% SDS, 0.5mg/ml proteinase 
K (Roche) added just before use. 
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Luria-Bertani (LB) broth: 
1% (w/v) tryptone (Difco), 0.5% (w/v) yeast extract, 85mM NaCl 
LB agar: 
1.5% (w/v) agar (Difco) in LB broth 
MOPS (10X): 
0.2M MOPS (pH 7.0), 20mM sodium acetate, 10mM EDTA (pH 8.0) 
TFB1: 
30mM potassium acetate, 10mM CaCl2, 50mM RbCl, 15% glycerol, pH adjusted to 
5.8 with 1M acetic acid and filter sterilised. 
TFB2: 
10mM MOPS, 75mM CaCl2, 10mM RbCl, 15% glycerol, pH adjusted to 6.5 with 
1M KOH and filter sterilised. 
PB1 (phosphate-buffered medium 1) 
The following were added in ultra high pressure (UHP) water to make a final volume 
520 ml PB1 solution: NaCl 4.11g, KCl 0.105g, Na3PO4 1.5g, KH2PO4 0.1g, glucose 
0.52g, sodium pyruvate 0.023g, penicillin 0.03g, CaCl2 0.6g, MgCl2 0.5g, 0.5% 
phenol red 1ml. pH adjusted to 7.0 and sterilised with 0.22 micron bottle-top filter. 
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The following solutions are for in situ hybridisation. 
Prehybridisation mix 
50% (v/v) formamide, 5X SSC, 2% Boehringer blocking powder, 0.1% Triton 
X-1000, 0.5% (w/v) CHAPS, 100ng/ml yeast RNA, 5mM EDTA, 50ng/ml heparin 
Solution 1: 
50% formamide, 5X SSC, 0.1% Triton X-1000, 0.5% CHAPS 
TBT: 
50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.1% Triton X-1000 
NTM: 
100 mM NaCl, 100 mM Tris-HCl (pH 9.5), 50 mM MgCl2 
2.2 Molecular biology methods 
2.2.1 Cloning 
Cloning of DNA fragments was achieved via restriction enzyme digestion, gel 
purification and ligation. Restriction enzyme digestions were preformed according to 
manufacturers’ instructions (all enzymes were from Roche or NEB). Digested DNA 
was separated by running on agarose gels (0.6~1.5% depending on size of the 
fragment) in TAE buffer. The desired fragment was cut from the gel and the DNA 
extracted using Qiagen gel extraction kit (Qiagen) according to manufacturer’s 
instructions. The concentration of the recovered DNA was estimated by agarose 
electrophoresis. Ligations were performed with a 3:1 insert:vector molarity ratio with 
1U of T4 DNA ligase (Roche) in 1X T4 ligation buffer (Roche) and incubated at 
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16ºC overnight. 
2.2.2 Preparation of chemical competent cells using the rubidium chloride method 
A DH5α colony was picked and added to 2.5 ml LB medium and incubated in a 
shaker at 37ºC overnight. The 2.5 ml culture was added to 250 ml of LB medium 
with 20 mM MgSO4 and incubated in a 1L flask in a shaker at 37ºC for 5-6 hours, 
until the O.D.600 reached 0.4 to 0.6. The 250 ml culture was centrifuged at 4500g for 
5 minutes at 4ºC. From this stage the protocol was carried out in a room at 4ºC with 
all equipment chilled. The cell pellet was gently resuspended in 0.4 volumes (100 ml) 
of ice-cold solution TFB1 and incubated on ice for 5 minutes. The cells were 
centrifuged at 4500g for 5 minutes at 4ºC. The cell pellet was gently resuspended in 
1/25 original culture volume (10ml) of ice-cold solution TFB2. The cells were 
incubated on ice for 15-60 minutes before aliquotting 200µl per tube and 
quick-freezing on dry ice. Tubes were then stored at -80ºC. 
2.2.3 Transformation of competent cells 
A 200µl aliquot of competent cells was thawed on ice. Approximately 10ng of 
plasmid DNA or ligation reaction was added in 1-3µl of dH2O, gently stirred and 
incubated on ice for 30 minutes. The tube was heated at 42ºC for 1 minute and then 
cooled on ice for 2 minutes. 1ml of LB was added to the tube and incubated in a 
shaker at 37ºC for 1 hour. 50 to 300ul of the culture were plated on LB agar plates 
with appropriate selection and incubated at 37ºC overnight. 
2.2.4 Plasmid isolation from bacteria 
To isolate plasmid from bacteria, the following mini-preparation protocol was used. 
Single colonies were used to inoculate a tube containing 3ml LB medium with 
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appropriate selection and incubated in a shaker at 37ºC overnight. 1.5ml of the 
culture was centrifuged at 13000rpm for 3 minutes and the supernatant was discarded. 
150µl of solution I was added to the tube and it was vortexed to mix well. To lyse the 
cells, 150µl of freshly prepared solution II was added and the tube was inverted 4-5 
times to mix. To neutralise the lysate, 250µl of cold solution III was added and the 
tube was inverted 4-5 times to mix. The sample was then centrifuged at 13000rpm 
for 15 minutes and the supernatant transferred to a clean tube. To precipitate the 
DNA, 1ml of cold ethanol was added and the tube was inverted 4-5 times to mix 
before incubating at -20ºC for 30 minutes. The sample was then centrifuged at 
13000rpm for 30 minutes to pellet the DNA, which was then dissolved in 50µl dH2O 
to give a final concentration of about 2.5 µg/ml. 
2.2.5 The construct of pCAGEn1IP 
The expression vector pCAGEn1IP (Figure 4-10 A, Appendix III) was used to 
generate En1 overexpression Pitx3GFP/+ ES cell lines. A plasmid containing En1 
cDNA was kindly provided by Alexandra Joyner (Joyner et al., 1985). A 1.8-kb 
fragment, including a 1.2-kb length of En1 cDNA, was cut using the restriction 
enzyme EcoR1 and recovered. The plasmid pCAGASIP (Appendix I) was linearised 
using the restriction enzyme EcoR1 as a vector and then phosphorylated with calf 
intestinal alkaline phosphatase (New England Biolab) to avoid self-ligation. Plasmids 
were isolated from the transformants and cut by the restriction enzyme EcoR1 to 
confirm successful insertion, and then checked with the restriction enzyme Cla1 and 
Sac1 for correct insertion orientation. The correct ligation product should release 2.4- 
and 5.9-kb fragments by Cla1, and 1.6- and 6.6-kb fragments by Sac1. 
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2.2.6 The construct pCAGfloxNeoKlf4 
To make an inducible Klf4 expression construct, the Klf4 cDNA fragment has to be 
modified with feasible restriction enzyme cutting ends then cloned into our 
pCAGfloxNeoPA inducible vector (Figure 2-1). Briefly, a 1.7-kb Kpn1-EcoR1 Klf4 
cDNA fragment was cloned from PMT3-Klf4 (Shields et al., 1996) into the 
pSP72poly4 vector (Appendix VI) in order to create pSP72poly4-Klf4. Then the 
pSP72poly4-Klf4 plasmid was cut with the restriction enzymes Xho1 and Sal1 to 
release the Klf4 fragment which was ligated into the pCAGfloxNeoPA vector that 
had been cut with Xho1 to create the pCAGfloxNeoKlf4 plasmid (Appendix V). 
2.3 Histological analysis 
2.3.1 Animal maintenance 
Mice were housed and bred in the Biomedical Unit within the Institute for Stem Cell 
Research, according to the Animals (Scientific Procedures) Act (UK) 1986. Mice 
were kept in a 12 hours dark, 12 hours light cycle with the midpoint of the dark cycle 
at 1am. For collection of embryos, matings were set up and female mice were 
checked daily before 10am for the presence of a vaginal plug. If present then 1pm on 
that day was designated as embryonic day (E) 0.5. Mice aged 6 weeks or older were 
used for mating. Litters were left with their mother until 3 weeks of age when they 
weaned by separating the offspring from the parent. At weaning the mice were sexed 
and tail tips were taken for genotyping. Maintenance of the mice, breeding set-up and 
tail biopsies were performed by the Biomedical Unit staff at the Institute for Stem 
Cell Research. 
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2.3.2 Cryostat sectioning 
Embryos were dissected in PBS, then fixed in 4% paraformaldehyde (PFA) in PBS 
(pH 7.4) at 4ºC overnight (for E12.5 and older) or 4 hours (E10.5 to E11.5). The 
embryos were then cryoprotected by placing them in a solution of 30% sucrose in 
PBS, which was left at 4ºC until the embryos sink. Embryos were then embedded in 
OCT (BDH) in foil parcels over dry ice and stored at -80ºC until use. Cryostat 
sectioning was performed at -16 to -20ºC using a Leica CM 1900 Cryostat and 
sections were cut at 10µm. Sections were collected on polysine slides (BDH) and 
allowed to dry at room temperature for 30 minutes and then were either used 
immediately or stored at -80ºC until use. 
2.3.3 Immunochemistry 
 For sections 
Frozen sections were allowed to equilibrate to room temperature. Sections were 
blocked with 3% normal serum in PBST for 1 hour at room temperature. Then the 
sections were incubated with primary antibodies in blocking solution at 4ºC 
overnight in a humidified box. Sections were washed three times for 20 minutes each 
in PBST, then incubated with fluorescence-conjugated secondary antibodies at room 
temperature for 1 hour or overnight at 4ºC, respectively. After washing three times 
with PBS, sections were mounted in Immunofluore (ICN Biomedicals) and analysed 
using a Zeiss Axiophot microscope or Leica confocal microscope. 
 For cells 
For immunohistochemistry, cells were washed twice with PBS and fixed in 4% PFA 
in PBS for 20 minutes at room temperature. They were then rinsed in PBST twice for 
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5 minutes to permeabilise the cell membrane, and then incubated in PBST with 3% 
normal serum (blocking solution) to prevent non-specific binding of the antibody. 
Then they were incubated in primary antibody at the appropriate dilution in blocking 
solution overnight at 4ºC. After the incubation, cells were washed 3 times with PBST 
for 20 minutes and then incubated for 3 hours with the secondary antibody in 
blocking solution in the dark. Then the secondary antibody was removed and the 
cells washed 3 times with PBS. The cells can be counterstained with DAPI or Topro 
for 30 minutes before observing under a microscope. 
 Antibody lists 
Lens part 
Antigen Species Supplier Concentration
β-crystallin rabbit Gift from Helen Makarenkova 1:100 
γ-crystallin rabbit Gift from Helen Makarenkova 1:100 
p27KIP1 rabbit Santa Cruz 1:100 
p57KIP2 rabbit Abcam 1:100 
ECCD2 rat Developmental Studies Hybridoma Bank 1:100 
APA5 rat Developmental Studies Hybridoma Bank 1:100 
pSmad rabbit Cell Signalling 1:100 
β-catenin rabbit Santa Cruz 1:200 
Pitx3 rabbit Gift from M. Smidt 1:200 
Pax6 rabbit Santa Cruz 1:300 
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ES cell part 
Antigen Species Supplier Concentration
GFP chicken Chemicon 1:3000 
TH rabbit Pel-Freeze 1:1000 
β-tubulin III mouse Babco 1:500 
Engrailed-1 rabbit Developmental Studies Hybridoma Bank 1:100 
Nurr1 mouse Santa Cruz 1:200 
 
Secondary antibody 
Conjugant Antigen Species Supplier Conc. 
Alexa Fluoro 488 chicken IgG goat Molecular Probes 1:1000
Alexa Fluoro 568 mouse/rat/rabbit IgG goat Molecular Probes 1:1000




DAPI Molecular Probes 1:1000 
Topro Molecular Probes 1:1000 
2.3.4 Image acquisition and manipulation 
Coverslips were examined using a Leica TCS SP2 AOBS confocal microscope 
equipped with krypton, krypton/argon and helium lasers. 
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2.3.5 Quantitative analysis of immunolabelled cells 
To determine the number of antibody-labelled cells in differentiated ES cell cultures, 
all positively stained cells in a well of a 4-well plate were counted manually. 
Antibody staining was performed in triplicates, and the data obtained from at least 3 
independent experiments were averaged. Numbers shown represented the average 
percentage and standard error of the mean (SEM). Statistical analysis for the 
counting data was performed using two sample student t-test by Microsoft Excel 
2002. 
2.4 Cell culture 
Generally cells were grown in tissue culture plastics (Iwaki) and incubated at 37ºC 
with 7% CO2 in a humidified incubator (Sanyo). All medium and solutions were 
tested for contamination 3 days before use. When passaging and thawing cells, all 
medium and solutions were prewarmed to 37ºC. To avoid bacterial and fungal 
contamination, all tissue culture manipulations were undertaken inside a laminar 
flow sterile hood (Microflow) and surfaces and objects were sprayed with 70% 
industrial methylated spirits (IMS) before use. 
2.4.1 Culture medium 
 Standard culture medium 
1X Glasgow minimum essential medium (GMEM, Sigma), 10% (v/v) foetal calf 
serum (FCS, Gibco), 1mM sodium pyruvate (Gibco), 1X MEM non-essential amino 
acid (Gibco), 2mM l-glutamine (Gibco), 0.1mM 2-mercaptoethanol (BDH). 
 ES cell culture medium 
Standard culture medium supplemented with 100 unit/ml leukaemia inhibitory factor 
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(LIF). LIF was prepared in house by transfecting COS-7 cells with a human LIF 
expression plasmid and harvesting the medium. The concentration of LIF was 
assayed using CP1 indicator cells (LIF preparation was performed by Louise Taylor). 
All medium were tested with established ES cell lines before use. 
 ES derivation medium 
ES culture medium with 20% FCS and 1% penicillin/streptomycin as antibiotics. 
 N2B27 medium 
1:1 mixture of DMEM/F12 (Gibco) supplemented with modified N2 (25µg/ml 
insulin, 100µg/ml apotransferrin, 6ng/ml progesterone, 16µg/ml putrescine, 30nM 
sodium selenite, 50µg/ml BSA) and Neurobasal medium (Gibco) supplemented with 
B27 (Gibco). 
 Differentiation medium 
1X GMEM, 10% (v/v) Knock Out Serum Replacement (KSR, Gibco), 1mM sodium 
pyruvate, 1X MEM non-essential amino acid, 2mM l-glutamine, 0.1mM 
2-mercaptoethanol. 
 Induction medium 
GMEM medium supplemented with modified N2, 100µM tetrahydrobiopterin 
(Sigma), 200µM ascorbate (Sigma), 1mM sodium pyruvate, 1X MEM non-essential 
amino acid, 2mM l-glutamine, 0.1mM 2-mercaptoethanol. 
2.4.2 Routine ES cell culture 
ES cells were cultured on 0.1% gelatine (Sigma) coated tissue culture flasks or plates 
in ES cell medium. 
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 Expansion 
To passage the cells the medium was removed using an aspirator then cells were 
washed twice with PBS. 1X 0.025% trypsin (Invitrogen) was added to just cover the 
cell monolayer and the flask was incubated at 37ºC for about 3 minutes. The trypsin 
activity was neutralised by addition of serum-containing medium; 4mls medium was 
added for every 1ml of 1X trypsin. The cell suspension was transferred to a universal 
tube (Nunc) and centrifuged for 5 minutes at 1200rpm. Cells were then resuspended 
in medium to achieve a single cell suspension, counted using a haemocytometer and 
replated at a density of 106 cells per 25cm2 flask. Routinely, cells were passaged 
every 2-3 days. 
 Freezing 
Cells in tissue culture flasks were trypsinised as before and centrifuged for 5 minutes 
at 1200rpm. Cells were resuspended in 1ml of freezing mix (10% dimethyl 
sulphoxide (DMSO, BDH) in normal culture medium) per 25cm2 flask and 
transferred into a cryotube (Nunc) at 0.5 ml per vial. Cryotubes were placed at -80ºC 
overnight and then transferred to a liquid nitrogen cell bank (Series 2300, Custom 
Biogenic Systems). 
 Thawing 
Frozen cryotubes were retrieved from liquid nitrogen storage and placed immediately 
into 37ºC waterbath. Once the cells were thawed they were transferred into 9.5ml 
warm medium to dilute out the DMSO. The cell suspension was then centrifuged for 
5 minutes at 1200rpm and subsequently the cells were gently resuspended in 10ml of 
medium and transferred to a gelatinised 25cm2 flask. The medium was then refreshed 
about 10 hours later to remove any dead cells and dilute out the remaining DMSO. 
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2.4.3 Feeder cell culture 
Feeder cells were cultured in standard culture medium on gelatine-free flasks. 
Passaging, freezing and thawing were as described for ES cells. Before coculture 
experiments, feeder cells were γ-irradiated to be mitotically inactive then replated 
into 4-well plates. 
Two lines of feeder cells were used in this thesis: mouse embryonic fibroblasts (MEF) 
for derivation of ES cells from mouse blastocysts, and PA6 stromal cells for in vitro 
differentiation from ES cells to mDA neurons. 
2.4.4 In vitro differentiation 
 PA6 coculture system 
PA6 stromal cells were irradiated to be mitotically inactive and replated into 4-well 
plates one day before use. There are 2 steps for in vitro differentiation from ES cells 
to mDA neurons by PA6 coculture (Kawasaki et al., 2000). ES cell colonies were 
cultured in differentiation medium at 100 colonies per well in 4-well plates. Medium 
change was performed on day 4 and every other day following that. The medium was 
replaced with induction medium on day 8 and then the cells were cultured in 
induction medium for an additional 8 days. 
 Monolayer differentiation 
The method used was based on that of Ying et al. (Ying et al., 2003b). Monolayer 
differentiation of ES cells was performed in 6-well plates (Iwaki) coated with 0.1% 
gelatin. Routinely, 0.5-1.5x104/cm2 cells were plated onto each well in N2B27 
medium. Medium was changed every 2 days. 
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2.4.5 Introduction of DNA into cells 
 Lipofectamine transfection 
1x106 cells were plated onto each well of a 6-well plate. 250µl of serum-free GMEM 
(prepared as normal but without serum) were mixed with 3µl of Lipofectamine 2000 
(Invitrogen) and left at room temperature for 5 minutes. 3µg of DNA in another 
250µl serum-free GMEM was then added and the mix left at room temperature for 20 
minutes. The DNA/Lipofectamine 2000 mixture was then added to the cells and 
rocked gently to mix. Then they were left in the incubator overnight. Cells were 
trypsinised and replated at a density of 5x104 or 2x105 per 10cm culture plate then 
appropriate selection was added. 
 Electroporation of ES cells 
ES cells were trypsinised and 2x107 cells pelleted and resuspended in 700µl of PBS. 
50µg of linearised DNA resuspended in 100µl of PBS was added to the cells, and the 
cell-DNA mix transferred to a sterile cuvette (BioRad 0.4cm gap) for electroporation 
in a BioRad Genepulser electroporator at 0.8kV and 3µF. Immediately after the 
electroporation, the cells were plated onto 10cm gelatinised tissue culture plates at a 
density of 2-5x106 cells per plate. 24 hours after the transfection, the medium was 
changed and the appropriate selection drug was added. For stable transfection, cells 
were grown in selection medium for 7-10 days until colonies appeared. Single 
colonies were picked into gelatinised 24-well plates and then expanded. 
Selection drug concentration: G418: 200µg/ml, puromycin 1µg/ml. 
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2.4.6 Flow cytometry analysis of GFP+ cells 
Cells were trypsinised and resuspended in PBS with 10% FCS at 4ºC and subjected 
to flow cytofluorometry analysis to assess the percentage of GFP+ cells. 
Approximately 10000 cells were analysed per sample using FACSCalibur (Becton 
Dickison Biosciences) using CellQuest software. Cell debris and some dead cells 
were excluded from the analysis based on electronic gates set using forward scatter 
(size) and side scatter (cell complexity) criteria, and then the gated cells were 
analysed for the proportion of GFP+ cells in the total population. One line of the 
undifferentiated Pitx3GFP/+ ES cells was used as control to set the boundaries. 
2.5 Derivation of homozygous Pitx3GFP/GFP ES cells from blastocysts 
2.5.1 Mouse set up and induction of implantation delay of blastocysts 
In order to obtain mutant blastocysts, we set up intercrosses of homozygous Pitx3 
mice with heterozygous ones (on a C57BL/6. genetic background) at a male/female 
ratio of 1:2. The female mice were examined for the presence of the vaginal plug for 
3 days. Noon on the day of finding a vaginal plug was designated embryonic day (E) 
0.5. The plugged mice were injected with Depo-Provera 1 mg in PBS subcutaneously 
and tamoxifen 0.1 mg in propyleneglycol intraperitoneally on E2.5 when the 
embryos were in the morula stage to delay implantation. 
2.5.2 Preparation of flushing medium and flushing pipette 
PB1 was used as flushing medium and 10% FCS was added only before use. Pasteur 
pipettes were finely drawn with appropriate calibration by alcoholic lamp for 
flushing and transferring cells or embryos. 
- 82 - 
 
2.5.3 Flushing delayed blastocysts 
All mice were sacrificed just before flushing to keep the viability of blastocysts. 
Mice were sacrificed on E7.5 with cervical dislocation and the uteri were collected. 
Under dissecting microscope, the uteri were trimmed to remove adipose and vascular 
tissue, and the uterine horns were cut to open. The pipette filled with flushing 
medium was inserted into the uterus through cervical region to flush the uterine 
cavity. The blastocysts flushed out were collected in an organ culture dish (Nunc), 
and then transferred to 4-well plates (Nunc) containing irradiated feeder layer, with 
up to 6 blastocysts per well.  
2.5.4 Disaggregration of primary colonies 
Disaggregration was performed 5 days after flushing out. The central mass of each 
explant was picked up from the trophoblasts and washed with PBS twice. Then the 
ICM-derived components were transferred to separate drops of trypsin. Following 
incubation at 37ºC for 3 min, the cell mass was gently disaggregated by repeated 
aspiration through a finely drawn-out Pasteur pipette, preloaded with medium, into 
smaller cell aggregates of 3-4 cells, and then transferred to 4-well plates with feeder 
cells in pre-equilibrated complete medium. Each single ICM-derived clump was 
disaggregated and plated into one single well of a 4-well plate. Medium was changed 
every other day. When growing into appropriate colony size, the primary ES cell 
colonies were individually removed, dissociated into single cells using the same 
procedure and reseeded into 4-well plates with or without feeder cells. 
Cells were transferred into 6-well plates, small flasks (25 cm2) or medium flasks (75 
cm2) then frozen when appropriate. After expansion into small flask, cells were 
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shifted into normal ES culture medium, which is 10% FCS without antibiotics. 
2.5.5 Genotyping 
Cells for DNA extraction were cultured in 24-well plates. When confluent, 0.5 ml of 
lysis buffer with 0.5 mg/ml of proteinase K (Roche) was added into each well and 
put in the 37ºC incubator overnight. The following day the lysate was transferred to 
1.5 ml ependorf tubes and an equal volume of isopropanolol was added to precipitate 
DNA. DNA was pelleted by centrifugation at 16000 rpm in a benchtop centrifuge 
(Eppendorf Centrifuge 5415D) for 15 min. After washing with 70% ethanol, the 
pellet was air-dried for about 10 min and resuspended with 50 µl of sterile water. The 
DNA solution was put at 4ºC for overnight and then 60ºC water bath for 30 min. 
After quick spin down, the DNA was ready for PCR reaction. 
5 µl of DNA was used for PCR reaction. The primers were O113 (wild type), O114 
(mutant) and O115 (common)(Figure 4-2). DNA was initially denatured for 3 min at 
94ºC then subjected to 45 cycles of denaturing at 94ºC for 30 sec, annealing at 55ºC 
for 30 sec and extension at 72ºC for 1 min. After a final elongation step of 10 min at 
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2.5.6 Mycoplasma test 
Cells for mycoplasma test were cultured in antibiotic free medium for at least 7 days. 
Two ml of medium was taken and the test was kindly performed by Louise Taylor. In 
brief, medium samples were used to culture 3T3K cells for 4 days. The medium was 
removed and 1 acetic acid: 3 methanol was added for fixation. After washing twice 
with PBS, cells were stained with 500 ng/ml Hoechst stain.  
2.6 Diploid aggregation method 
The method used was based on that of Nagy. A and Rossant. J (Nagy and Rossant, 
1993). 
2.6.1 Preparation of aggregation plate 
KSOM (Speciality Media) microdrops (roughly 3 mm in diameter) were made in a 
tissue culture dish (Falcon; Surface Modified Polystyrene) and covered with mineral 
oil (Sigma). Five depressions were created in each microdrop by pressing a sterilised 
darning needle into the plastic and making slight circular movement.  
2.6.2 Preparation of eight-cell stage wild type embryos 
The oviducts along with the upper part of the uterus attached were removed from 
E2.5 superovulated F1 (CBA x C57BL/6) females and placed into a drop of PB1. 
Under a dissecting microscope the oviducts are flushed by inserting the flushing 
needle (Microlance 0.3 x 13mm) attached to a 1 ml syringe of PB1 into the 
infundibulum. The embryos were collected using a mouth pipette and washed 
through a drop of PB1 medium to remove any debris. 
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Groups of embryos (5 max per group) were transferred with as little medium as 
possible to a drop of Acid Tyrode's in a Petri dish and zona dissolution was carefully 
observed. As soon as the dissolution was completed the embryos were washed in 
PB1 drops. Then the zona-free morulae were transferred into aggregation plates by 
placing one embryo inside each depression. 
2.6.3 ES cell/embryo aggregation 
ES cells were replated one day before aggregation in order to keep the cells in log 
phase. On the day of aggregation, one 25cm2 flask of ES cells were trypsinised and 
replated on a non-adherent bacterial culture dish and cultured in a 37ºC incubator for 
2 hours to allow aggregation formation. Each ES cell aggregate (8-15 cells) was 
plated in a depression in the microdrop containing a zona-free wild type morula, and 
cultured in a 37ºC incubator. After overnight culture, the blastocysts formed from 
aggregates were transferred into the uterine horn of a 2.5 dpc pseudopregnant F1 
recipient and the pregnancies were timed according to the pseudopreganat females. 
2.7 In situ hybridisation 
The method used was based on that of Wilkinson (1992). 
2.7.1 Preparation of mouse embryo powder 
E14.5 wild type mouse embryos were homogenised with PBS. 4 volumes of ice-cold 
acetone were added, mixed and incubated on ice for 30 minutes. Then the mixture 
was centrifuged at 10000g for 10 minutes and the supernatant removed. The pellet 
was washed with ice-cold acetone and centrifuged again. Then the pellet was ground 
into a fine powder and allowed to be air dried. The embryo powder was stored at 
4ºC. 
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2.7.2 Preparation of embryos for in situ hybridisation 
E10.5 embryos were dissected out in diethyl pyrocarbonate (DEPC, Sigma)-treated 
PBS and fixed in 4% PFA in PBS at 4ºC overnight. Then embryos were washed 
twice in PBST at 4ºC then washed with 25%, 50%, 75% methanol/PBST for 20 
minutes and stored in 100% methanol at -20ºC. 
2.7.3 Riboprobe synthesis 
Plasmid DNA was digested with an appropriate restriction enzyme to create a linear 
DNA template for digoxigenin-labelled riboprobe synthesis. The transcription 
mixture (50µl) included 1 µg of linearised template DNA, ATP, GTP, and CTP at 
1mM each, UTP 0.7mM, digoxigenin-UTP 0.3mM, DTT 10mM, RNase inhibitor (1 
unit/µl of transcription mix), and T3 or T7 RNA polymerase (1unit/µl). Transcription 
was performed for 2 hours at 37ºC. The template DNA was then digested by 
RNase-free DNase (2µl at 1unit/µl) for 30 minutes at 37 ºC, and all reactions were 
stopped by addition of 4µl, 250mM EDTA. The riboprobes were then purified by 
addition of 2.5M NH4-acetate and 2.5 volume of ethanol. After centrifugation for 30 
minutes at 4ºC, the pellet was air dried and resuspended in 100µl DEPC-treated 
water. 
2.7.4 Preabsorption of antibody 
Anti-digoxigenin antibody (Roche) was diluted 1 in 1000 in TBT with 10% sheep 
serum and 2% BSA. Embryo powder was added to the mixture and shaken gently at 
4ºC overnight. Then the mixture was centrifuged and the supernatant collected for 
antibody reaction. 
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2.7.5 Prehybridisation and hybridisation 
Embryos were rehydrated with methanol in PBST in reverse series and washed with 
PBST 3 times for 10 minutes. Then the E10.5 embryos were treated with 10 µg/ml 
proteinase K in PBST for 20 minutes and washed with PBST twice for 5 minutes. 
The embryos were refixed with fresh 0.2% glutaraldehyde/4% PFA in PBST for 20 
minutes and washed twice with PBST for 10 minutes. The embryos were treated with 
prehybridisation mix and allowed to sink. Then they were incubated with fresh 
prehybridisation mix at 65ºC overnight. 
For hybridisation, the embryos were treated with prehybridisation mix with 1 mg/ml 
digoxigenin-labelled RNA probe, and incubated at 65ºC overnight. 
2.7.6 Posthybridisation wash 
After hybridization, the embryos were washed at 65ºC with 100% solution 1, 70% 
solution 1 in 2X SSC and 30% solution 1 in 2X SSC, respectively. Then they were 
washed with 2X SSC, 0.1% CHAPS twice for 30 minutes, and 0.2X SSC, 0.1% 
CHAPS twice for 30 minutes, all at 65ºC. After washing with TBT twice for 10 
minutes at room temperature, embryos were preblocked with 10% heat-inactivated 
sheep serum, 2% BSA in TBT for 3 hours at room temperature. Then the embryos 
were treated with preabsorbed antibody overnight at 4ºC. 
2.7.7 Post-antibody wash and colour development 
After antibody reaction, embryos were washed 5 times at room temperature for 1 
hour then overnight at 4ºC with TBT containing 0.1% BSA. Then embryos were 
washed twice with TBT for 30 minutes and 3 times with NTM for 10 minutes. Then 
the embryos were incubated with NTM containing 0.45 mg/ml NBT (4-nitro blue 
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tetrazolium chloride, Roche) and 0.175 mg/ml BCIP (5-bromo-4-chloro- 
3-indolyl-phosphate, Roche). When colour had developed to the desired extent, 
embryos were washed with PBST. The stain was fixed with 4% PFA in PBST at 4ºC 
overnight. 
For sectioning, the fixed embryos were cryopreserved with 30% sucrose and 
embedded in OCT as described in cryostat sectioning. 
 
Figure  2-1 pCAGfloxNeoKlf4 vector construction 
A 1.7-kb Kpn1-EcoR1 PMT-Klf4 (A) fragment was cloned into a pSP72poly4 vector 
cut with Kpn1-EcoR1 to create pSP72poly4-Klf4 (B). Subsequently, the 
pSP72poly4-Klf4 plasmid was cut with Xho1-Sal1 to release the Klf4 fragment 
which was then ligated into the pCAGfloxNeoPA vector (C), which had been cut 
with Xho1, inserting the Klf4 cDNA in between the floxed neoPA and the irespac to 
create the pCAGfloxNeoKlf4 plasmid (D). See appendix V for plasmid maps. 
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Maintenance of lens epithelial cell property by Pitx3 
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During the course of my PhD study, the expression and functional role of the 
transcription factor Pitx3 in midbrain dopaminergic neurons has been investigated by 
other members of our laboratory and other groups (Hwang et al., 2003; Maxwell et 
al., 2005; Nunes et al., 2003; Smidt et al., 2004; van den Munckhof et al., 2003; Zhao 
et al., 2004). Pitx3-GFP has been confirmed as an accurate reporter of Pitx3 
expression in Pitx3-GFP knockin mice, and has been used successfully for 
identification of ontogenetically distinct subgroups of mDA neurons in early stages 
of development (Maxwell et al., 2005; Zhao et al., 2004). These studies inspired me 
to investigate the molecular mechanisms regulated by Pitx3 in lens development 
using the Pitx3-GFP reporter mice and ES cells. (Derivation of the Pitx3GFP/+ and 
Pitx3GFP/GFP ES cells that were used to produce mouse chimeras is described in detail 
in Chapter 4.) 
3.1 Pitx3-GFP expression during lens development 
First of all I carried out an investigation into the targeted Pitx3-GFP reporter and Pitx3 
protein expression during lens development in both wild type and phenotypically 
normal Pitx3 heterozygous (Pitx3GFP/+) mice. The Pitx3GFP/+ mice showed no 
abnormality in lens development compared to the wild type littermates. Pitx3-GFP 
was first visualised in E10 embryos when expression was confined to the lens cup. At 
E10.5, all cells throughout the lens vesicle expressed Pitx3-GFP (Figure 3-1 A), 
which could be easily visualised directly under the fluorescence microscope. 
Between E11.5 and E17.5 Pitx3-GFP expression was observed throughout the lens in 
both the epithelial and fibrous compartments (E11.5 to E13.5 illustrated in Figure 3-1 
B-D). After E14.5, however, Pitx3 protein was primarily found in the lens epithelium 
and the lens equatorial region where lens epithelial cells exit from cell cycle and 
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initiate differentiation into fibre cells (Figure 3-2), although Pitx3-GFP was still 
detectable in the lens fibrous compartment, whereas Pitx3 protein was barely 
detectable. 
The physiological relevance of Pitx3 in lens expression is demonstrated by severe 
developmental lens defects in Pitx3 null mice. While the lens vesicles were formed in 
Pitx3 null embryos by E10.5, they appeared slightly smaller than in the wild type and 
the Pitx3 heterozygous control lens (Figure 3-1 E). Furthermore, the Pitx3 null lens 
remained attached to the surface ectoderm with a persistent lens stalk. Starting at 
E11.5, the lens vesicle structure collapsed and lost a regular spherical geometry in 
comparison with that of the wild type and heterozygous littermates (Figure 3-1 F-H). 
The lumen was filled with disorganised cells and the Pitx3-GFP positive lens 
remnants did not detach from the surface ectoderm (Figure 3-1 F-G). The lens 
remnants in the mutant eyes decreased in size as development proceeded. By E15, 
the lens cells were barely present in the Pitx3 mutant eye as observed through 
examination of Pitx3-GFP expression under a fluorescence microscope. The lens 
defect could be detected by directly visualising the GFP reporter expression in a 
whole embryo. This feature is useful to distinguish the Pitx3 homozygous embryos 
from the Pitx3 heterozygous ones without the need for molecular genotyping (Figure 
3-1 D, H). 
In contrast to the severe lens defect, the neural retina developed fairly normally with 
the basic architecture of the neural retinal layer forming (Figure 3-1 A-C, E-G). At 
later foetal stages following the complete loss of the lens-derived tissue, the Pitx3 
mutant neural retina was folded into the empty chamber. It is likely, therefore, that 
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Figure  3-1 Pitx3-GFP expression in Pitx3GFP/+ and Pitx3GFP/GFP mice 
Pitx3-GFP mirrors the expression of the transcription factor Pitx3 during lens 
development (A-D). At E10.5 the Pitx3-GFP was expressed throughout all cells of 
the lens vesicle (A). At E11.5, cells at the posterior part of the lens vesicle began to 
elongate (B) and occupied the cavity of the lens vesicle at E12.5 (C). In Pitx3GFP/GFP 
mice, the expression of Pitx3-GFP throughout the lens vesicle was comparable to 
Pitx3GFP/+ lenses at E10.5 (E). The lens vesicle collapsed and filled with disroganised 
mutant cells after E11.5 (F-H). 
Scale bars are 100 µm for A-C, E-G and 1 mm for D, H. 





Figure  3-2 Pitx3 expression during lens development  
Immunohistochemistry revealed that the transcription factor Pitx3 was expressed 
throughout cells at E11.5, the lens vesicle stage (A-B). Later, Pitx3 was 
downregulated after differentiation (C-F). 
Scale bars are 100 µm. 
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3.2 A cell-autonomous requirement of Pitx3 in lens epithelium: a chimeric 
analysis 
The rapid dysmorphogenesis of Pitx3 null lens at E11.5 and the distorted lens 
structure precludes a direct investigation on the potential specific requirement of 
Pitx3 function by lens epithelial or fibre cells. To gain insight into the cellular events 
underlying deformed lens formation, a series of chimera experiments were performed 
to provide a fine-scale analysis of the cellular change in Pitx3 null cells in 
developing lens. 
3.2.1 Introduction for chimeric analysis 
A chimera is a composite organism with two or more genetically distinct populations 
of cells that are derived from more than one individual. Chimera experiments are 
classic tools to determine whether a gene functions cell-autonomously or 
non-autonomously, information that cannot be reliably gained by any other means 
(Collinson et al., 2004; Rossant and Spence, 1998). A cell-autonomous requirement 
is apparent when the mutant cells exhibit a mutant phenotype within the tissue to 
which they contribute, or they are excluded from the affected tissue, including 
depletion of numbers or abnormal distribution. At high contribution in the affected 
tissues, mutant cells impose a mutant phenotype on surrounding wild type cells. On 
the other hand, if the mutant cells are defective in a cell non-autonomous function, 
the presence of wild type cells can rescue the mutant phenotype. By comparing the 
behaviour of wild type and mutant cells in chimeras, it is possible to assess the 
ability of mutant cells to contribute to lens tissues and to participate during 
development when in direct competition with wild type cells. 
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Previously I have shown that Pitx3-GFP expression was fairly uniform in both 
non-chimeric Pitx3GFP/+ and Pitx3GFP/GFP developing lens. In addition, Pitx3-GFP is 
easy to detect and cell-localised, thus it could be used as a lineage marker to track the 
distribution of Pitx3 expressing cells in chimera experiments. 
Chimeras can be produced by aggregation of two genetically distinct embryos at the 
eight-cell stage, or by introducing donor ES cells into recipient embryos via 
blastocyst injection. In the case of morula aggregation, either embryo to embryo or 
ES cells to embryo, chimeric embryos are cultured in vitro to the blastocyst stage 
then they are surgically transferred to the uteri of pseudopregnant fosters for further 
development. 
Before the advances of gene targeting made in ES cells, making chimeras between 
wild type and homozygous lethal mutants involved the use of embryos derived from 
heterozygous crosses as one of the chimeric partners. Thus, it was not 
straightforward to distinguish heterozygote ↔ wild type chimeras from homozygote 
↔ wild type combinations, even if a linked marker for the mutation was available. 
Since Pitx3 mutation is not lethal and Pitx3 null morulae or blastocysts are available, 
it is possible to derive chimeras from early mutant embryos by designed crossmating, 
without genotyping to distinguish whether the chimeric embryo is derived from 
heterozygotes or homozygotes. Furthermore, using Pitx3GFP/+ and Pitx3GFP/GFP ES 
cell lines, which I have established from mutant blastocysts (Chapter 4.2), to 
generate chimeras, there is no limitation on numbers of mutant embryos available 
and all offspring are of the required genotypic combination, dramatically simplifying 
chimeric analysis of mutants. 
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Pitx3 heterozygous (Pt3A) and Pitx3 null (Pt2B) ES lines were used to produce 
Pitx3GFP/+ ↔ wild type and Pitx3GFP/GFP ↔ wild type chimeras, respectively. In brief, 
ES cells were dissociated by trypsinisation and cultured in a non-adherent bacterial 
culture dish for 2 hours at 37ºC to allow the formation of ES cell aggregates. Each 
ES cell aggregate (8-15 cells) was then cultured with a zona-free wild type morula 
overnight. The following day the blastocysts formed from those chimeric embryos 
were transferred into the uterine horn of a pseudopregnant foster female and 
collected at E11.5 and E14.5. All aggregations and embryo transfers were performed 
by Renee MacLay, Ken Jones, Gregor Russel and John Agnew at the ISCR. The 
embryos in which Pitx3GFP/+ or Pitx3GFP/GFP cells successfully contributed were 
identified by visualising Pitx3-GFP expression in the developing lens under a 
fluorescence microscope and collected for further analysis.  
With the use of eGFP in the heterozygous and homozygous Pitx3 mutant ES cells, 
the distribution of donor cells can be easily detected and quantified. The expression 
of Pitx3 in the developing tongue is developmentally neutral, that is, Pitx3 does not 
influence tongue development. Although the contributions of the donor ES cells in 
different chimeric embryos varies widely, tissues within an individual chimera 
usually have a similar composition, so Pitx3-GFP distribution in the developing 
tongue can be used as an indicator to give a global value of the percentage of cells 
contributed from donor ES cells, and the distribution of mutant cells in the 
developing lens can be compared. 
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3.2.2 Underrepresentation of Pitx3 null cells in lens epithelium 
Chimeric embryos were firstly analysed at E11.5. A total of 8 out of 23 and 7 out of 
27 embryos collected contained GFP expressing cells in Pitx3GFP/GFP ↔ wild type 
and Pitx3GFP/+ ↔ wild type group, respectively. All the Pitx3-GFP positive cells in 
the left eye of each chimera were counted to determine their contribution, while the 
contribution of Pitx3-GFP+ cells in the tongue (%T) was determined by counting 200 
cells. The contribution of Pitx3-GFP+ cells in the tongue (%T), the lens epithelium 
(%E), and the lens fibre compartment (%Ftotal) of the Pitx3GFP/GFP ↔ wild type 
chimeras was compared to the distribution of Pitx3-GFP+ cells in Pitx3GFP/+ ↔ wild 
type chimeras. These data are presented in Table 3-1 and summarised in Figure 3-5, 
3-6. 
In Pitx3GFP/+ ↔ wild type chimeras, GFP+ cells contributed fairly randomly to both 
the epithelial part and the fibre cell part of the E11.5 lens (Figure 3-3 A, C). The E/T 
ratio (%E over %T) and the F/T ratio (%Ftotal over %T) were calculated separately 
for each chimera for obtaining a quantitative comparison of the donor cell 
distribution in different tissues. Both the E/T and F/T ratios were close to 1.0 (Figure 
3-5 A-B), demonstrating that the chimerism of these tissue were strongly positively 
correlated. Therefore, the distribution of these heterozygous Pitx3GFP/+ cells in both 
the epithelial and the fibrous compartment was comparable to their chimerism 
determined by tongue distribution. 
In the Pitx3GFP/GFP ↔ wild type group, one homozygous chimera with high ES cell 
contribution (%T=89.1) showed disorganised lens vesicle formation which was 
similar to that observed in non-chimeric Pitx3 homozygous mutant lens at E11.5 
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(Figure 3-3 B). The collapsed lens structure did not detach from the surface ectoderm 
and the lens cavity was abnormally filled with mutant cells. However, relatively 
normal lens were formed in moderate and low chimeric Pitx3GFP/GFP ↔ wild type 
embryos (Figure 3-3 D). Interestingly, Pitx3GFP/GFP cells were rarely observed in the 
lens epithelium of these chimeras. 
For heterozygous chimeras, the mean (± SEM) of the E/T ratio was 0.84 ± 0.31 (n=7). 
For homozygous chimeras, the E/T ratio was 0.41 ± 0.23 (n=7), indicating significant 
underrepresentation of Pitx3GFP/GFP cells in the lens epithelium (p<0.02, t-test)(Table 
3-1). Pitx3GFP/GFP ↔ wild type chimeric embryos provide an environment in which the 
wild type and Pitx3 null cells can mix and interact. The underrepresentation of the 
Pitx3GFP/GFP cells in the lens epithelium shows that they cannot be rescued by 
neighbouring wild type cells and implies that Pitx3 acts cell-autonomously within the 
lens epithelium. 
The contribution of Pitx3 mutant cells in the fibrous part of the E11.5 lens was 
comparable to that of the Pitx3 heterozygous cells. This was reflected by the F/T 
ratio of 0.93 ± 0.29 for heterozygous and 1.15 ± 0.37 for homozygous chimeras, 
respectively (p=0.25). These Pitx3 mutant cells appeared morphologically normal 
and were intermingled with differentiating wild type host fibre cells. However, 
aggregation and physical exclusion of some Pitx3 mutant cells into the lumen of the 
lens vesicle was observed (Figure 3-3 D, arrowhead). 
3.2.3 Segregation of Pitx3 mutant cells in lens fibrous part after differentiation 
Chimera experiments at E11.5 revealed that Pitx3 had an autonomous role in the lens 
epithelial cells. However, Pitx3 null cells at E11.5 were not eliminated from the 
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fibrous part although some aggregations of mutant cells were observed. To 
investigate the developmental potential of these remaining Pitx3 homozygous mutant 
cells in the lens fibrous part, E14.5 chimera experiments were performed. A total of 
28 and 16 embryos were produced in homozygous and heterozygous groups, and 14 
and 5 of them were chimeric embryos with GFP+ cell distribution, respectively 
(Table 3-2, Figure 3-5, 3-6). 
In the Pitx3GFP/+ ↔ wild type embryos, GFP+ cells were randomly mixed with wild 
type cells in both the lens epithelium and the fibrous compartment (Figure 3-4 A).  
In the Pitx3GFP/GFP ↔ wild type group, three high chimeric (%T >85%) embryos 
were found to have collapsed lens structure with a persistent lens stalk, showing the 
same morphology as E14.5 non-chimeric Pitx3 null lens (Figure 3-4 B). In addition 
to these 3 high chimeric embryos, another 11 chimeras, of which the chimerisms of 
Pitx3GFP/GFP cells were mild or moderate, showed formation of lens proper by wild 
type cells with various degrees of mutant cell distribution (Figure 3-4 C-F). 
For heterozygous chimeras, the E/T ratio was 0.93 ± 0.12 (n=5), confirming that 
Pitx3GFP/+ cells contributed equally between the lens epithelium and the developing 
tongue (Figure 3-4 A). In contrast, for homozygous chimeras, the E/T ratio was 
0.0057 ± 0.0134 (n=11). These values were very significantly different (p<0.0001, 
t-test)(Table 3-2, Figure 3-5 C), showing that in E14.5 eyes there was a 
near-complete absence of Pitx3GFP/GFP cells from the lens epithelium of homozygous 
chimeras (Figure 3-4 C-E). Those Pitx3GFP/GFP cells that had populated the lens 
epithelium at E11.5 were rarely seen in E14.5 lens. This suggested that proliferation 
and/or survival capacity of the lens epithelial cells was greatly compromised in the 
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absence of functional Pitx3. 
In the fibrous compartment of the homozygous chimeras of mild or moderate 
chimerism, very few mutant cells differentiated into elongated mature fibre cells 
(Figure 3-4 C-E). The %Fdiff, the percentage of elongated differentiated Pitx3-GFP+ 
lens fibre cells, was only 0.3 ± 0.8%. However, the fibrous region contained 
significant proportions of mutant cells, which occurred as segregated patches 
between the lens epithelium and the lens fibre compartment, or at the posterior edge 
of the lens proper (Figure 3-4 C-E). In the Pitx3GFP/GFP ↔ wild type embryos with 
moderate chimerism, outside the lens proper there were protruding buds, surrounded 
by elongated mutant cells, physically excluded from the lens proper (Figure 3-4 D-F). 
Sometimes a stalk of tissue can be observed to connect the ectopic bud to the lens 
proper (Figure 3-4 E, arrow). Similar ectopic protruding was never observed in 
Pitx3GFP/+ ↔ wild type chimeras. Segregation of cell types suggested that 
interactions between Pitx3GFP/GFP and wild type cells were abnormal so that they 
failed to mix freely, but actively sorted themselves out into homogenous patches.  
To ask the nature of those protruding buds of Pitx3GFP/GFP cells from the lens proper, 
antibody staining of β-crystallin was performed. The strong expression of β-crystallin, 
a key fibre cell-specific marker, indicated that molecular differentiation has occurred 
in these Pitx3GFP/GFP cells in the fibrous compartment (Figure 3-4 F-G). Although the 
F/T ratios of the homozygous and heterozygous chimeras were comparable at E11.5 
(Figure 3-5 B), the F/T ratio in the Pitx3GFP/GFP ↔ wild type chimeras (0.34 ± 0.22, 
n=11) was significantly lower than that of Pitx3GFP/+ ↔ wild type chimeras (0.97 ± 
0.04, n=5, p<0.0001)(Figure 3-5 D) at E14.5. The E/T and F/T ratios were not 
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affected by the chimerism of the mice (%T). However, when the percentage of Pitx3 
null cells was higher than a certain threshold (~85%), the lens development could not 
be maintained by the wild type host cells and the morphogenesis of the disorganised 
lens structure resembled that of non-chimeric Pitx3 null lenses (Table 3-2). 
Accordingly, three distinctive classes of embryonic lens arose in the Pitx3GFP/GFP ↔ 
wild type chimeras. The first class (dysmorphology I, 4 embryos) includes normal 
developing lens with segregated patches of Pitx3 null cells. In the second class 
(dysmorphology II, 7 embryos) the development of the lens proper was maintained 
by wild type cells but the ectopic protrusions surrounded by Pitx3GFP/GFP cells were 
found. In the third class (dysmorphology III, 3 embryos), which included a high 
percentage of Pitx3GFP/GFP cells, the wild type host cells could not maintain lens 
development and the disordered morphogenesis of Pitx3 null lens was reproduced 
(Table 3-2). 
In summary, while the distributions of the Pitx3GFP/+ cells in the lens epithelium and 
the lens fibrous part were comparable to those in the tongue, Pitx3GFP/GFP cells were 
specifically excluded from the lens epithelium of phenotypically rescued developing 
lens, demonstrating that Pitx3 is autonomously essential for the development of lens 
epithelial cells. In the fibrous part at E14.5, most Pitx3GFP/GFP cells were not 
integrated well with wild type fibre cells in the lens proper. They were segregated 
and even physically excluded from the lens proper although they had shown signs of 
fibre cell differentiation. This suggests that Pitx3 may also promote cell 
surface/adhesion molecule change during fibre cell differentiation (Figure 3-6). 
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Table  3-1 Analysis of distribution of Pitx3GFP/+, Pitx3GFP/GFP cells in E11.5 chimeric 
lenses 
Chimeras %T %E %FTotal %FDiff E/T F/T dysmorphology 
Pitx3GFP/GFP ↔ wild type      
EO2 89.1%      ++ 
EO5 96.1% 2.6% 78.3% 73.5% 0.03 0.82 + 
EO3 70.7% 29.6% 73.7% 61.8% 0.42 1.04 + 
EO8 63.9% 31.1% 60.3% 57.0% 0.49 0.94 + 
EO4 63.7% 27.8% 76.7% 69.3% 0.44 1.20 + 
EO7 56.7% 33.3% 55.6% 54.5% 0.59 0.98 + 
EO1 46.7% 10.3% 53.5% 53.5% 0.22 1.14 + 
EO6 26.3% 18.6% 50.6% 50.6% 0.71 1.93 + 
Mean 60.6% 21.9% 64.1% 60.0% 0.41 1.15  
SEM 21.5% 11.7% 11.8% 8.6% 0.23 0.37  
        
Pitx3GFP/+ ↔ wild type     
EE2 96.4% 71.4% 66.2%  0.74 0.69  
EE4 92.1% 82.1% 73.4%  0.89 0.80  
EE8 69.8% 71.4% 76.7%  1.02 1.10  
EE3 68.2% 41.7% 53.6%  0.61 0.79  
EE6 53.0% 26.7% 38.8%  0.50 0.73  
EE5 46.3% 65.2% 70.7%  1.41 1.52  
EE1 31.4% 21.4% 28.8%  0.68 0.92  
Mean 65.3% 54.3% 58.3%  0.84 0.93  
SEM 23.7% 24.1% 18.5%  0.31 0.29  
%T, %E: percentage of GFP+ cells in the tongue and the lens epithelium, 
respectively. 
%FTotal: percentage of all GFP+ cells in the fibre part, including the integrated and 
excluded cells. 
%FDiff: percentage of GFP+ cells integrated well with wild type cells in the fibre part. 
Lens dysmorphology is shown as: (+) Normal morphology with some mutant cell 
aggregations; (++) collapsed lens vesicle with a persistent lens stalk. 
SEM: standard error of the mean 
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Table  3-2 Analysis of distribution of Pitx3GFP/+, Pitx3GFP/GFP cells in E14.5 chimeric 
lenses 
Chimeras %T %E %FTotal %FDiff %FIn E/T F/T dysmorphology 
Pitx3GFP/GFP ↔ wild type      
LO1 91.5%     III 
LO3 85.1%     III 
LO7 95.6%     III 
LO4 91.0% 0 29.7% 2.7% 8.2% 0 0.33 II 
LO2 72.3% 2.9% 41.8% 0.3% 10.3% 0.04 0.58 II 
LO12 65.4% 0 15.1% 0 0.4% 0 0.23 II 
LO9 63.2% 1.4% 9.5% 0 0 0.02 0.15 II 
LO10 51.9% 0 15.6% 0 10.7% 0 0.30 II 
LO8 48.2% 0 8.4% 0.6% 8.4% 0 0.17 I 
LO14 36.3% 0 18.2% 0 12.8% 0 0.50 II 
LO11 35.3% 0 3.0% 0 3.0% 0 0.08 I 
LO3 33.5% 0 5.1% 0 5.1% 0 0.15 I 
LO5 32.8% 0 14.4% 0 14.4% 0 0.44 I 
LO6 22.2% 0 17.4% 0 12.9% 0 0.78 II 
Mean 50.2% 0.4% 16.2% 0.3% 7.8% 0.0057 0.339  
SEM 20.8% 0.9% 11.2% 0.8% 5.1% 0.0134 0.217  
   
Pitx3GFP/+ ↔ wild type    
LE3 96.6% 80.6% 93.4% 0.83 0.97 
LE1 76.3% 70.3% 78.8% 0.92 1.03 
LE2 70.0% 71.1% 68.9% 1.02 0.98 
LE5 53.5% 42.8% 50.5% 0.80 0.94 
LE4 33.0% 35.6% 31.1% 1.08 0.94 
Mean 65.9% 60.1% 64.5% 0.93 0.97 
SEM 24.0% 19.7% 24.3% 0.12 0.04 
 %T, %E: percentage of GFP+ cells in the tongue and the lens epithelium, 
respectively. 
%FTotal: percentage of all GFP+ cells in the fibre part, including those fully 
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differentiated elongated fibre, segregated patches and ectopic buddings. 
%FDiff: percentage of elongated differentiated GFP+ fibre cells in the fibre part. 
%FIn: percentage of GFP+ cells kept in the lens proper, including differentiated cells 
and segregated patches. 
Lens dysmorphology is shown as: (I) Normal morphology with some mutant cell 
aggregations; (II) normal lens proper with ectopic buddings; (III) club shaped lens 
remnant with a persistent lens stalk. 




Figure  3-3 Lens of chimeras derived from Pitx3GFP/+ and Pitx3GFP/GFP ↔ 
wild type embryos at E11.5 
In Pitx3GFP/+ ↔ wild type embryos, Pitx3GFP/+ cells contributed randomly in both the 
epithelial and fibre part (A, C). In Pitx3GFP/GFP ↔ wild type embryos with high 
contribution of Pitx3 null cells, there was disorganised lens development with 
persistent lens stalk (B). In lower contribution chimeric embryos, there was 
underrepresentation of Pitx3 null cells in the lens epithelium (D), suggesting Pitx3 
was autonomously required for lens epithelial cells. In the fibre part Pitx3 null cells 
differentiated into elongated fibre cells, but some Pitx3 mutant cells began to be 
physically excluded from the lens proper (D, arrowhead). 
Scale bars are 80 µm for A and 40 µm for B-D. 




Figure  3-4 Lens of chimeras derived from Pitx3GFP/+ and Pitx3GFP/GFP ↔ 
wild type embryos at E14.5 
In Pitx3GFP/+ ↔ wild type embryos, Pitx3GFP/+ cells contributed randomly in both the 
epithelial and fibrous part (A). In Pitx3GFP/GFP ↔ wild type embryos with high 
contribution of Pitx3 null cells, there was disorganised lens development with 
persistent lens stalk (B). In lower contribution chimeric embryos, Pitx3GFP/GFP cells 
rarely contributed to the lens epithelium (C-E). Few Pitx3 null cells differentiated 
into mature elongated fibre cells. Most Pitx3GFP/GFP cells were segregated from wild 
type cells (C-E, arrow: a stalk connected to the lens proper). The excluded 
Pitx3GFP/GFP cells expressed β-crystallin (G: β-crystallin staining of F) showing 
differentiation property. Nuclear morphology of the excluded Pitx3GFP/GFP cells 
revealed no signs of apoptosis (inset of F). 
Scale bars are 80 µM. 




Figure  3-5 E/T and F/T ratios of Pitx3GFP/+ ↔ wild type and Pitx3GFP/GFP ↔ 
wild type chimeras 
The percentage of GFP+ cells in the lens epithelium or the lens fibrous part was 
divided by the percentage of GFP+ cells in the tongue (%T) for each of the chimeric 
animals and the ratios E/T and F/T were plotted against %T. The E/T and F/T ratios 
of Pitx3GFP/+ ↔ wild type chimeras were around 1.0. Analysis at E11.5 showed that 
Pitx3 null cells tended to be eliminated from the lens epithelium (A), while 
Pitx3GFP/GFP cells still remained in the fibrous part (B). By E14.5, the elimination of 
Pitx3GFP/GFP cells from the lens epithelium was almost complete (C), and Pitx3GFP/GFP 
cells were also underrepresented at the fibrous part (D). The E/T and F/T ratios were 
not affected by %T at E14.5. 
 




Figure  3-6 Distribution of GFP+ cells in the Pitx3GFP/+ ↔ wild type and 
Pitx3GFP/GFP ↔ wild type chimeras. 
In Pitx3GFP/+ ↔ wild type chimeras, the distribution of Pitx3GFP/+ cells in the 
epithelial and fibrous parts were both comparable to the distribution in the tongue 
(n=7 at E11.5; n=5 at E14.5). In Pitx3GFP/GFP ↔ wild type chimeras, the distribution 
of Pitx3 mutant cells in the lens epithelium was significantly lower than that of the 
tongue (p<0.02 at E11.5, n=7; p<0.0001 at E14.5, n=11). There was also 
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3.3 Premature fibre cell differentiation of Pitx3 null lens cells 
The lens epithelial cells are predominately cuboidal with strong intercellular 
adhesion. They are firmly attached to the lens capsule and form an epithelial sheet 
that covers the anterior surface of the fibre mass. Cell proliferation in the lens is 
restricted to the epithelial layer. When the progeny of these divisions migrate into the 
transition zone at the lens equator, they exit from cell cycle, differentiate into 
post-mitotic fibre cells and persist in the fibre mass throughout life. The balance 
between proliferation and differentiation is crucial for the maintenance of the lens 
polarity and the order of cellular architecture that contributes to the transparency and 
optical properties of the lens (McAvoy et al., 2000). 
My chimera experiment has suggested that Pitx3 is autonomously required for the 
lens epithelial cells. Therefore further experiments were performed to investigate 
whether the lens epithelial characteristics are changed in Pitx3 null lenses, by 
exploiting several key regulators or marker genes normally active in lens epithelial 
cells. Embryos at E10.5, the lens vesicle stage, were used for most of these 
experiments because this stage is the last time point when the morphology of Pitx3 
null lens is indistinguishable from that of Pitx3 wild type or Pitx3 heterozygous 
littermates. 
3.3.1 Lens epithelial cell identity is not maintained in Pitx3 deficient mice 
Platelet-derived growth factors (PDGFs) are disulfide-bonded homodimers or 
heterodimers of two polypeptide chains, A and B. Their receptors are two tyrosine 
kinases, PDGFRα and PDGFRβ, which can also homodimerise or heterodimerise 
upon binding of the ligand. PDGF-A is expressed by the cells and tissues of the 
anterior segment of the embryonic eye, including the ciliary body and iridial region. 
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The receptor PDGFRα is typically expressed at high levels in lens epithelial cells 
(Morrison-Graham et al., 1992; Reneker and Overbeek, 1996). In this experiment, I 
used a mouse monoclonal PDGFRα antibody APA5 (Takakura et al., 1997) to 
examine the lens epithelial identity. 
In the E12.5 Pitx3GFP/+ developing lens, the expression of PDGFRα was restricted to 
the cytoplasm of the lens epithelium, demonstrating that PDGFRα is a specific lens 
epithelial marker (Figure 3-7 I-J). At E10.5 and E11.5, PDGFRα was expressed in 
the entire lens vesicle of the Pitx3GFP/+ lens (Figure 3-7 A-B, E-F). While no 
difference in PDGFRα expression was observed between the Pitx3 null and the Pitx3 
heterozygous control lens at E10.5 (Figure 3-7 A-D), a significant reduction of 
PDGFRα expression was observed in the Pitx3 null lens at E11.5 (Figure 3-7 E-H), 
suggesting downregulation of PDGFRα with the loss of Pitx3. 
Cadherins comprise of a large family of calcium-dependent cell adhesion molecules 
(Gumbiner, 2000). They maintain the structure and functional integrity of epithelial 
tissues through calcium-dependent interaction at sites of cell-cell contact. During eye 
development, E-cadherin is expressed ubiquitously in the lens epithelial cells that 
originate from the surface ectoderm, and is downregulated when these epithelial cells 
commit to fibre cell differentiation (Xu et al., 2002). In this experiment, the 
monoclonal antibody ECCD2 was used to detect mouse E-cadherin expression 
(Shirayoshi et al., 1986; Tada et al., 2005) in the developing lens. 
Similar to PDGFRα, E-cadherin was also preferentially expressed in the lens 
epithelium in E12.5 Pitx3 heterozygous control lens (Figure 3-7 S-T). At E10.5, the 
expression pattern of E-cadherin in the Pitx3 null lens was not different from the 
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Pitx3 heterozygous control lens (Figure 3-7 K-N). However, the homozygous Pitx3 
mutant lenses exhibited a reduced E-cadherin staining at E11.5 (Figure 3-7 O-R). 
These studies together demonstrate that the properties associated with lens epithelial 
cells could not be properly maintained in Pitx3 deficient mice. This led to subsequent 
investigating of the signalling pathway associated with the lens epithelium. Most 
studies have concentrated on identifying factors that control fibre cell differentiation, 
and there is strong evidence that members of the FGF growth factor family 
(Govindarajan and Overbeek, 2001; McAvoy et al., 2000) and the TGFβ superfamily 
(Belecky-Adams et al., 2002; de Iongh et al., 2001; Faber et al., 2002) are key 
regulators of this process. In contrast, little is known about the maintenance of the 
lens epithelium. Recent reports have shown that Wnt signalling and β-catenin are 
required for lens epithelial cells (Smith et al., 2005; Stump et al., 2003). Wnt signals 
play important roles in cellular adhesion and differentiation (Hinck et al., 1994a; 
Hinck et al., 1994b). In the absence of a Wnt signal, a complex containing GSK-3β 
(glycogen synthase kinase-3β) promotes phosphorylation of β-catenin and its 
subsequent destruction via ubiquitination and proteolysis (van Noort et al., 2002). In 
response to a Wnt signal, the β-catenin destruction complex is inactivated and, as a 
consequence, β-catenin is stabilised. The cytoplasmic accumulation of β-catenin can 
result in its entry into the nucleus and subsequently binding to members of the 
TCF/LEF (T cell factor/lymphocyte enhancer binding factor) transcription factor 
family, and activation of a set of Wnt target genes (Huber et al., 1996). In addition to 
playing a part in the Wnt signal pathway, the molecule β-catenin can also bind to the 
calcium-dependent adhesion proteins, cadherins, at the plasma membrane, where it 
stabilises the cell-cell adhesion complex (Giarre et al., 1998; Hinck et al., 1994a; 
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Hinck et al., 1994b). 
The cessation of Wnt/Fz expression during fibre differentiation is at about the time 
when the fibre cell-specific marker β-crystallin appears (Ang et al., 2004; Chen et al., 
2004). In LRP6 null mice, Wnt signalling through the β-catenin pathway is blocked 
and the central lens epithelial layer exhibits irregular shaped β-crystallin positive 
cells (Stump et al., 2003). These data suggest that Wnt signalling in the anterior 
epithelium of the lens may have a role in inhibiting aspects of fibre differentiation. 
Additionally, Wnt signalling has been reported to regulate E-cadherin and 
Connexin-43 (Ai et al., 2000; Huber et al., 1996; van der Heyden et al., 1998), an 
adhesion protein which might be regulated by Pitx3 according to the chimeric 
experiments. On the other hand, the molecule β-catenin is also involved in cell-cell 
adhesion via cadherin molecules, as conditional deletion of β-catenin in the 
presumptive lens results in a failure of epithelial cell adhesion, and formation of 
ectopic cell clusters in the periocular ectoderm expressing β-crystallin and Prox1, 
which is a transcription factor required for fibre cell differentiation (Smith et al., 
2005). Thus, the Wnt/β-catenin pathway or β-catenin molecule per se may be 
involved in the Pitx3-mediated regulation of lens epithelial cell development. 
To determine whether there might be a differential expression of β-catenin between 
lens epithelial cells and fibre cells, I have performed immunohistochemistry using an 
antibody against β-catenin on E12.5 Pitx3 heterozygous control lens. Interestingly, 
the β-catenin expression was restricted to the cytoplasm of the anterior lens 
epithelium in E12.5 lens and downregulated at the equatorial region where fibre cell 
differentiation is initiated (Figure 3-8 A-B), indicating that β-catenin may be used as 
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another lens epithelial marker. However, there is no significant difference between 
the cytoplasmic β-catenin accumulation of E10.5 Pitx3 heterozygous control (Figure 
3-8 C-D) and Pitx3 null lens (Figure 3-8 E-F). 
3.3.2 Pitx3 null lens epithelial cells exit cell cycle prematurely 
During normal lens fibre cell differentiation, the lens epithelial cells arrest their 
proliferative status and exit from the cell cycle before their elongation and expression 
of fibre cell-specific genes. The earlier downregulation of the lens epithelial markers 
in Pitx3GFP/GFP lens led to the examination of the expression of cell cycle inhibitors, 
which are molecules associated with initiation of lens fibre cell differentiation. 
Cell proliferation involves the activation of cyclin-dependent kinase (cdk), which 
catalyses events required for cell cycle transition. The activity of these cdks is 
regulated by cdk inhibitors, including p27KIP1 (also known as cdkn1b) and p57KIP2 
(also known as cdkn1c) which inhibit cdks involved in the G1/S transition. Both 
p27KIP1 and p57KIP2 are post-mitotic cell markers of which the expression is inversely 
correlated with cell proliferation. Data from mRNA in situ hybridisation shows that 
at E11.5, posterior lens vesicle cells begin to express p57KIP2 mRNA prior to their 
elongation and subsequent expression of the lens fibre-specific marker β-crystallin 
(Lovicu and McAvoy, 1999). Onwards from E11.5, the expression of p57KIP2 
becomes progressively restricted to cells within the transitional zone. 
Mice lacking p27KIP1 and p57KIP2 show hyperproliferation and impaired 
differentiation in the developing lens, suggesting that these two cdk inhibitors 
cooperate to control cell cycle exit and differentiation in the developing lens (Zhang 
et al., 1997; Zhang et al., 1998). However, the late-stage fibre-cell differentiation 
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marker γ-crystallin is not affected. Furthermore, Prox1 mutant lens shows 
downregulated expression of p27KIP1 and p57KIP2 but no significant difference with 
the α- and β-crystallin gene expression (Wigle et al., 1999). These data suggest that 
the two requirements of fibre cell differentiation, cell cycle exit and crystallin 
expression, are regulated by separate pathways.  
The correlation of p27KIP1 and p57KIP2 expression with lens epithelial cell cycle 
withdrawal and the onset of lens fibre differentiation make them useful markers for 
initiation of lens fibre cell differentiation (Lovicu and McAvoy, 1999). 
My immunohistochemistry experiment showed that both p27KIP1 (Figure 3-9 E-F) 
and p57KIP2 (data not shown) were only expressed at the most posterior part of the 
Pitx3 wild type lens vesicle at E11.5, where fibre cell differentiation is initiated. This 
is in keeping with the p57KIP2 mRNA expression data (Lovicu and McAvoy, 1999). 
Neither p27KIP1 nor p57KIP2 was expressed at E10.5 in the wild type lens (Figure 3-9 
A-B, I-J). Strikingly, both p27KIP1 and p57KIP2 were expressed throughout the 
morphologically normal Pitx3 null lens vesicles at E10.5 (Figure 3-9 C-D, K-L). 
They were also highly expressed in cells of the malformed lens structure at E11.5 
(Figure 3-9 G-H).  
Therefore, Pitx3 mutant cells show earlier withdrawal from the cell cycle at E10.5 
when they still show morphology of epithelial cells of the lens vesicle. These data 
demonstrate that Pitx3 activity is pivotal for the maintenance of mitotic activity of 
lens epithelial cells, supporting my chimera result that Pitx3 null cells do not 
contribute to the proliferative lens epithelium. 
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3.3.3 Premature expression of fibre differentiation markers β- and γ- crystallin 
Lens cells abundantly synthesise a group of proteins called crystallins. In the mature 
lens, crystallins are accumulated at high concentrations in a soluble form that 
maintains the transparency and high refractivity of the lens. Major crystallins are 
classified into α-, β- and γ-crystallins in mammals. Expression of most of these 
crystallins is restricted to lens, so their expression is a good indicator of lens 
differentiation (McAvoy, 1978). Expression of α-crystallin begins at the lens vesicle 
stage, whereas expression of β- and γ-crystallin usually occurs concomitantly with 
lens fibre differentiation. During normal lens development, the cell cycle withdrawal 
of differentiating fibre cells involving the anti-mitotic signals p27KIP1 and p57KIP2 is 
regulated co-ordinately with transcriptional activation of β- and γ-crystallins (Lovicu 
and McAvoy, 1999; Treton et al., 1991). To determine whether the premature cell 
cycle withdrawal of lens epithelium caused by the loss of Pitx3 is accompanied by 
fibre cell differentiation, I have investigated the expression of β- and γ-crystallins in 
the Pitx3 heterozygous control and Pitx3 null lenses by staining frozen sections with 
appropriate antibodies from the lens vesicle stage at E10.5 to the nearly formed lens 
at E12.5. 
At E12.5 in the Pitx3GFP/+ lens, β-crystallin was expressed in the fibrous part and 
γ-crystallin was expressed at the more central part of the fibre cell mass (Figure 3-10 
E-F, M-N). Neither staining was observed in the lens epithelial cells in the anterior 
part of the lenses. Both β- and γ-crystallins were expressed in most, if not all, cells in 
the collapsed Pitx3 null lens structure at E12.5 (Figure 3-10 G-H, O-P), 
demonstrating that some aspects of fibre cell differentiation occur in the Pitx3GFP/GFP 
cells at E12.5 despite the disorganised structure. Neither β- nor γ-crystallin was 
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expressed in Pitx3 heterozygous control lenses at E10.5 when all the cells of the lens 
vesicle are proliferative epithelial cells (Figure 3-10 A-B). Strikingly, prominent 
β-crystallin staining covering the entire lens vesicle was observed at E10.5 in the 
Pitx3 null lens (Figure 3-10 C-D) when the morphology of the lens vesicle was still 
comparable to that of Pitx3 heterozygous control or wild type littermates. 
The temporal expression profile of γ-crystallin in the Pitx3 mutant lens was also 
changed. Earlier expression of γ-crystallin at E11.5 was found in the malformed 
Pitx3 null lens (Figure 3-10 K-L) compared to the Pitx3 heterozygous control lens 
(Figure 3-10 I-J). 
These data suggest that there is earlier expression of β- and γ-crystallin proteins in 
the Pitx3 mutant lens, indicating that fibre cell differentiation starts in lens epithelial 
cells inappropriately early. These experiments demonstrate that Pitx3 acts as a 
negative regulator for β- and γ-crystallin expression in the lens epithelium. The 
detailed mechanism by which Pitx3 regulates crystallin expression, either directly or 
indirectly, is still unknown. 
In summary, the molecular characterisations of Pitx3 null lens showed precocious 
downregulation of the lens epithelial markers, PDGFRα and E-cadherin, and 
premature activation of the cell cycle inhibitors p27KIP1 and p57KIP2, and the fibre 
cell-specific proteins β- and γ-crystallin. Pitx3 null cells therefore show aspects of 
premature differentiation into fibre cells. This suggests that Pitx3 is required for the 
maintenance of lens epithelial cells and to prevent fibre cell differentiation events 
including cell cycle exit and crystallin expression (Figure 3-11). 
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3.3.4 Downregulation of the transcription factor Foxe3 in the Pitx3 null lens vesicle  
The concurrent and distinct functions of numerous transcription factors have been 
implicated in lens epithelial cell maintenance and fibre cell differentiation (Lang, 
2004; Ogino and Yasuda, 2000; Reza and Yasuda, 2004a). The molecular 
characterisation of Pitx3 null lens directed attention towards another interesting 
question, the integration of Pitx3 into the genetic pathway for lens development. I 
have chosen several transcription factors and examined their expression to determine 
whether the transcription factor Pitx3 is associated with their regulation during lens 
development. These candidates included Foxe3, Prox1, Six3 and Pax6. 
The winged helix forkhead transcription factor Foxe3 has a similar expression 
pattern to that of Pitx3 in the ocular lens (Blixt et al., 2000; Brownell et al., 2000; 
Semina et al., 1998; Semina et al., 2000). Foxe3 is initially expressed in the lens 
placode at the early stages of mouse lens formation. During differentiation of the lens, 
expression of Foxe3 is downregulated in differentiating fibre cells and remains active 
only in the relatively undifferentiated, proliferative cells of the anterior lens 
epithelium, thus being a marker of lens epithelial cells (Blixt et al., 2000; Brownell et 
al., 2000). Functionally Foxe3 promotes proliferation and prevents differentiation in 
the lens epithelium. It is also essential for lens vesicle closure and subsequent 
separation of the lens vesicle from the surface ectoderm (Blixt et al., 2000). 
Loss-of-function of Foxe3 in mouse mutants dyl  (dysgenetic lens) and Foxe3 
knockout mice give rise to premature differentiation of lens epithelial cells, reduced 
lens size, and formation of the keratolenticular connection (Blixt et al., 2000; 
Medina-Martinez et al., 2005). In humans, FOXE3 mutations cause cataracts and 
anterior segment mesenchymal dysgenesis (ASMD), similar to those of mutations in 
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PITX3 (Semina et al., 2001; Semina et al., 1998). The similarity of the expression 
domain and the mutant phenotypes of lens between Pitx3 and Foxe3 prompted an 
experiment to examine whether Pitx3 regulates Foxe3.  
Whole mount mRNA in situ hybridisation was performed 3 times and a total of 8 
Pitx3 wild type and 8 Pitx3 homozygous mutant embryos were analysed with the 
Foxe3 riboprobe. Whilst there was clear expression of Foxe3 in the forming lens 
vesicle of E10.5 Pitx3 wild type embryos (Figure 3-12 A), expression of the Foxe3 
transcript was lost at this stage in the Pitx3 null lens (Figure 3-12 B), suggesting that 
the expression of Foxe3 was regulated by Pitx3 during lens development. This might 
partially explain the phenotypes of the Pitx3 null lens since the Foxe3 mutant lens 
also demonstrated diminished pdgfra expression and inappropriate expression of 
p27KIP1 and β-crystallin in the lens epithelial cells (Blixt et al., 2000). 
The homeobox gene Prox1 has been shown to be essential for the terminal 
differentiation of lens fibre cells. Loss of Prox1 in mice causes abnormal cellular 
proliferation and downregulation of the cell cycle inhibitors p27KIP1 and p57KIP2, 
resulting in a hollow lens due to a failure of lens fibre cell elongation (Wigle et al., 
1999). This raised the question of whether the premature cell cycle exit in the Pitx3 
null lens vesicle is caused by deregulation of Prox1. To address this question, I 
examined the expression of Prox1 by mRNA in situ hybridisation in E10.5 embryos. 
A total of 7 Pitx3 wild type and 8 homozygous Pitx3 mutant embryos were analysed 
with the Prox1 riboprobe. In the Pitx3 wild type lens, Prox1 was differentially 
expressed in the posterior part of the lens where fibre cell differentiation is about to 
take place (Figure 3-12 C). However, Prox1 expression was extended into the 
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anterior part of the lens vesicle in Pitx3 homozygous mutants (Figure 3-12 D). The 
data indicates that Prox1 expression is repressed in the lens epithelium by Pitx3 
during normal lens development. 
The homeobox-containing transcription factor Six3 in the developing lens is 
expressed in the lens pit and the lens vesicle, and is later restricted to the anterior lens 
epithelium. A promoter experiment has suggested that Six3 may be a repressor of the 
γ-crystallin gene (Lengler et al., 2001). In medaka fish eye development, Six3 
antagonises the cell cycle inhibitor geminin to regulate the proliferation of retinal 
precursors cells, and prevents their premature differentiation (Del Bene et al., 2004). 
Since Six3 and Pitx3 have similar expression patterns in the developing lens, and 
both may be negative regulators of the expression of γ-crystallin, mRNA in situ 
hybridisation was performed to examine whether Pitx3 regulates Six3. 
A total of 7 Pitx3 wild type and 6 homozygous Pitx3 mutant embryos were analysed 
with the Six3 riboprobe. The result showed that the Six3 transcript was still present in 
the E10.5 Pitx3 null lens (Figure 3-12 F), and the expression pattern was not 
different from that of the Pitx3 wild type control lens (Figure 3-12 E). This is in 
keeping with the previous report that Six3 expression was observed throughout the 
lens remnants of the Pitx3 hypomorphic aphakia mice (Grimm et al., 1998). 
The homeobox gene Pax6 is an essential transcription factor for lens development 
and functions upstream of most lens regulators including Foxe3, Prox1, Maf and 
Sox2 (Collinson et al., 2000; Dimanlig et al., 2001; Fujiwara et al., 1994; Lang, 2004; 
Quinn et al., 1996). In later stages of lens development, Pax6 is expressed 
exclusively in the lens epithelial cells, and downregulated in the lens fibrous part 
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(Grindley et al., 1995; Kamachi et al., 1998). A number of promoter studies also 
propose a later role for Pax6 as a repressor for mouse lens fibre cell-specific 
βB1-crystallin (Cui et al., 2004; Duncan et al., 1998). These data suggest that Pax6 
may function to maintain the undifferentiated lens epithelium during later stages of 
lens development. Thus the loss of Foxe3 expression or the precocious activation of 
β-crystallin in the Pitx3 null lens might be due to a compromised maintenance of 
Pax6. However, antibody staining in E10.5 and E11.5 embryos showed that Pax6 
expression was maintained in both the normal Pitx3 heterozygous control lens and 
the Pitx3 null rudimentary lens (Figure 3-13). A previous report also demonstrates 
that Pax6 is expressed in the lens remnants of the Pitx3 hypomorphic aphakia mice 
(Grimm et al., 1998). 
In summary, the Pitx3 null lens vesicle demonstrated significantly reduced 
expression of Foxe3 and expanded expression of Prox1. This suggests that Pitx3 
regulates Foxe3 in order to maintain lens epithelial properties and normal closure and 
separation of the lens vesicle, and represses Prox1 directly or indirectly to prevent 
lens fibre cell differentiation (Figure 3-14). 
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Figure  3-7 Expression of epithelial markers in Pitx3 heterozygous null 
lens 
PDGFRα and E-cadherin were expressed in developing lens at E12.5 as epithelial 
markers (I-J, S-T). They were expressed throughout cells in the lens vesicle stage 
before differentiation into fibre cells in Pitx3 heterozygous (A-B, K-L) and 
homozygous (C-D, M-N) mice. However, the Pitx3 null lens at E11.5 showed earlier 
downregulation of PDGFRα (G-H) and E-cadherin (Q-R), compared to the Pitx3 
heterozygous control lens (E-F, O-P).  





Figure  3-8 β-catenin expression in Pitx3 heterozygous and null lens 
Cytoplasmic accumulation of β-catenin was restricted to the lens epithelial layer in 
the E12.5 Pitx3 heterozygous control (A-B), suggesting it might have a functional 
role in lens epithelial cells. At E10.5, β-catenin was expressed throughout the lens 
vesicle (C-D). Its expression in the Pitx3 null lens at E10.5 was not different from the 
heterozygous control. 
Scale bars are 100 µm for A-B, and 50 µm for C-F. 




Figure  3-9 Activation of markers for cell cycle exit in Pitx3 wild type and 
null lens 
Expression of cell cycle exit markers p27KIP1 begins at the posterior part of the 
developing lens when differentiation is initiated (E-F). p27KIP1 and p57KIP2 were 
activated in all cells of the lens vesicle in Pitx3 null mice from E10.5 (C-D, G-H, 
K-L). 
Scale bar is 100 µm. 




Figure  3-10 Expression of crystallin in Pitx3 heterozygous and null mice. 
β-crystallin was expressed in the fibrous part of the lens (E-F). In Pitx3 null mice 
β-crystallin was expressed earlier in the lens vesicle (A-D). γ-crystallin began to be 
expressed in mature fibre cells from E12.5 (M-N). It was expressed earlier (E11.5) in 
Pitx3 null lens (I-L). Expression of both β- and γ-crystallin was maintained in the 
disorganized E12.5 Pitx3 null lens (G-H, O-P). 
Scale bar is 100 µm. 
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Figure  3-11 Model for the role of Pitx3 in epithelial maintenance in the 
lens 
The Pitx3 null lens exhibits premature fibre cell differentiation, including earlier 
downregulation of lens epithelial markers with precocious withdrawal from the cell 
cycle and expression of the fibre cell-specific protein β-crystallin. This suggests that 
Pitx3 is required for the maintenance of lens epithelial status. 
- 126 - 
 
 
Figure  3-12 Expression of Foxe3, Prox1 and Six3 in Pitx3 wild type and 
null lens vesicle at E10.5 
In situ hybridisation showed Foxe3 expression in the normal lens vesicle at E10.5 but 
it was downregulated in Pitx3 null mice (A-B). There was expanded expression of 
Prox1 in Pitx3 null lens vesicle (C-D). The expression of Six3 was not affected (E-F). 
Scale bars are 200 µm for A-D, and 2 mm for E-F.
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Figure  3-13 Pax6 expression at E10.5 in Pitx3 heterozygous and null 
lens 
There was no differential expression of Pax6 between heterozygous and homozygous 
Pitx3 mutant lenses. 
Scale bar is 100µm. 
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Figure  3-14 Model for Pitx3 regulation of the expression of Foxe3 and 
Prox1 
In the Pitx3 null lens vesicle, there was downregulation of Foxe3 and expanded 
expression of Prox1. This suggests that Pitx3 maintains the lens epithelial cell 
properties partly via Foxe3 regulation, and directly or indirectly represses Prox1 in 
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3.4 Discussion 
3.4.1 The Pitx3-GFP reporter for studying lens development 
Previously a Pitx3-GFP reporter mouse line has been created in our laboratory to 
analyse Pitx3 expression and to create a mutation in the Pitx3 gene which results in a 
Pitx3 knockout (Maxwell et al., 2005; Zhao et al., 2004). The Pitx3 hypomorphic 
aphakia studies and the studies of Pitx3 null mice reveal that the phenotypes of these 
mice are largely similar (Maxwell et al., 2005), but there is a more severe mDA 
defect in the Pitx3 null mice than in aphakia mutants. This is probably due to the 
creation of a true null mutation by gene targeting since the entire Pitx3 coding 
sequence is deleted in the targeted Pitx3 locus (Maxwell et al., 2005; Zhao et al., 
2004)(Figure 1-1 C). In contrast, the entire coding sequence remains intact in the 
aphakia mutants and around 5% of the wild type level of Pitx3 transcript has been 
detected in E13.5 aphakia embryos (Rieger et al., 2001)(Figure 1-1 B). Additionally, 
in the Pitx3GFP/GFP mice the Pitx3 coding sequence is replaced with the cDNA of 
eGFP. This knockin-knockout strategy makes the Pitx3-GFP reporter mice a useful 
tool to track the Pitx3 expressing cells during development. Indeed, previous work 
carried out in our laboratory have shown that Pitx3-GFP expression mirrors that of 
the Pitx3 RNA and protein during development and in the adult mDA neuron system 
(Maxwell et al., 2005; Zhao et al., 2004). My study described here confirmed that 
Pitx3-GFP also serves as a reporter for cells of the lens lineage. However, Pitx3-GFP 
was still detectable in differentiated fibre cells in later foetal lens when Pitx3 protein 
was rarely detected in these cells. This is probably due to the difference in the 
stability between the Pitx3 and eGFP protein. In the midbrain studies, Pitx3 is 
expressed in post-mitotic mDA neurons and is maintained into adulthood, so the long 
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half life of Pitx3-GFP does not affect the faithful report of Pitx3 expression. In the 
developing lens, the Pitx3 protein disappears in differentiated fibre cells, which 
cannot be correctly reproduced due to the stability and accumulation of eGFP. A 
solution to this problem as a transcription reporter has been achieved by fusing the 
degradation domains of other proteins to the C terminus of eGFP to accelerate 
degradation (Li et al., 1998b). The half life of the destabilised eGFP is only 2 hours, 
thus such a rapid-turnover fluorescence protein may provide a better temporal 
transcription reporter to directly correlate gene induction with other cellular and 
molecular effects. 
However, Pitx3-GFP is still useful as a lineage marker to track the fate of Pitx3 
expressing cells during lens development in both the Pitx3 heterozygous and Pitx3 
null mice, at least before E14.5. This strategy has been used in Ngn2-GFP 
heterozygous mice for short-term lineage tracing of the progeny of Ngn2 expressing 
precursors because they maintain the GFP expression for a limited time (Andersson 
et al., 2006a). One example of this use of Pitx3-GFP is demonstrated in the current 
research in the identification of the origin of the persistent lens stalk. The property of 
the lens stalk has been suggested to be related to surface ectoderm rather than to 
lens-derived tissue because it expresses Pax6 but not Six3 (Grimm et al., 1998), and 
it expresses keratin, an epithelial marker for surface ectoderm (Zwaan and Webster, 
1985). In contrast, it has also been suggested that the persistent lens stalk may be a 
result of autonomous deficiency in the lens by a chimera study, in which the lens 
stalk was not observed when the corneal epithelium derived from surface ectoderm 
was predominantly mutant (Collinson et al., 2001). Our Pitx3-GFP reporter provides 
direct evidence that the lens stalk corresponds to Pitx3 expressing lens cells (Figure 
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3-1 F-G, 3-3 B, 3-4 B). In addition, since Pitx3 is only expressed in the lens during 
eye development, the anterior segment dysgenesis in our Pitx3 mutant mice provides 
more evidence that correct lens development is essential for the proper development 
of the anterior chamber of eyes, and anterior segment dysgenesis in Pitx3 
hypomorphic aphakia and Pitx3 null mice arises as a secondary consequence of 
primary defects in the lens. 
3.4.2 Chimera experiments in lens development 
Pitx3-GFP is also used as a lineage marker to track the fate of Pitx3GFP/+ or 
Pitx3GFP/GFP cells in chimera analysis. An important issue of chimera experiments is 
to distinguish the contribution and genotypes of mutant cells, and provide qualitative, 
quantitative and spatial information about their distribution in the chimeric tissues. 
Since I have both the heterozygous and homozygous Pitx3 mutant ES cell lines, no 
further molecular tests are needed to distinguish the genotype of the chimeras, which 
is necessary when embryos from crossmating of heterozygous animals are used for 
aggregation with wild type embryos. Additionally, in the current chimera studies, 
Pitx3-GFP positive cells could be readily distinguished from wild type cells in the 
developing lens of chimeras derived from either Pitx3GFP/+ or Pitx3GFP/GFP ES cells. It 
is straightforward to observe and quantitatively analyse the distribution and 
morphological change of these mutant cells in the developing lens. Therefore, the 
production of chimeras with my Pitx3-GFP reporter ES cells provides a fine-scale 
analysis of autonomy of the transcription factor Pitx3 function at the single cell level. 
However, the interpretation of this experiment is limited by the fact that the donor ES 
cells can only be detected by virtue of their Pitx3-GFP expression. As there is no 
constitutive marker for the donor ES cell-derived cells in this system, Pitx3 
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expressing cells which have contributed the lens but have downregulated Pitx3-GFP 
expression are therefore undetectable. 
My experiment has extended the finding of the previous chimera report that the gene 
aphakia acts cell autonomously in the lens (Liegeois et al., 1996). Chimeria 
experiments using aphakia mutants have also been used in the blastocyst 
complementation assay for developing lenses because mutant cells are genetically 
impaired to form a lens autonomously and the lens will derive entirely from donor 
cells (Liegeois et al., 1996; Zhao et al., 2006). Our highly sensitive eGFP reporter 
demonstrated that a certain proportion of lens cells are still Pitx3GFP/GFP derived in 
the phenotypically rescued lens. Therefore using aphakia blastocysts in this lens 
complementation system may have problems for genetic analysis of some candidate 
genes of lens development and the interpretation should be very careful. 
In the homozygous chimeric embryos in which relatively normal lens development 
was maintained by the wild type cells, the distribution of Pitx3 null cells was 
significantly lower in the lens epithelium, compared to that of heterozygous chimeras 
(E/T ratio 0.41 ± 0.23 vs. 0.84 ± 0.31, p<0.02), at E11.5. The Pitx3GFP/GFP cells were 
more severely underrepresented in the lens epithelium at E14.5 (E/T ratio 0.0057 ± 
0.0134 vs. 0.93 ± 0.12, p<0.0001). Thus, there is an autonomous requirement for 
functional Pitx3 for normal development of lens epithelial cells. 
Quantitative analysis did not show underrepresentation of Pitx3 mutant cells in the 
fibrous part at E11.5 although qualitative observation revealed segregation of some 
Pitx3GFP/GFPcells. By E14.5, Pitx3 mutant cells were underrepresented in the lens 
fibres as well as the lens epithelium in Pitx3GFP/GFP ↔ wild type chimeras (F/T ratio 
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0.34 ± 0.22 vs. 0.97 ± 0.04, p<0.0001). The lens epithelium acts as the source of lens 
fibres so this underrepresentation in E14.5 lens fibres (Figure 3-5 D) may partly 
reflect the earlier depletion of Pitx3 null cells from the lens epithelium (Figure 3-5 
A). 
An interesting finding in my Pitx3GFP/GFP ↔ wild type chimeras is the non-random 
distribution into separate populations and physically excluded buddings of Pitx3 
mutant cells at the fibrous compartment, especially in E14.5 chimeric lenses. Rare 
Pitx3 null cells differentiated into elongated fibre cells and integrated well in the 
fibrous compartment. These events are most likely the result of different adhesive 
properties of wild type and Pitx3 mutant cells at this stage in Pitx3GFP/GFP ↔ wild 
type chimeras. The transcription factor Pax6 has also been suggested to be involved 
in the regulation of surface/adhesion molecules because of similar patterns of 
segregation or physical exclusion observed in chimera studies (Collinson et al., 2000; 
Collinson et al., 2001; Collinson et al., 2003; Quinn et al., 1996). The sharp 
partitioning of the Pitx3GFP/GFP cells and wild type cells suggests a mechanism 
operating at an earlier developmental stage, most likely during differentiation that 
sorts the cells into large patches. 
Downregulation of Pitx3 expression in the differentiated lens cells suggests Pitx3 
may not be functionally activated in fibre cells. The abnormality of surface/adhesion 
molecules in the mutant fibre cells may be caused by deficiencies in the mutant lens 
epithelium, direct effects on the differentiating fibre cells, or both. Another 
explanation of the segregation picture is that asynchronous development, i.e. 
premature or impaired differentiation, of Pitx3 mutant cells makes their expression of 
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surface/adhesion molecules different from wild type cells. This question needs to be 
further investigated. 
In addition to the application in lens development research, chimeras derived from 
Pitx3GFP/+ and Pitx3GFP/GFP ES cells have also been used to study the autonomy of 
Pitx3 in mDA development by other members in our laboratory. In heterozygous 
chimeric mice, the Pitx3-GFP+ cells contributed to both the VTA and the SN area. On 
the other hand, in homozygous chimeras the Pitx3-GFP+ cells showed contribution to 
the VTA but rarely to the SN. The ratio of the number of Pitx3-GFP+ cells in the SN 
to the number of Pitx3-GFP+ cells in the VTA was compared between chimeras. The 
VTA acts as a control region where no variation is expected between Pitx3 
heterozygous and the Pitx3 null ES cell contribution as the VTA phenotype is the 
same in Pitx3 heterozygous and Pitx3 null E14.5 embryos. It has been demonstrated 
quantitatively that Pitx3 null cells were impaired in contributing to the SN, as the 
ratio of SN:VTA Pitx3-GFP+ cells in homozygous chimeras was much lower than in 
heterozygous chimeras (Maxwell, 2006). Therefore, these chimera experiments have 
shown a cell-autonomous requirement of Pitx3 for both SN mDA neurons and lens 
epithelium during development. 
3.4.3 Premature differentiation of lens cells in the absence of Pitx3 
Further immunohistochemistry studies in this chapter have revealed a reduced 
expression of the lens epithelial markers PDGFRα and E-cadherin, showing that 
Pitx3 null cells lose their epithelial properties. Additionally, Pitx3 null lens 
prematurely activated fibre cell-specific β- and γ-crystallins. Furthermore, cells 
throughout the Pitx3 null lens vesicle expressed cell cycle inhibitors p27KIP1 and 
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p57KIP2, suggesting that these Pitx3 null cells has arrested the cell cycle. This 
supported the chimera data that Pitx3 null cells hardly contribute to the proliferative 
lens epithelium. 
It has been shown that PDGF-A is a potent mitogen for lens epithelial cells (Kok et 
al., 2002), and signalling through PDGFRα is believed to mediate the growth of lens 
epithelium (Brewitt and Clark, 1988; Reneker and Overbeek, 1996). Therefore, it 
may be argued that PDGFRα also has a functional role for lens epithelial 
maintenance in addition to being a lens epithelial cell-specific marker. It has been 
reported that mice of the patch mutation, which includes a deletion of the PDGFRα 
gene (Stephenson et al., 1991), display abnormally shaped lenses with a decreased 
number of fibre cells (Morrison-Graham et al., 1992). More recent targeted mutation 
experiments have shown mice that lack the PDGFRα have apparently normal lenses, 
and the patch phenotype is multigenic with some but not all features attributed to the 
loss of the PDGFRα (Soriano, 1997). The lack of a phenotype may indicate that 
PDGFRα receptor pathway is not essential or may be functionally compensated in 
maintaining lens epithelial proliferation in vivo. The diminishment of PDGFRα 
indicates that Pitx3 null cells lose lens epithelial characteristics, rather than mutant 
epithelial cells experience a decreased growth factor receptor signalling.  
I have also examined the expression of β-catenin, which is a dual-functional 
molecule with a critical role in both Wnt signal transduction and cell-cell adhesion 
(Giarre et al., 1998). In the immunohistochemistry of E12.5 Pitx3GFP/+ lens, β-catenin 
was expressed exclusively in lens epithelial cells and disappeared in the lens fibre 
cells, implying a functional role for lens epithelial cell adhesion. This also indicates 
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that β-catenin may be another lens epithelial marker during lens development. 
Further immunohistochemistry data has shown that the β-catenin expression pattern 
was not altered in the E10.5 Pitx3 null lens vesicle, compared to the Pitx3 
heterozygous controls. This reveals that β-catenin-mediated epithelial cell adhesion 
is not altered in Pitx3 null lens at least at E10.5. However, it is still an unsolved 
question whether the Wnt signalling pathway is involved or not. It has been reported 
that Wnt signalling is essential for the maintenance of lens epithelial cells and to 
prevent fibre cell differentiation (Stump et al., 2003). However, my antibody staining 
pattern of β-catenin was mostly cytoplasmic rather than nuclear localisation. 
Although cytoplasmic accumulation of β-catenin is a common result of Wnt 
activation (Giarre et al., 1998), nuclear localisation is believed to provide more direct 
evidence of the activation of Wnt signalling to its target genes (Cong et al., 2003). It 
has been suggested that the antibody may be used against non-phosphorylated 
β-catenin to confirm the activation of the Wnt/β-catenin signalling pathway. However, 
it is worth noting that most of the reactivity of non-phosphorylated β-catenin in the 
lens epithelium is still cytoplasmic and only punctate reactivity is detectable in some 
nuclei (Stump et al., 2003). Therefore, alternative strategies should be used to 
investigate the role of the Wnt/β-catenin pathway in Pitx3 regulation of lens 
development. For example, lens epithelial cells can be placed in culture and used to 
determine the ability of purified growth factors to regulate lens epithelial cell 
proliferation or fibre cell differentiation (Chamberlain and McAvoy, 1989). In this 
primary cell culture system the Wnt/β-catenin pathway may be activated by 
treatment with lithium, which stabilises β-catenin by inhibiting GSK-3β (Hedgepeth 
et al., 1997; Klein and Melton, 1996), and the behaviour of Pitx3GFP/+ and 
Pitx3GFP/GFP lens cells can be compared. 
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Fibre cell elongation, which is a morphological hallmark of lens fibre cell 
differentiation, is severely impaired in both Pitx3 hypomorphic aphakia and the 
Pitx3 null mice. Therefore it has been suggested that loss of Pitx3 leads to impaired 
lens differentiation. More detailed molecular studies in lens development indicate 
that the lens fibre cell differentiation process can be uncoupled into several events, 
including cell cycle arrest, crystallin accumulation and cell elongation, among which 
each event can be regulated by different molecular pathways. Fibre cell elongation is 
a complex morphological change which involves precise regulation of cytoskeleton 
and cell-cell adhesion properties (Piatigorsky et al., 1972; Xia et al., 2006), 
appropriate membrane permeability, intracellular osmotic pressure and concentration 
of the structural proteins including crystallins (Bassnett et al., 1994; Beebe et al., 
1979; Parmelee and Beebe, 1988; Wang et al., 2005; Zelenka, 2004). Therefore, the 
impairment of elongation in Pitx3 null lens might be a secondary consequence of 
abnormal regulation of crystallins or surface/adhesion molecules. 
FGF signalling could be a candidate pathway involved in Pitx3 regulated lens 
development. In vivo studies using transgenic mice have demonstrated that 
lens-specific expression of several different FGF ligands induce lens epithelial cells 
to exit from the cell cycle prematurely and undergo ectopic fibre cell differentiation 
(Robinson et al., 1995). Experiments using the rat lens epithelial explant culture 
system suggested that a high concentration of FGF induces fibre cell differentiation 
events, including β- and γ-crystallin accumulation and cell elongation. The ERK 
pathway is responsible for FGF-induced fibre cell elongation and expression of the 
fibre cell-specific protein filensin (Lovicu and McAvoy, 2001). Phosphorylated 
ERKs are expressed in the rat lens epithelial layers and the transition zone, similar to 
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the expression domain of Pitx3. However, FGF-induced β-crystallin accumulation in 
lens cell culture experiments is independent of ERK signalling, suggesting that an as 
yet unidentified pathway is involved. Further detailed investigation about the 
functional roles of FGF signalling in Pitx3 regulated pathway could be achieved by 
primary culture of Pitx3GFP/+ and Pitx3GFP/GFP lens cells with the treatment of FGF 
and its inhibitors to examine the proliferation, cell elongation and expression of lens 
fibre cell-specific proteins. 
In summary, Pitx3 null lens cells show precocious activation of fibre cell 
differentiation programmes, suggesting that Pitx3 maintains the lens epithelial cell 
property (Figure 3-11). 
3.4.4 Comparison of Pitx3 to other transcription factors involved in lens epithelium 
development 
Transcription factors regulating lens development can be classified into two groups: 
those involved in lens fibre cell differentiation and those that maintain the lens 
epithelium. Known transcription factors functionally required for lens fibre cell 
differentiation include Prox1, c-Maf and Sox1. Comparison of the phenotype of 
Prox1, c-Maf and Sox1 knockout mice suggests distinct but overlapping functions for 
these genes in fibre cell differentiation. All three mutants show impairment in fibre 
cell elongation to fill the lens vesicle, so they all have a similar lens malformation 
characterised by a hollow lens (Kamachi et al., 1998; Kawauchi et al., 1999; Ring et 
al., 2000; Wigle et al., 1999). 
Transcription factors required for lens epithelial cells include Foxe3 and Pitx3. My 
experiments have revealed that Pitx3 is a more potent transcription regulator than 
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Foxe3 in the maintenance of lens epithelial cells (Chapter 3.3). There are a lot of 
similarities in the expression domain and the null phenotypes between these two 
transcription factors (Blixt et al., 2000; Brownell et al., 2000; Semina et al., 2001). 
Both mutants have the impaired growth of the lens structure which subsequently 
makes abnormal folding of the retina tissue and shrinkage of the eye, thus the mutant 
mice can not open their eyes. The lens vesicle of both mutants is not detached from 
the surface ectoderm and the persistent lens stalk interferes with the formation of the 
anterior chambers of the eye. The Foxe3 mutant mice show inappropriate expression 
of β-crystallin in some lens epithelial cells whereas the Pitx3 mutant mice show 
precocious expression of β-crystallin protein throughout the lens vesicle. Both 
mutants show earlier expression of p27KIP1 and expanded expression of Prox1, which 
are involved in cell cycle arrest and initiation of differentiation. The Foxe3 null lens 
shows diminished expression of the lens epithelial marker PDGFRα in the small 
population of lens epithelial cells that remain; however, the lens epithelial cells in the 
Pitx3 null mice completely disappear and the whole lentoid structure is absorbed 
before birth. Therefore, the phenotype of Pitx3 hypomorphic aphakia or Pitx3 null 
mice is much more severe than that of dyl mutants or Foxe3 knockout, supporting 
that Foxe3 is a Pitx3 downstream target. This is in agreement with a recent report 
demonstrating that pitx3 is required for foxe3 expression in zebrafish lens 
development (Shi et al., 2006b). Since mutation of Foxe3 also reveals an expanded 
Prox1 expression pattern in the lens epithelium, suggesting that Prox1 is genetically 
repressed by Foxe3 in a mouse lens developmental pathway (Blixt et al., 2000), 
further investigation is needed to examine whether Pitx3 represses the expression of 
Prox1 directly or via the Foxe3 pathway. 
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Pax6 and Six3 have also been implicated in a similar function. They are both 
evolutionarily conserved homeodomain transcription factors, and share a temporally 
and spatially overlapping expression pattern in the developing eye, including the 
optic stalk, optic vesicle, lens pit, lens vesicle, and later exclusively in lens epithelial 
cells and downregulated in differentiated lens fibre cells. Mutual regulation of these 
two transcription factors in the developing lens has been suggested previously 
(Goudreau et al., 2002). Although both Pax6 and Six3 function in broader regions at 
earlier stages, they may be involved in lens epithelial cell maintenance at later stages 
of lens development. It has been shown that lens-specific expression of Six3 or Pax6 
in transgenic mice gives rise to upregulation of PDGFRα and defective maturation of 
lens fibre cells (Duncan et al., 2004; Goudreau et al., 2002). Ectopic expression of 
Pax6 in the lens fibre cells reduces the transcript levels of βB1-crystallin and the 
protein levels of c-Maf, which is an important transcription factor in fibre cell 
differentiation, implying that the loss of Pax6 expression is essential for fibre cell 
differentiation and maturation (Duncan et al., 2004). Pax6 haploinsufficient mice and 
mice in which an upstream ectoderm enhancer of Pax6 has been deleted (Pax6∆EE/∆EE) 
both show defects in lens epithelial proliferation, smaller lens and a persistent lens 
stalk (Dimanlig et al., 2001; Hill et al., 1991). Promoter experiments have also 
shown that Pax6 and Six3 may be repressors of β- and γ-crystallin genes, 
respectively (Cui et al., 2004; Duncan et al., 1998; Lengler et al., 2001). Considering 
their inversely related temporospatial expression pattern to crystallin genes during 
lens development, it has been suggested that Pax6 and Six3 may be inhibitors of 
crystallin gene expression in lens epithelial cells while the activators such as Prox1 
and c-Maf are expressed. During fibre cell differentiation the repressors Pax6 and 
Six3 disappear and crystallin expression begins in the fibre cells. 
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Since the expression of Pax6 and Six3 is restricted to the lens epithelial cells, their 
remaining expression throughout the aphakia lens remnants has led to the hypothesis 
that the aphakia eye lacks fibre cell differentiation (Grimm et al., 1998). However, in 
my experiments the expression of β- and γ-crystallin observed in the Pitx3 mutant 
lens provides direct evidence that Pitx3 null cells activate aspects of fibre cell 
differentiation. The remaining expression of Pax6 and Six3 in the β- and γ-crystallin 
expressing Pitx3 null lens remnants implicated that the cooperation of Pitx3 might be 
required for the repression effect of Pax6 and Six3 on the crystallin genes. A good 
example is that indirect recruitment of Prox1 via other molecules collaborates with 
c-Maf in order to activate the mouse βB-crystallin promoter (Chen et al., 2002). A 
more detailed β- or γ-crystallin promoter experiment may be helpful to examine the 
interaction of Pitx3 with the repressors Pax6 and Six3, and the activators c-Maf and 
Prox1 in lens cells. 
Microarray and RT-PCR analysis of Pax6 heterozygous lens has suggested that Pitx3 
may be a direct target of Pax6 (Chauhan et al., 2002a; Chauhan et al., 2002b). The 
overlap in phenotypes of Pitx3 null, Foxe3 null and Pax6 haploinsufficient mice, and 
the similarity of clinical manifestation of ASMD with cataracts from heterozygous 
mutations in human PAX6, PITX3 and FOXE3 suggests that they may be part of a 
pathway involved in lens development. These data lead to the hypothesis that the 
transcription factor Pitx3 is located downstream of Pax6 and upstream of Foxe3 in 
the genetic regulation of lens development. Whether Pitx3 expression is directly 
regulated by Pax6 in the lens remains to be further investigated. 
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The transcription factor Six3 is also expressed at broader regions at earlier stages 
before being progressively restricted to lens epithelium, thus making it possible to 
function upstream of Pitx3. Further research is needed to investigate whether Six3 
regulates or cooperates with Pitx3 during lens development. 
3.4.5 Functional homology of Pitx3 in vertebrates 
Zebrafish pitx3 and Xenopus XPitx3 are more closely related to each other than to 
their mammalian Pitx3 orthologs. The Xenopus Xpitx3 and zebrafish pitx3 are both 
expressed in the prospective lens and pituitary (Dutta et al., 2005; Pommereit et al., 
2001). They may have subsumed the functions of mouse Pitx1 and Pitx3. Mouse 
Pitx1 expression is required for development of Rathke’s pouch and subsequently all 
endocrine adenohypophyseal cells (Gage et al., 1999; Lanctot et al., 1999; Szeto et 
al., 1999). However, mouse pituitary does not express Pitx3, and Pitx3 hypomorphic 
aphakia mice do not have any apparent pituitary defect (Gage et al., 1999; Semina et 
al., 1998; Smidt et al., 1997). Additionally, human foetal mesencephalon, but not 
anterior pituitary, expresses PITX3 (Pellegrini-Bouiller et al., 1999). 
In zebrafish, the pitx3 expressing cells constitute an equivalent domain of cells that can 
form either pituitary or lens, and in which a non-hedgehog signal initially specifies the 
placode field (Dutta et al., 2005). The smoothened mutant embryos that cannot 
transduce hedgehog signals lack pituitary and instead form ectopic lenses. The cell 
fate depends on the level of hedgehog signalling: the median pitx3 expressing cells 
respond to hedgehog signalling and acquire pituitary characteristics, whereas in the 
lateral region absence of hedgehog signal might favour lens specification (Dutta et al., 
2005). At later stages, pitx3 expression in the eye is restricted to the zebrafish lens 
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equator (Shi et al., 2005). In the zebrafish pitx3 knockdown experiment, the morphant 
lenses display disorganised and irregularly shaped cells, similar to the collapsed lens 
vesicle in Pitx3 null mice. Furthermore, immunohistochemistry has shown that the 
morphologically disordered morphant lens epithelial cells lack the molecular 
characteristics of the wild type lens epithelial cells. This supports a conserved 
requirement of Pitx3 for normal lens development. However, the pitx3 morphants also 
exhibit retina defects that are characterised by cell death and a significant reduction in 
some retinal cell types. The retina defects highlight a difference to the mouse Pitx3 
null phenotype, and are likely to be a non-autonomous effect from the aberrant lens 
development (Shi et al., 2005). 
Xenopus Xpitx3 transcripts are found in the thickening lens placode during early steps 
of eye cup function. In the later stages, expression of Xpitx3 in the lens is restricted to 
the anterior epithelial layer but is not detected in lens fibres, similar to the mouse Pitx3 
expression pattern (Pommereit et al., 2001). Overexpression and inhibition of the 
Xpitx3 function early in development alters the size of the medial pre-optic field as 
assessed by the markers Pax6 and Six3 (Khosrowshahian et al., 2005). Xpitx3 
knockdown results in abrogation of lens function, and in the absence of this critical cue, 
further prohibits induction of the retina, a phenotype similar to that of zebrafish. 
Therefore, although zebrafish pitx3 and Xenopus XPitx3 are also expressed in 
prospective pituitary, there is a conserved requirement of Pitx3/Xpitx3/pitx3 for the 
lens epithelial cells during development. 
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3.4.6 PITX3 and human cataracts 
Mutation of PITX3 in humans is responsible for autosomal dominant posterior polar 
cataract, which is a clinically distinctive opacity located at the back of the lens and 
can have a marked effect on visual acuity. The human PITX3 gene is mapped to 
10q25 (Semina et al., 1998). The genomic structure of PITX3 appears to be the same 
as that of the mouse gene. Human and mouse PITX3/Pitx3 are 88% identical at the 
nucleotide level throughout the coding region and 80% identical in the 3’ UTR. At 
the protein level, PITX3 and Pitx3 appear to be 99% identical (4 amino acid 
substitutions out of 302), with 100% identical in the homeodomain. 
Detailed sequence analysis has revealed that a recurrent 17 base pair duplication 
(657ins17bp) in PITX3 is primarily associated with this familial cataract (Addison et 
al., 2005; Berry et al., 2004; Semina et al., 1998). The duplication in exon 4 results in 
a frameshift in codon 220 and produces an aberrant protein consisting of 94 
additional residues. In addition to this duplication mutation, another recently 
identified mutation in PITX3 is 650delG (Berry et al., 2004; Bidinost et al., 2006). 
This novel locus in 10q25 encompassing PITX3 for the posterior polar cataract has 
been termed CPP4 (Berry et al., 2004). Two cases that are homozygous for this 
PITX3 mutation have been reported to display microphthalmia and significant 
neurological impairment (Bidinost et al., 2006). It has been suggested that the 
mutation CPP4, which is located outside the homeodomain region, alters the 
complex protein-protein interaction which imparts the specificity and efficiency to 
homeoprotein function (Semina et al., 1998), but further investigation is needed for 
the mechanisms giving rise to the specific manifestation of the ocular disease. 
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Other mutation of known genes associated with posterior polar cataract include 
CRYAB (Berry et al., 2001). Since my mouse experiments have revealed that Pitx3 is 
involved in the regulation of crystallin expression, it would be interesting to 
investigate whether the PITX3 mutation in humans is associated with crystallin 
regulation. 
Although the posterior polar cataract is the predominant feature of the PITX3 
mutation, some affected families have ASMD in addition to the cataract. Within these 
families the phenotype is variable with only some affected members of the pedigrees 
displaying ASMD (Burdon et al., 2006). This variability within families and between 
families suggests the presence of modifying genes or environmental factors for 
ASMD. This is also in keeping with my Pitx3 null mouse experiments that the lens 
deformity is the predominant phenotype and the dysgenesis of the anterior chamber 
is secondary to the developmental defect of the lens. 
A number of mutations in transcription factors have been shown to cause ASMD and 
cataracts, including PAX6, FOXE3, MAF and EYA1. In my mouse experiments, 
expression of Foxe3 is regulated by Pitx3. Other studies have suggested that Pitx3 
may be regulated by Pax6 in lens development (Chauhan et al., 2002a; Chauhan et al., 
2002b). A notable overlap in the phenotypes arising from mutations in PAX6/Pax6, 
PITX3/Pitx3 and FOXE3/Foxe3 suggests that they may be part of a pathway that 
involves mutual activation during human lens development (Semina et al., 2001; 
Semina et al., 2000). 
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Developing the Pitx3-GFP ES cell systems for the 
identification of midbrain dopaminergic regulators 
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4.1 Introduction 
4.1.1 A lineage-specific reporter ES cell system 
A key property of ES cells is that their genome can be manipulated without 
compromising their pluripotency. Therefore these cells provide an excellent tool to 
study the cellular and molecular basis of commitment and differentiation events 
during early development. To achieve this goal, the commitment or differentiation 
events should be induced reproducibly in a controlled, stepwise fashion. It should be 
possible to identify differentiated cells at various stages along the lineage and these 
cells should express expected patterns of markers and exhibit functional capacity 
during stages of development. Since current differentiation protocols generally result 
in a mixed population of cells which are enriched only to a limited degree for the 
cells of interest, ES cells with an engineered lineage marker can provide a useful tool 
for evaluating molecules which regulate cell fate and/or differentiation (Aubert et al., 
2002; Li et al., 1998a; Ying et al., 2003b). In order to study mDA fate specification, 
we have generated ES cell lines in which a reporter has been linked to reproduce the 
expression of Pitx3. 
Reporter proteins can generally be visualised due to bioluminescence, fluorescence 
or enzymatic properties. The gene encoding the reporter protein may be expressed 
under the control of a specific promoter by a number of methods. For example, in a 
traditional transgenic approach, a construct can be made containing a cell 
type-specific promoter fused to a reporter gene, which is introduced into ES cells. 
However, the integration of the reporter gene into the genome is random and the 
neighbouring sequences may interfere with the regulation of the reporter gene 
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expression, thus obscuring reporter gene analysis. To avoid this problem, the reporter 
gene may be placed under an endogenous gene promoter via homologous 
recombination in ES cells, thus it can recapitulate the expression of the gene of 
interest. 
A number of proteins have been successfully used as reporters, including a vital 
fluorescent reporter such as green fluorescent protein (GFP) from the bioluminescent 
jellyfish Aequorea victoris (Chalfie et al., 1994). Several mutants of wild type GFP 
have been created to allow increased brightness and thermostability in mammalian 
expression. For example, the enhanced GFP (eGFP), the most popular variant for use 
in mice, has two amino acid changes in the vicinity of the fluorophore (F64L and 
S65T), thus it is more thermostable at 37ºC and it is 350-fold brighter than wild type 
GFP (Hadjantonakis et al., 2003). Whilst eGFP may not be as sensitive as some 
enzymatic reporters it has the advantage that no substrate or reaction cofactors are 
required. In addition, eGFP can be directly visualised under the fluorescence 
microscope in both fixed tissue and live cells. This non-invasive visualisation of GFP 
opens up the possibility for direct observation and purification of these cells by 
fluorescence-activated cell sorting (FACS) for further experiments without fixing the 
cells (Aubert et al., 2003; Maxwell et al., 2005; Wang et al., 1998). 
Other options for reporters include the enzymes β-galactosidase (β-gal), luciferase 
and β-lactamase. Enzymatic reporters are sensitive detectors of gene expression as 
each molecule of enzyme can catalyse many reactions to produce the detected 
product. However, a substrate must be present in order to facilitate the visualisation 
of the reporter expression and it can be difficult to deliver the substrate to live cells. 
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A good example of the application of enzyme reporter is the improvement of 
subcellular resolution by the axon-targeted fusion protein tauLacZ. This recombinant 
protein fuses β-gal, the product of the E.Coli LacZ gene, to bovine tau, a member of 
the microtubule-associated protein family (Callahan and Thomas, 1994; Callahan et 
al., 1998). This reporter labels cell bodies and axons which are sensitively detected 
by X-gal staining. The Pitx3-tauLacZ reporter system is being developed by other 
people in our laboratory for in vivo analysis of mDA axon pathfinding and in vitro 
experiments for testing important chemoattractive or chemorepulsive factors for axon 
guidance during mDA development (Vives and Li, in preparation). 
The drawback of either the GFP or β-gal reporter is the stability and accumulation of 
these reporter proteins in the cell when the gene of interest is no longer expressed. 
Since Pitx3 is expressed and maintained in post-mitotic mDA neurons into adulthood, 
the accumulation of Pitx3-GFP and Pitx3-tauLacZ does not affect the faithful 
reporting of the Pitx3 protein. 
4.1.2 Gain-of-function experiments for ES cells 
Gain-of-function analysis by putting transgenes into ES cells has proved to be a 
valuable system for the study of fate commitment. Gene transfer into mammalian 
cells may be achieved by infection with a virus that carries the recombinant gene of 
interest. In this thesis the transgenes were introduced into cells using plasmid DNA. 
Most of the expression vectors used in this study were derived from pCAGASIP 
(Appendix I), unless specially notified. 
The essential elements of mammalian expression vectors include (1) prokaryotic 
origin of replication and selection markers for vector propagation in bacteria; (2) a 
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constitutive or inducible promoter capable of robust transcriptional activity; (3) 
optimised mRNA processing and transcriptional signals; (4) a eukaryotic selection 
marker in order to screen the successfully transfected cells (Makrides, 1999). The 
components of expression vectors used in this thesis are introduced as follows. 
The prokaryotic selection box enables the plasmid to be screened and amplified in 
bacteria E Coli. All the plasmids used in the current research contain Amp, therefore 
successful transformants can be selected using 50 µg/ml ampicillin. 
Promoters or enhancers: A lot of promoters are available to activate transcription in a 
ubiquitous or tissue specific manner. The widely used promoters include the human 
cytomegalovirus (CMV) immediate early promoter, SV40 virus promoter and the 
murine 3-phosphoglycerate kinase (PGK) promoter. All the expression vectors in this 
investigation contain the CAG promoter which includes: human CMV immediate 
early enhancer; chicken β-actin promoter, the untranslated exon 1 and most of intron 
1; the 3’ portion of intron 2 and part of exon 3 from rabbit β-globin. It is thought that 
both intron 1 of the β-actin gene and the 3’ region of the rabbit β-globin gene contain 
enhancer-like activity, in addition to the CMV sequence. The CAG promoter can 
effectively drive high levels of transgene expression in a wide variety of cell lines, 
including undifferentiated ES cells (Chambers et al., 2003; Chung et al., 2002a; 
Niwa et al., 2000; Niwa et al., 1991). 
Polyadenylation (polyA) signal: The polyA signal is put at the 3’ end of target gene 
cDNA to stop transcription. There are several efficient polyA signals to be used in 
mammalian expression vectors, including those derived from bovine growth 
hormone, mouse β-globulin, the SV40 early transcription unit and the Herpes 
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simplex virus thymidine kinase (HSV tk) gene (Makrides, 1999). In this thesis, the 
bovine growth hormone polyA was put at the 3’ end of the pac (puromycin 
N-acetyltransferase) cDNA for puromycin resistance. For inducible expression 
constructs, polyA derived from HSV tk was put after neo cDNA.  
Internal ribosomal entry site (IRES): IRES is now widely used in many applications 
that require co-expression of multiple genes from a single transcript by the same 
regulatory promoter or enhancer (Mountford et al., 1994; Mountford and Smith, 
1995). Most expression constructs in this study contain irespac (IP) following the 
gene of interest. Upon transcription, this cassette will create a bicistronic transcript 
which is translated to make the protein of interest and puromycin N-acetyltransferase. 
Therefore it is possible to select and maintain cells expressing the gene of interest by 
puromycin. 
All the expression vectors used also contain ori, the origin of polyoma virus 
replication. If the host cells also express the large T protein of polyoma virus, the 
vectors will be replicated in multiple copies and maintained in episomal status. 
ES cell gain-of-function analysis has previously been used for studying mDA neuron 
differentiation. For example, forced expression of Lmx1a by Nestin-enhancer in ES 
cells results in generation of TH+ neurons that all co-express mDA markers, 
including Nurr1, Pitx3, and En1/2 (Andersson et al., 2006b). Genetic modification of 
ES cells with the transcription factor Nurr1 leads to increased production of TH+ DA 
neurons (Chung et al., 2002b; Kim et al., 2002). Recently, Nurr1 has been shown to 
induce TH expression in non-neuronal cells in ES cell differentiation (Sonntag et al., 
2004), suggesting that Nurr1 controls the biochemical neurotransmitter phenotypes 
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of DA neurons independent of their neuronal cell fate specification. During my PhD, 
data in our laboratory have shown that Pitx3 overexpression does not alter the total 
number of TH+ DA neurons generated by in vitro differentiation, but enhances the 
proportion of TH+ DA neurons that also express the midbrain marker Pitx3-GFP 
(Maxwell et al., 2005). Another group has also reported that Pitx3 overexpression 
increases the proportion of Pitx3 expressing cells in the TH+ population from 21.1% 
to 92.8% (Chung et al., 2005) 
4.2 Derivation of homozygous Pitx3GFP/GFP ES cells 
4.2.1 Purpose of derivation of homozygous Pitx3 null ES cells 
ES cells with genetic defects may provide useful tools for defining the functional role 
of particular genes during development, and to study human genetic disease in 
cellular models (Pera and Trounson, 2004; Wilmut, 2004). We have shown that Pitx3 
is required for maintenance/survival of mDA neurons and the regulation of TH 
expression (Maxwell et al., 2005). Further work is required to elucidate the detailed 
molecular mechanisms involved. A homozygous Pitx3 null ES cell system may 
provide a platform to evaluate mDA differentiation and maintenance, and to test 
candidate Pitx3 downstream targets.  
In addition to producing homozygous ES cells where both alleles of the Pitx3 gene 
are inactivated, other methods to silence or inactivate the target gene include RNA 
interference (RNAi) or expression of dominant-negative proteins, which are mutant 
and inactive forms of the target gene but can interfere with normal protein function 
(Porter, 1998). The advantage of the latter two methods is that the target gene 
inactivation is reversible and can be quantitatively controlled. However, the 
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specificity of RNAi and dominant-negative experiments are not as predictable as 
knockout studies, and it is necessary to have complementary experiments to confirm 
that the phenotype is reversed by an expression construct for the target gene in 
question. 
Furthermore, homozygous Pitx3GFP/GFP ES cells can also be used to produce chimeric 
animals to investigate the functional role of Pitx3 in developing lens and midbrain 
(Collinson et al., 2004; Rossant and Spence, 1998). 
4.2.2 Methods for derivation of homozygous transgenic ES cells 
Several methods can be used to produce ES cells that are double knockout. These 
include sequential targeting of both alleles of the gene of interest (Mortensen et al., 
1991; te Riele et al., 1990). In these experiments, inactivation of the targeted gene 
has been achieved by insertion of a drug resistant gene, so two separate constructs 
with two different selection markers are required. Another approach is to use a single 
targeting construct and select the targeted ES cells undergoing spontaneous loss of 
heterozygosity using high concentrations of drugs (Lefebvre et al., 2001; Mortensen 
et al., 1992). For sequential gene targeting strategies, there are concerns that the 
presence of the selectable marker expression cassette, i.e. the drug resistant gene, 
may influence the expression of neighbouring genes (Nagy, 2000). In our laboratory, 
the heterozygous Pitx3GFP/+ ES cells had been established by a targeting construct 
carrying a floxed PGK promoter-driven hygromycin-thymidine kinase (hygro-tk) for 
selection. The floxed selection cassette has been deleted by transient expression of 
Cre-recombinase, so the established heterozygous ES cell line is hygro-tk negative. 
Thus it is possible to perform another round of gene inactivation via homologous 
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recombination using the same targeting construct again. All the methods above use 
the strategy of gene targeting by homologous recombination, so it is required to 
screen colonies to confirm their correct integration. 
An alternative method could be to derive ES cells de novo from homozygous Pitx3 
null embryos. The expression of Pitx3 is first detected at E10 (Semina et al., 2000). 
There is no phenotype of homozygous Pitx3 null embryos before the blastocyst stage, 
so it is therefore likely to be possible to generate Pitx3 null ES cells from 
homozygous mutant blastocysts. The literature has reported derivation of germ-line 
competent ES cell lines from denuded preblastocyst mouse embryos when 
blastomeres are not yet committed to either the inner cell mass (ICM) or 
trophectodermal lineage (Tesar, 2005). However, it still remains to be further 
investigated whether these ES cells derived during the preblastocyst period have a 
wider differentiation potential than those derived from blastocysts. It has also been 
reported recently that mouse and human ES cells can be derived from single 
blastomeres by using a technique of single cell embryo biopsy similar to that used in 
pre-implantation genetic diagnosis (PGD) of genetic defects in IVF clinics (Chung et 
al., 2006; Klimanskaya et al., 2006). In these experiments each isolated blastomere 
was aggregated with a small clump of GFP positive mouse or human ES cells, and 
after incubation on mouse embryonic fibroblast (MEF) feeder cells, the growing GFP 
negative cells were separated and expanded. Although the authors have claimed that 
this approach circumvents the ethical concerns about embryo destruction, further 
evaluation is needed to assess the developmental potential of those parental embryos 
after biopsy.  
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The procedure used in this thesis to derive ES cell lines from whole blastocysts on 
feeders has been described elsewhere (Nichols et al., 1990). It is technically less 
complicated and the efficiency in generating transgenic ES cells is acceptable. 
4.2.3 Derivation of Pitx3 null ES cells from mutant blastocysts 
To obtain Pitx3 mutant blastocysts, mice were set up to intercross Pitx3 homozygous 
with Pitx3 heterozygous. A total of 9 mice were plugged in 3 days. Mice of the strain 
129 were also set up as the control group and 14 of them were plugged. The mice 
with plugs were injected with Depo-Provera 1 mg subcutaneously and tamoxifen 
0.1mg intraperitoneally on E2.5 to delay implantation. 
MEF cells, which were used as feeders for ES cell derivation, were exposed to 
γ-irradiation in order to render them mitotically inactive before being plated into 
4-well plates. The medium for the feeder cells was always replaced at least one hour 
before experiments for pre-equilibration. All mice were sacrificed at E7.5 just before 
flushing to keep the viability of the blastocysts and a total of 54 blastocysts from the 
mutant group and 70 from the strain 129 were recovered. 
After 5 days the blastocysts attached separately and spread out on the feeder layer 
whilst the ICMs remained central and began to grow rapidly. The central mass of 
each explant was picked up for trypsin treatment. Following incubation at 37ºC for 3 
minutes, the border of the cell mass began to look rough due to enzyme digestion. 
Then the cell mass was gently disaggregated into smaller cell aggregates of 3-4 cells, 
and subsequently transferred to 4-well plates with feeder cells in pre-equilibrated 
complete medium. Each single ICM-derived clump was disaggregated and plated 
into one single well of 4-well plates. The dissociated cell clumps began to grow into 
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different differentiated states, as trophectoderm, primitive endoderm, epithelial-like 
cells, and primary ES cell colonies. Once they had reached an appropriate colony 
size, the primary ES cell colonies (Figure 4-1 A) were individually picked and 
expanded in feeder-free, gelatinised plates (Figure 4-1 B-C). The efficiency of ES 
line yield from the strain 129 and the mutant group is 16.2% and 13.7%, respectively 
(p=0.85 by Chi-square test)(Table 4-1). It took one month to establish ES cell lines 
from blastocysts (Table 4-2). 
Since the intercrossing was set up as homozygous x heterozygous, 50% of the 
blastocysts would be Pitx3 homozygous (Pitx3GFP/GFP) and 50% heterozygous 
(Pitx3GFP/+). The genomic DNA of the mutant ES cell lines was extracted for PCR 
genotyping by a combination of three primers (Figure 4-2 A). The Pitx3GFP allele 
produced a band of 590 bp, and the wild type allele a band of 369 bp. Of the 7 lines 
tested, Pt2A, Pt2B, Pt2C, Pt7B and Pt8C were homozygous Pitx3GFP/GFP ES cells; 
Pt3A and Pt3B were heterozygous Pitx3GFP/+ ones (Figure 4-2 B). 
After disaggregation from primary ES cell colonies, 2 lines (Pt2A and Pt2C) showed 
a tendency to differentiate. When expanded into feeder-free, gelatinised 6-well plates, 
only a small percentage of cells remained an undifferentiated state (Figure 4-3 A). To 
test whether serum-free medium N2B27 plus LIF plus BMP4 (Ying et al., 2003b) 
could rescue these 2 lines, cells were split equally into 2 parts: one part was cultured 
in normal ES medium with FCS plus LIF; the other was cultured in N2B27 medium 
with the combination of LIF plus BMP4 10 ng/ml (R&D). A large proportion of 
differentiated cells persisted in serum-containing medium (Figure 4-3 B), while in 
serum-free condition, differentiated cells disappeared gradually and undifferentiated 
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cells began to dominate (Figure 4-3 D). After 2 passages in N2B27 medium a highly 
purified population of undifferentiated ES cells were obtained (Figure 4-3 D). When 
returning to serum-containing medium, they still kept growing in an undifferentiated 
state, and could be expanded and frozen when appropriate. 
The heterozygous line, Pt3A, and the homozygous, Pt2B, were used to produce 
chimeric animals with wild type morulae via the diploid aggregation procedure. 
These cells contributed extensively in resulting chimeras as demonstrated by GFP 
expression in midbrain, developing lens and tongue, thus validating these 2 lines as 
true ES cells. 
- 158 - 
 
 
 129 mutant 
Mice plugged 13 9 
Blastocysts flushed out 70 54 
Colonies after disaggregration 11 7 
Transfer to 6-well dish 11 7 
Transfer to small flask 11 6 
Established/frozen 10 6 
Derivation efficiency 16.2% 13.7% 
Table  4-1 ES cell derivation efficiency from blastocysts 
 
9 Feb Mouse set up   
12 Mouse plugged Day 3 of set up 
14 Depo Provera/Tamoxifene injection E2.5 
19 Blastocysts flush out E7.5 
24 Disaggregation of ICM clumps 5 days after flush 
4 Mar Disaggregation of primary colonies 9 days after disaggregation 
7 Expansion into 6-well plate   
9 Expansion into 25cm2 flask   
15 Freeze   
Table  4-2 Time required for derivation of ES cells from blastocysts. 
 





Figure  4-1 Derivation of Pitx3 null ES cells.  
(A) Primary ES cell colony. After disaggregation of primary ES cell colonies, ES 
cells expanded with (B) and without (C) feeder cells. 
 




Figure  4-2 PCR analysis for genotyping. 
(A) PCR strategy: The homozygous cells should show one band at 590 bp and the 
heterozygous ones should show 2 bands of 369 bp and 590 bp. (B) In the seven lines 
tested, 2 were heterozygous and 5 were homozygous. 
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Figure  4-3 Undifferentiated ES cells enriched by serum-free medium. 
(A-B) Differentiated cells maintained during culture of Pt2A ES cell lines. (C-D) 
Undifferentiated ES cells were enriched when cultured in serum-free medium N2B27 
with a combination of LIF plus BMP4. Arrow: undifferentiated ES cells. 
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4.3 Characterisation of Pitx3GFP/+ ES cell-derived GFP positive cells 
ES cells derived were then used for mDA differentiation experiments using the PA6 
coculture system. After a total of 2 weeks of in vitro differentiation, Pitx3-GFP 
positive cells with a typical polarised neuronal morphology could be detected. 
Pitx3-GFP was also expressed in other cell types after in vitro differentiation, in 
keeping with the proposal that in vitro differentiation gives rise to a mixture of cell 
types, of which the detailed phenotype needs to be further investigated. In this thesis 
the Pitx3-GFP positive cells are referred to as those GFP expressing cells with 
neuronal morphology. 
Most Pitx3-GFP positive cells co-expressed β-tubulin III (Figure 4-4 A-C), a marker 
of neuronal cells, and TH (Figure 4-4 D-F), a marker for DA neurons. Based on 
expression analysis of Pitx3-GFP in developing mouse embryos and adult brain by 
other members in our laboratory (Zhao et al., 2004), it suggested that these 
Pitx3-GFP positive cells were mDA neurons. However, only 13.5±2.7% 
(average±SEM) of TH+ cells co-expressed Pitx3-GFP. Since Pitx3 is a specific 
marker for mesencephalic DA neurons in the central nervous system (Smidt et al., 
1997), this data suggested that in vitro differentiation produced a mixture of DA 
neurons and not all of them display mesencephalic characteristics. 
ES cells have the ability to respond to normal developmental cues when introduced 
into early embryos. However, appropriate inductive signals might not be present 
during in vitro differentiation. Therefore there are concerns whether the differentiated 
end cells have the expected patterns of marker gene expression and functional capacity. 
This led to the requirement to characterise the Pitx3-GFP+ cells using alternative 
independent mDA antigenic expression. The immunohistochemistry experiments 
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revealed that the majority of Pitx3-GFP+ cells exhibited nuclear distribution of En1 
and Nurr1 protein (Figure 4-5), demonstrating their mesencephalic identity. 
The Pitx3GFP/+ ES cells have been used in gain-of-function analysis by other members 
of this laboratory. It has been shown that Pitx3 overexpression in Pitx3GFP/+ ES cells 
produces around 3 times more Pitx3-GFP+TH+ cells but does not change the total 
number of TH+ DA neurons (Maxwell et al., 2005). This led to the question of whether 
the increased proportion of Pitx3-GFP+ cells by Pitx3 was due to terminal fate 
determination or initiation of ventral mesencephalic neural precursor generation. 
Therefore, it is necessary to ask whether constitutive expression of Pitx3 in ES cells 
affect the production of neural progenitors. En1 expression, which is observed in early 
midbrain neural precursors as well as in differentiated mDA neurons (Alberi et al., 
2004), was examined at day 6 of in vitro differentiation when neural progenitors were 
generated from ES cells. First of all, the differentiation experiment was performed by 
using 46C (Sox1-GFP reporter) ES cells to determine whether En1 expression during 
in vitro differentiation of ES cells was restricted to neural lineage or not. The 
transcription factor Sox1 is an early marker expressed in ectodermal cells committed 
to the neural fate (Pevny et al., 1998), thus the 46C ES cells have proved to be a useful 
tool in evaluating neural differentiation from ES cells (Aubert et al., 2003; Barraud et 
al., 2005; Watanabe et al., 2005; Ying et al., 2003b). My immunohistochemistry 
experiments showed that all En1+ cells co-expressed Sox1-GFP (Figure 4-6), 
suggesting that En1+ cells were of neural cell identity, at least at day 6 in the PA6 
coculture system. Nurr1 staining was also evaluated at this stage but was not 
co-expressed with Sox1-GFP at all. Therefore, En1 could be used as a marker to 
examine midbrain neural progenitors at day 6 of differentiation. Further experiments 
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showed a similar percentage of En1 expressing cells in the Pitx3 overexpression 
(9.2±1.1%) and the control (10.3±2.5%) cultures at day 6, suggesting that Pitx3 
overexpression does not appear to have an effect on the generation of mesencephalic 
DA precursors, and the increased proportion of Pitx3-GFP+ cells is probably due to 





Figure  4-4 β-tubulin III and TH expression of Pitx3-GFP  cells 
Pitx3  ES cell-derived GFP  cells with neuronal morphology were detected with 
GFP distribution in the cell bodies and cytoplasm, including in the axons. Almost all 
Pitx3-GFP  cells co-expressed cytoplasmic distribution of the neuronal marker 
β-tubulin III and TH, the rate-limiting enzyme for dopamine synthesis, suggesting 
that they were dopaminergic neurons.  









Figure  4-5 En1 and Nurr1 expression in Pitx3-GFP  neurons. 
Nuclear expression of En1 and Nurr1 in the majority of Pitx3-GFP  neurons 
validates their mDA characteristics.  











Figure  4-6 En1 expression in Sox1  neural precursors during in vitro 
differentiation.  
At day 6 of in vitro differentiation in PA6 coculture system, nuclear distribution of 
the En1 protein and cytoplasmic distribution of Sox1-GFP was detected in 46C ES 
cells. All En1  cells co-expressed Sox1-GFP, suggesting that they were neural 
precursor cells. (F) Inset of D, E.  
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4.4 In vitro differentiation of Pitx3GFP/GFP ES cells into mDA neurons 
The GFP reporter can also be exploited to track the fate of Pitx3 expressing neurons 
during in vitro differentiation from Pitx3 null ES cells. With the loss of the Pitx3 
protein, GFP+ cells with neuronal morphology could still be detected after 2 weeks of 
in vitro differentiation. No difference in Morphology could be observed between the 
Pitx3 null ES cells and those derived from Pitx3GFP/+ ES cells (Figure 4-7). The 
majority of these GFP+ cells co-expressed the neuronal marker β-tubulin III, and 
mDA markers TH and Nurr1, suggesting that they were mDA neurons. There was no 
significant difference in the number of TH+ neurons in heterozygous and 
homozygous Pitx3-GFP reporter ES cell lines after in vitro differentiation. 
Additionally, there was no difference between the percentage of Pitx3-GFP+ cells 
that also expressed TH from heterozygous Pitx3GFP/+ (92.8±2.2%) and homozygous 
Pitx3GFP/GFP ES cells (92.2±3.4%) (Figure 4-8 A). However, the percentage of 
GFP+TH+ cells in the TH+ population was 5.8±3.4% in the homozygous group, 
whilst the percentage of the heterozygous group was 13.5±2.7% (Figure 4-8 B). Thus 
the proportion of the ES-cell derived TH+ DA neurons that also expressed Pitx3-GFP 
was significantly reduced (p<0.001) in the homozygous Pitx3GFP/GFP group, 
compared to the heterozygous Pitx3GFP/+ group. This suggests a reduction in the 
proportion of TH+ DA neurons of midbrain dopaminergic type. 
A replacement experiment was performed by introducing Pitx3 expressing vector 
into Pitx3GFP/GFP ES cells to examine whether the impaired potential to differentiate 
into mDA neurons could be rescued. The Pitx3 expression construct, pCAGPitx3IP 
(Figure 4-9 A, Appendix II) has been previously described (Maxwell et al., 2005). 
Briefly, the Pitx3 cDNA is driven by the constitutive promoter complex CAG. The 
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puromycin resistant gene pac is linked downstream of the Pitx3 cDNA via an internal 
ribosome entry site to ensure that all puromycin resistant cells co-express the Pitx3 
cDNA. A total of 4 lines has been picked up and expanded. The Pitx3GFP/GFP ES cells 
engineered with a Pitx3 transgene will be referred to as PtBR ES cells. 
These PtBR ES cells behaved similarly to their parental ES cell lines in standard ES 
cell culture medium. They did not express Pitx3-GFP or TH in the undifferentiated 
state. The line#1 was used for further differentiation experiments. Following a 
2-week in vitro differentiation, PtBR ES cell-derived GFP+ cells exhibited neuronal 
morphology and also expressed TH (Figure 4-9 B-D). The majority of Pitx3-GFP+ 
cells co-expressed Nurr1 (Figure 4-9 E-G). There was no significant change in the 
number of TH+ cells generated, but the percentage of TH+ DA neurons that also 
expressed Pitx3-GFP was 47.98±7.29%, which was significantly higher than that 
were obtained from Pitx3GFP/GFP ES cells (5.79±3.43%, p<0.001), and even higher 
than that from heterozygous Pitx3GFP/+ ES cells (13.5±2.72%, p<0.001) (Figure 4-8 
B). 





Figure  4-7 Marker expression in Pitx3  ES cell-derived GFP  
neurons 
Pitx3 null ES cells gave rise to GFP  neurons after in vitro differentiation in the PA6 
coculture system. Morphologically there was no difference from those derived from 
Pitx3  ES cells. The majority of these GFP  cells co-expressed the neuronal 
marker β-tubulin III (A-C) and mDA markers TH (D-F) and Nurr1 (G-I), suggesting 
that they were mDA neurons.  










Figure  4-8 Production of Pitx3-GFP  cells from Pitx3 null ES cells.  
(A) The majority of Pitx3  and Pitx3  ES cell-derived GFP  neurons 
co-expressed TH, suggesting that they are mDA neurons. (B) In the homozygous 
group, the proportion of TH  cells that also expressed Pitx3-GFP was significantly 
reduced (p<0.001), compared to the heterozygous group. Overexpressing Pitx3 











Figure  4-9 In vitro differentiation of rescued Pitx3  ES cells. 
In the construct of pCAGPitx3IP (A), the Pitx3 cDNA is driven by the constitutive 
expression unit CAG and the puromycin resistant gene (Pac) is linked downstream 
of the Pitx3 cDNA via an internal ribosome entry site (IRES). Pitx3 null ES cells 
with replacement of Pitx3 derived to GFP  cells after in vitro differentiation. Most of 
these GFP  neurons co-expressed mDA markers TH (B-D) and Nurr1 (E-G). 





- 172 - 
 
4.5 En1 overexpression in ES cells during differentiation 
The transcription factor En1, a specific midbrain marker for mDA identity, was 
considered as a candidate regulator of mDA neurons (Alberi et al., 2004; Simon et al., 
2001; Wurst et al., 1994). Therefore, I have performed gain-of-function analysis 
using ES cells to determine whether En1 is involved in mDA specification. 
The Pitx3GFP/+ ES cell line, Pt3A, was used for the En1 gain-of-function test. En1 
overexpression construct (Figure 4-10 A, Appendix III) was introduced into 
Pitx3GFP/+ ES cells. Since there would be a wide variation in the level of transgene 
expression, dependent on the chromosomal site of plasmid integration, these 
puromycin resistant cell lines were checked for protein expression by 
immunohistochemistry using an antibody against the En1 protein when cultured in 
24-well plates. 4 lines (#6, 18, 24, and 29) showed high expression of En1 with 
nuclear distribution in the undifferentiated state (Figure 4-10 B-D). They were 
expanded and referred to as PtEn ES cells. 
The PtEn ES cells behaved similarly to their parental ES cell lines in standard ES cell 
culture conditions. They did not express Pitx3-GFP or TH in the undifferentiated 
state. Following 2 weeks of in vitro differentiation, PtEn ES cell-derived Pitx3-GFP+ 
cells with neuronal morphology were detected. These Pitx3-GFP+ cells also 
expressed TH (Figure 4-11), β-tubulin III and Nurr1 (data not shown). Cell counting 
analysis showed that 13.5±2.72% and 19.72±6.76% of TH+ DA neurons 
co-expressed Pitx3-GFP in the parental and En1 overexpression Pitx3GFP/+ ES cells, 
respectively (Figure 4-12). The difference is statistically significant. However, the 
proportion of GFP+TH+ cells in TH+ DA population by forced expression of the 
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transcription factor En1 was not enhanced as significantly as other factors (eg. Pitx3), 
suggesting that En1 does not have a key role in generation or survival of mDA 




Figure  4-10 En1 expression in PtEn ES cells. 
En1 overexpression construct (A) was introduced into Pitx3  ES cells. Antibody 
staining showed nuclear distribution of the En1 protein in PtEn ES cells in ES cell 
state with high (B-D) and low (E-G) expression levels. PtEn ES cells with high En1 
expression were used for further differentiation experiments.  
Scale bar is 40µm. 
GFP/+





Figure  4-11 In vitro differentiation of PtEn ES cells 
Pitx3-GFP  cells differentiated from En1 overexpression Pitx3  ES cells 
co-expressed TH, suggesting that they were mDA neurons. 
Scale bar is 80µm 
+ GFP/+





Figure  4-12 Production of Pitx3-GFP  cells from PtEn ES cells. 
(A) The majority of PtEn ES cell-derived GFP  neurons co-expressed TH, suggesting 
that they were mDA neurons. 
(B) When overexpressing En1, the proportion of TH  cells that also expressed 
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4.6 Characterisation of a Cre-loxP based ES cell inducible system 
4.6.1 Klf4 as a candidate mDA regulator 
By microarray analysis, we have identified Krüppel-like transcription factor 4 (Klf4) 
as a differentially expressed gene in the Pitx3 positive cell population. Expression 
levels of Klf4 in Pitx3-GFP positive cells and Pitx3-GFP negative cells were 680.0 
and 87.2 (measured in fluorescence signal intensities), respectively. Klf4 is also 
known as gut-enriched Klf (GKLF), and was initially identified as an epithelially 
enriched gene with preferential expression in the terminally differentiated, 
post-mitotic epithelial cells of the intestine and epidermis (Shields et al., 1996). In 
the intestinal epithelium, Klf4 is expressed in the upper region of the crypt, in which 
cells have undergone growth arrest and begun to differentiate into mature 
colonocytes (Shie et al., 2000; Shields et al., 1996). Mice homozygous for a null 
mutation in Klf4 die shortly after birth and show selective perturbation of the late 
stage differentiation structures of the epidermis, resulting in loss of skin barrier 
function (Segre et al., 1999). Klf4 homozygous mutant mice also show disturbed 
terminal differentiation of goblet cells in the colon (Katz et al., 2002). In cultured 
cells, expression of Klf4 is associated with conditions that lead to growth arrest such 
as serum deprivation or contact inhibition. In addition, Klf4 is also known as a 
tumour suppressor gene and its expression is decreased in conditions that involve 
increased proliferation such as neoplasm of the intestinal tract and in cancer cell lines 
(Rowland et al., 2005; Rowland and Peeper, 2006; Shields et al., 1996). 
On the other hand, the functional role of Klf4 in other tissues remains elusive. It is 
worth noting that Klf4 overexpression in ES cells promotes self-renewal and inhibits 
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ES cell differentiation (Li et al., 2005). This is because Klf4 expression sustains Oct4 
expression in ES cells (Nakatake et al., 2006). A recent report demonstrates that 
introducing Klf4, in combination with Oct3/4, Sox2 and c-Myc, induces mouse 
embryonic and adult fibroblasts into pluripotent stem cell-like cells exhibiting the 
morphology and growth properties of ES cells and expressing ES cell marker genes 
(Takahashi and Yamanaka, 2006), supporting the proposal that Klf4 is important 
molecule for self-renewal in ES cells. 
Further validation in our laboratory by RT-PCR and RNA in situ hybridisation 
confirmed differential expression of Klf4 in Pitx3-GFP positive cells compared to 
Pitx3-GFP negative cells in the E14 midbrain (Figure 4-13). Since most functional 
studies of Klf4 show that it is required for terminal differentiation by regulating the 
cell cycle, it is interesting to investigate whether Klf4 is also involved in mDA 
differentiation. However, constitutive expression of Klf4 in ES cells precludes 
differentiation and promotes self-renewal (Li et al., 2005; Takahashi and Yamanaka, 
2006). Therefore, a temporally controlled activation of Klf4 is necessary in the ES 
cell gain-of-function experiment for mDA development. This led to the development 
of an inducible Pitx3GFP/+ ES cell system. 
4.6.2 Inducible gene expression in ES cells 
If a gene of interest has multiple roles and acts during different stage of ES cell 
differentiation, constitutive expression of such a molecule in ES cells may lead to 
confusing outcome and preclude a precise evaluation of its functional role in later 
stages of development. Conditional expression allows such multiple or stage 
dependent roles to be investigated in ES cells. 
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An ideal inducible system should fulfil two requirements, specificity and efficiency. 
For specificity, the system should not respond to endogenous factors and should be 
activated only by exogenous drugs that do not interfere with cellular regulatory 
pathways. For efficiency, the basal activity of the system (leakage) should be 
minimal, while in the active state it should quickly generate high levels of gene 
expression. Currently conditional transgenesis can be achieved by transcriptional 
transactivation, which may be induced by tetracycline, rapamycin, mifepristone 
(RU486) and ecdysone (Rossi and Blau, 1998; Saez et al., 1997). An alternative 
system is based on the site-specific DNA recombination by Cre recombinase.  
The bacteriophage P1 Cre (cyclisation recombination) recombinase recombines DNA 
at the 34-bp sequence called loxP (locus of crossover of P1). If the loxP sites are 
placed in the same orientation on a strand of DNA, the Cre recombinase efficiently 
excises DNA flanked by the two loxP sites (floxed) in mammalian cells (Nagy, 2000). 
Feil et al. have fused Cre recombinase to a mutant (G525R) ligand-binding domain 
(LBD) of human oestrogen receptor (ER) in order to generate the chimeric 
recombinase CreERT, whose activity in cultured cells is dependent on the presence of 
the synthetic ligand 4-hydroxy-tamoxifen (4OHT), rather than endogenous oestrogen 
(Feil et al., 1996). Short-term 4OHT treatments have very little toxicity to cultured 
cells. The later developed CreERT2, which contains triple mutation (G400V, L539A 
and L540A) to the human ER (Feil et al., 1997), is 10-fold more sensitive than 
CreERT in a dose-responsive recombinase activity (Indra et al., 1999). It has also 
been claimed that there is undetectable background activity of Cre recombinase in 
the absence of 4OHT (Feil et al., 1996; Indra et al., 1999). 
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To achieve conditional transgene expression, a floxed ‘transcription stop sequence’ 
has to be placed between a gene promoter and the transgene so that transcription of 
the transgene does not proceed until Cre recombinase excises the stop sequence. The 
‘transcription stop sequence’ can be served by a polyadenylation (polyA) signal 
constructed following cDNA of a reporter or selection gene. This strategy allows the 
establishment of transgenic cell lines with a silent genetic alteration that can be 
activated by Cre-mediated excision. 
4.6.3 Principle of PtCreER ES cell system 
Our laboratory have developed an inducible system for conditional gene expression 
in Pitx3GFP/+ ES cells that relies on 4OHT-dependent Cre recombinase-mediated 
activation. There are two important components in the inducible system: the 
PtCreERT ES cells which are Pitx3GFP/+ ES cells constitutively expressing CreERT2, 
and the inducible construct which contains a floxed stop signal (neoPA) between 
CAG promoter and the transgene cDNA (Figure 4-14). 
The CreERT2 construct, which was kindly provided by Lars Grotewold in Austin 
Smith’s laboratory, was put into the ROSA26 locus of Pitx3GFP/+ ES cells. The 
ROSA26, located at chromosome 6, is a gene locus from which proteins can be 
expressed ubiquitously at a moderate level (Zambrowicz et al., 1997). Therefore, 
these cells constitutively express the fusion protein CreERT2. They are referred to as 
PtCreERT ES cells. The CreERT2 is retained and sequestered in the cytoplasm until 
4OHT administration which allows nuclear localisation and the site-specific 
recombination. 
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Various doses of 4OHT were used to test its toxicity in ES cell culture conditions. 
After 24 hours of culture, ES cell numbers were counted and compared with the 
minus 4OHT control group. As shown in Figure 4-15, concentration of 4OHT up to 1 
uM did not show detrimental effects on ES proliferation/maintenance. 
The construct pCAGfloxedNeoIP (Appendix IV) is available to put the candidate 
genes in the region between the floxed neoPA and irespac. The neomycin resistant 
gene (neo) and the following polyA signal, which is derived from HSV thymidine 
kinase, is floxed by two loxP sites. After introduction into the PtCreERT ES cells, the 
cells in which the plasmid is successfully integrated can be selected for with G418 
because neo is driven by the CAG promoter. The transgene is silent at this time 
because there is a polyA signal in front of it (Figure 4-14 A). Following activation of 
the Cre recombinase by 4OHT, the floxed neoPA will be deleted and the cells will 
become G418 sensitive, puromycin resistant and the transgene cDNA will be 
expressed (Figure 4-14 B). 
4.6.4 Characterisation of induction in ES cell status 
A control experiment was performed to test the efficiency of induction for transgene 
expression using an inducible vector which contains the GFP reporter following the 
floxed neoPA. The PtCreERT ES cells with stable integration of this plasmid are GFP 
negative. However, GFP is expected to be activated following Cre-mediated excision 
of the floxed neoPA. 
4 lines of PtCreERT ES cells were tested for proper inducibility of GFP expression. 
In the absence of 4OHT induction, GFP expression was detected in a very small 
percentage of cells in all 4 lines tested (Figure 4-16 A). Flow cytometry analysis 
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revealed that this leakage rate of transgene expression was 0.95%, 0.64%, 0.89% and 
1.39%, for each of the four lines. 
24 hours after the addition of 1 µM 4OHT, the majority of cells in 3 of the 4 lines 
tested expressed GFP (Figure 4-16 B). Flow cytometry analysis for the proportion of 
GFP+ cells in the total population showed that the induction efficiency after 24 hours 
of treatment was 17.60%, 92.38%, 96.37% and 93.40%, respectively (Figure 4-16 C). 
Therefore, these cells showed low basal levels of expression in the uninduced state 
and rapidly achieved high levels of expression upon induction. 
For a more detailed time and dosage relationship in ES cell status, the PtCreERT#3 
ES cells carrying the GFP inducible vector were treated with various doses of 4OHT 
with various durations of treatment (Figure 4-17). I found that 12 hours of treatment 
with 0.05 µM 4OHT was sufficient to induce GFP expression in the majority of cells. 
Higher concentrations or longer treatment did not further improve induction 
efficiency, at least in undifferentiated ES cell cultures. 
4.6.5 Characterisation of transgene induction during neural differentiation 
Induction efficiency was also examined during in vitro differentiation by the 
monolayer differentiation method. PtCreERT#3 ES cells, carrying the inducible 
vector containing the GFP reporter, were plated on gelatinised 6-well plates with a 
density of 5 x 103 cell/cm2. At day 3 of monolayer differentiation, various doses of 
4OHT were added to induce the transgene expression. After 24 hours of treatment, 
flow cytometry analysis revealed that 4OHT dosage higher than 0.5 µM did not 
induce more cells to express GFP (Figure 4-18). However, the induction efficiency of 
24 hours of treatment at day 3 of monolayer differentiation was ~87.61%, less than 
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that of ES cell status (96.54%). 
The lower induction rate during differentiation could be caused by lower efficiency 
of the Cre-based induction process or lower CAG promoter activity. To clarify this 
question, I divided the induction experiments into 4 groups at day 3 of monolayer 
differentiation: (a) 48 hours of 0.5 µM 4OHT treatment, (b) 24 hours of 4OHT 
treatment followed by another 24 hours without 4OHT, (c) 24 hours without 4OHT 
followed by 24 hours of 4OHT treatment, and (d) 48 hours of minus 4OHT as a 
control (Figure 4-19 A). Flow cytometry analysis on day 5 of differentiation showed 
that 48 hours of 4OHT treatment resulted in a high induction efficiency of ~93.61% 
which was comparable to that observed in undifferentiated ES cell status. 
Interestingly, the same level of induction efficiency could be obtained if 4OHT was 
added in the first 24 hours then removed in the following 24 hours, suggesting that 
the first 24 hours of induction was sufficient to delete the floxed sequence in the 
majority of cells. These data demonstrated that the CreERT2 system is as efficient 
during differentiation as in undifferentiated ES cells, but more culture time is needed 
for the CAG promoter to drive transgene expression during differentiation. However, 
a further 24 hour culture following a 24 hour 4OHT induction allows maximum GFP 
expression during monolayer differentiation (Figure 4-19 B). 
In summary, the combination of ROSA26 driven CreERT2 and the floxed-stop 
transgene vectors driven by CAG promoter is an efficient inducible system for 
transgene expression. In ES cell status, 0.05 µM 4OHT for 12 hours of treatment is 
sufficient to obtain the maximal expression of induced transgene. During monolayer 
differentiation, 0.5 µM 4OHT for 24 hours is sufficient to delete the floxed stop 
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Figure  4-13 Klf4 validated as a candidate mDA regulator 
(A) Pitx3-GFP  and Pitx3-GFP  cells in the E14 midbrain were isolated by FACS and 
RT-PCR showed differential expression of Klf4 in Pitx3-GFP positive cells (data 
kindly provided by Joaquim Vives). (B) RNA in situ hybridisation revealed the 









Figure  4-14 Principle of Pitx3  inducible system. 
(A) In the PtCreERT ES cells, the fusion protein CreER  is constitutively expressed 
by the ROSA26 regulatory elements. The transgene cDNA can be inserted 
downstream of the floxed neoPA, which prevents the transcription of the transgene 
cDNA. (B) With the addition of 4OHT, the Cre recombinase will be activated and 
will excise the floxed stop signal simultaneously bringing the transgene cDNA under 
CAG promoter control. 
HSP: heat shock protein; ER-LBD: oestrogen receptor-ligand binding domain. 
GFP/+
T2





Figure  4-15 Toxicity of 4OHT for ES cell proliferation 
PtCreER ES cells were plated at the same cell density with the addition of various 
doses of 4OHT and compared with the control group after 24 hours of culture in ES 
cell status. 4OHT concentration up to 1 µM showed no detrimental effects on ES cell 
proliferation. 





Figure  4-16 Induction efficiency of 4 PtCreERT lines 
The inducible plasmid carrying GFP reporter was inserted into 4 PtCreERT ES cell 
lines to test the induction efficiency. The percentage of GFP  cells was determined 
by FACS. Without induction, a very small percentage of cells expressed GFP (A). 
Twenty-four hours after treatment with 1 µM 4OHT, the majority of cells in the line 
PtCreERT#3 expressed the GFP reporter (B). PtCreERT#2, #3 and #4 showed a low 
leakage of transgene expression before treatment and high induction efficiency after 
treatment with 4OHT (C). 
+
 






Figure  4-17 Time-dosage characterization of induction in ES cell state. 
PtCreERT#3 ES cells were treated with various doses of 4OHT for differing 
durations. 0.05 µM 4OHT treatment for 12 hours is sufficient to induce transgene 
expression in ES cell status. 
 





Figure  4-18 Dosage titrations for induction during monolayer 
differentiation. 
Various doses of 4OHT were used to induce transgene expression at day 2 of 
monolayer differentiation. After 24 hours the percentage of GFP  cells was obtained 
for flow cytometry analysis. 
+
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Figure  4-19 Time characterisation of induction efficiency during 
monolayer differentiation. 
(A) 24 hours of 4OHT treatment is sufficient for maximal induction efficiency. (B) 
48 hours is sufficient for the induced transgene to be expressed during monolayer 
differentiation. 
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4.7 Episomal gene expression system 
By microarray analysis, other members in our laboratory are searching for mDA 
regulators. It is helpful to establish an ES cell system to screen the candidate genes in 
an efficient manner. The polyoma-based episomal replication system allows 
maintenance of exogenous DNA sequences in episomal plasmids, that is, as 
non-integrated circular DNA. The cells in this system are easily transfected and 
provide a means for rapid validation of candidate genes (Aubert et al., 2002; 
Chambers et al., 2003). 
4.7.1 Introduction for episomal gene expression system 
 Polyoma virus and the viral-derived vector 
The original polyoma viral genome contains a circular, double-stranded DNA of 5.3 
kb. The genome is functionally divided into an early region, which is transcribed and 
expressed early after the virus enters the cells; a late region, which encodes for the 
viral capsid proteins; and a noncoding regulating region. The early region encodes 
for: (a) large tumour (T) antigen, a 100 kDa nuclear protein essential for initiating 
viral DNA replication; (b) middle T, a 48 kDa protein involved in cellular 
transformation; and (c) small T, a 22 kDa protein of unknown function. These 
proteins are generated from alternative splicing of the same transcript. Stable 
replication of polyoma-derived vectors within transfected cells requires a functional 
polyoma origin of replication (ori), large T protein with its intact DNA-binding, 
helicase activity and the set of cellular proteins involved in replicating DNA 
synthesis.  
The viral part of the vector pMGD20neo (Appendix VII) consists of the polyoma ori; 
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a modified early regulatory region, which lacks the splice sites for processing the 
middle and small T mRNAs; and a mutant enhancer region, PyF101, which was 
originally selected for the ability to replicate the polyoma genome in embryonic 
carcinoma cells (Fujimura et al., 1981). This plasmid also contains a eukaryotic 
selection cassette, the neomycin resistance gene driven by PGK promoter (PGKneo), 
thus it is possible to screen the transfected cells by G418 selection. The vector 
pMGD20neo is unable to transform host cells because it cannot express middle T 
protein, which is responsible for viral oncogenic transforming activity. 
It has been shown that pMGD20neo can be maintained episomally at about 10-30 
copies per cell for at least 74 ES cell generations in the presence of G418 (Gassmann 
et al., 1995). Removal of selective pressure does not affect the episomal status of the 
polyoma-derived vectors, suggesting that the copy level is probably held constant by 
autoregulation of polyoma viral T protein synthesis. This vector also amplified 
expression of the inserted cDNA located on the same plasmid, which results in a 
higher expression of the gene of interest (Camenisch et al., 1996). Furthermore, this 
autonomously replicating plasmid can efficiently replicate and maintain a second 
transfecting ori-containing plasmid carrying genes of interest in multiple copies 
episomally (Gassmann et al., 1995). 
 Episomal expression system for gene therapy 
Not only feasible in transgene expression experiments, episomal expression systems 
may also be used in gene therapy for human genetic disorders. Optimal vectors for 
gene therapy require (a) high-level and stable expression of the transgene, (b) a high 
transfection efficiency, (c) no integration into the chromosomal DNA to avoid effects 
on the cell’s own DNA and on the vector itself, and (d) no transformation features. 
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Nonviral vectors have attracted a lot of attention in gene therapy because of the lack 
of specific immune response, endogenous viral recombination, or oncogenic effects, 
as can occur with viral gene transfer agents (Conese et al., 2004; Thomas et al., 
2003). On the other hand, nonviral vectors have some disadvantages, including low 
efficiency and the lack of a sustained gene expression. Extrachromosomally 
self-replicating systems offer multiple advantages in gene therapy, including large 
packaging capacity and stability without integration. Until now, most progression 
towards the development of an efficient episomal gene therapy vector has come from 
Epstein-Barr viral vectors. A non-infectious and non-transforming Epstein-Barr 
virus-based vector, carrying the entire 185 kb human β-globin gene locus including 
the control region, has been shown to be maintained as episomes for a period of 3 
months in the absence of selection (Black and Vos, 2002). However, the major 
drawback of such viral-derived episomal expression vectors in the use of gene 
therapy is the presence of the viral components, while the risk of transforming the 
transfected cells is still a concern. 
4.7.2 Generation of supertransfectable Pitx3GFP/+ ES cells 
Two plasmids, pMGD20neo and pCAGGfpIP (Appendix VIII), are needed to 
generate the supertransfectable ES cells. Firstly, ES cells are transfected with 
pMGD20neo and treated with G418 to select cells expressing large T protein (Figure 
4-20 A). Then the G418 resistant cells are transfected with pCAGGfpIP, which 
contains the polyoma ori and GFP reporter, and treated with a high concentration of 
puromycin immediately to select supertransfectable cells (Figure 4-20 B). Among the 
cells resistant to both G418 and puromycin, those carrying pCAGGfpIP episomally 
will lose GFP expression gradually when puromycin selection is withdrawn. Then 
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the GFP negative cells will be collected as supertransfectable ES cells. 
5x106 of Pitx3GFP/+ (Pt3A) ES cells were electroporated with 20µg supercoiled 
plasmid pMGD20neo or the mock control at 200V and 960µF in a 0.4 cm cuvette. 
The cells were then plated 5x106 per 10 cm plate and 200 µg/ml of G418 was added 
the next day. After 10 days of G418 selection, the mock control plates were clear. 
One plate from the pMGD20neo group was stained with Leishmann solution and the 
number of the surviving colonies was counted to establish the transfection efficiency 
of the parental line. Cells in all other plates were pooled, expanded and stock frozen. 
These are Pitx3GFP/+ ES cells carrying the plasmid pMGD20neo, either 
intrachromosomally or extrachromosomally. 
106 G418 resistant Pitx3GFP/+ cells were subsequently plated in one well of a 6-well 
plate and transfected with a combination of 3µg of supercoiled pCAGGfpIP and 3µl 
of Lipofectamine 2000 by the lipofection method. After 24 hours the cells were 
replated at 2x105 or 5x104 cells in 10 cm plates with 200µg/ml of G418 and 2µg/ml 
of puromycin. After 4 days of double selection, the transiently transfected cells had 
been cleared and almost all the surviving cells expressed GFP (Figure 4-21 B-B’), 
which were either supertransfectable or integrated stable transfectants. The colonies 
which expressed high level of GFP were marked, then puromycin was removed and 
the cells were cultured in G418-containing medium. Supertransfectable cells, which 
were carrying the pCAGGfpIP episomally, lost GFP fluorescence gradually. After 
culturing in the absence of puromycin for 6 days, most cells were GFP negative 
when examined under a fluorescence microscope. Colonies which were still highly 
expressing GFP might have the GFP expression vector integrated 
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intrachromosomally (Figure 4-21 C-C’). At this point the marked colonies which had 
lost most of the GFP fluorescence (Figure 4-21 D-D’) were picked, expanded and 
stock frozen. The rest of the cells were pooled altogether and sorted for GFP negative 
cells by FACS. They were then expanded for frozen stocks 
A total of 6 lines of supertransfectable Pitx3GFP/+ ES cells, 5 from colony pick up 
(3ATC2, 3ATA2, 3ATA3, 3ATA4, 3ATA5) and one by FACS sorting (3ATP), were 
established and expanded. To check the transfection efficiency of these clones, 
supercoiled plasmid pCAGGfpIP 3µg was transfected into these cells again by 
lipofection and selected with G418 200 µg/ml plus puromycin 2µg/ml for a total of 
10 days. After Leishmann staining, the numbers of colonies per plate were recorded 
to determine the transfection efficiency (Table 4-3). Compared to the transfection 
efficiency of their parental lines, these cells had increased transfection efficiency 
(0.008% vs. 0.02 to 0.49). 
4.7.3 Characterisation of supertransfectable Pitx3GFP/+ ES cells during in vitro 
differentiation. 
Although the ES cells of episomal gene expression system showed high transfection 
efficiency with ori-containing plasmids, these supertransfectable ES cells lost their 
episomal GFP overexpression plasmids gradually when the high concentration of 
puromycin were withdrawn. This led to the differentiation experiments for 
examining whether expression of the gene of interest in the second transfecting 
ori-containing plasmid could be maintained during differentiation into mDA neurons, 
which takes about 2 weeks. It has been reported that the first plasmid pMGD20neo 
can be maintained without significant loss for about 50 cell generations in the 
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absence of selection for G418 resistance (Gassmann et al. 1995). In addition, the 
episomal maintenance of pMGD20neo is not affected as the cells differentiate in 
vitro, and in mouse cell lines including mouse L-fibroblasts, renal adenocarcinoma 
RAG cells and teratocarcinoma F9 cells (Camenisch et al., 1996). 
The construct pCAGGfpIP was used as a reporter again and the expression of GFP 
without antibiotic selection was examined during in vitro differentiation. Briefly, 106 
cells were transfected with 3µg of supercoiled pCAGGfpIP in one well of a 6-well 
plate by lipofection. Twenty-four hours after transfection, cells were replated into a 
10 cm gelatinised dish with G418 200µg/ml plus puromycin 2µg/ml. Six days after 
selection, almost all cells that survived expressed GFP. They were pooled into a T25 
flask and replated for differentiation on PA6 cells with or without puromycin 
selection. The interval from the transgene transfection (26/05/05) to the start of the 
differentiation experiment (04/06/05) was only 9 days, showing their high efficiency. 
On day 2, 4, 6, 8 of in vitro differentiation, the cells were fixed and counterstained 
with DAPI. For each experiment 20 colonies were selected randomly and cells 
counted to determine the percentage of GFP expressing cells. The percentage of cells 
expressing GFP (GFP+/DAPI) decreased gradually during in vitro differentiation in 
the absence of puromycin selection. When differentiated into neural precursor cells 
on day 8 of in vitro differentiation, only 25.4% of cells maintained GFP expression 
(Figure 4-22, 4-23). All ES cells kept in puromycin containing medium expressed 
GFP, but their growth was much slower and rarely differentiated into neural 
progenitor cells on day 8. 




Parental line 0.008% 







Table  4-3 Transfection efficiency of supertransfectable Pitx3GFP/+ ES cells 
pCAGGfpIP was transfected into Pitx3GFP/+ ES cells carrying the large T protein and 
selected with G418 and puromycin for 10 days. The numbers of colonies were 
counted to determine the transfection efficiency. All 6 lines carrying large T 
demonstrated higher transfection efficiency than their parental line. Line P, which 
was sorted by FACS, showed lower transfection efficiency than others which were 
selected by colony pick up. 
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Figure  4-20 Mechanism of the episomal expression system 
(A) When introduced into Pitx3  ES cells, the plasmid pMGD20neo will utilise 
autoregulation to replicate and maintain multiple copies episomally in the presence 
of G418 selection. (B) The candidate transgene is inserted into a plasmid carrying the 
polyoma origin of replication. When introduced into cells with a large T protein 
expressed episomally, the second plasmid will also be replicated and maintained in 
multiple copies episomally and the transgene expressed at higher levels. 
PyOri: polyoma origin of replication, L.T.: large T protein. 
GFP/+
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Figure  4-21 Generation of supertransfectable Pitx3GFP/+ ES cells 
Pitx3GFP/+ ES cells carrying pMGD20neo were transfected with pPyCAGGfpIP and 
selected with G418 plus puromycin (A-A’). After 4 days of double selection, colonies 
which displayed increased GFP expression were marked (B-B’). After culturing in 
puromycin free medium for 6 days, colonies which still expressed GFP highly might 
have the GFP overexpression construct intrachromosomally (C-C’). Colonies which 
lost GFP expression in the absence of puromycin had previously expressed GFP 
episomally (D-D’). These were the colonies which were picked and expanded.





Figure  4-22 Maintenance of transgene expression during in vitro 
differentiation 
The GFP reporter was used to track the maintenance of transgene expression during 
ES cell differentiation. ES cells transfected with pPyCAGGfpIP were selected in the 
presence of G418 plus puromycin then in vitro differentiation was performed by use 
of the PA6 coculture system in puromycin free conditions. Some cells began to lose 
GFP expression on day 2 of differentiation (B-B’). On day 8 of differentiation, while 
neural progenitors were derived, some colonies maintained GFP expression (C-C’), 
but most colonies lost expression of the GFP reporter (D-D’), suggesting that the 
expression of the second plasmid was lost during differentiation in puromycin free 
conditions. 





Figure  4-23 Percentage of transgene expression of supertransfectable 
Pitx3GFP/+ ES cells during in vitro differentiation. 
The number of GFP+ cells during differentiation was counted in order to estimate the 
percentage of cells expressing the transgene. In puromycin free conditions, cells lost 
the episomally-expressed transgene gradually. 
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4.8 Discussion 
In this chapter, Pitx3GFP/+ and Pitx3GFP/GFP ES cells have been derived from 
blastocysts. These ES cells can differentiate into Pitx3-GFP positive DA neurons 
with mesencephalic characteristics. The production of Pitx3-GFP expressing cells 
thus can be observed in a cellular system to investigate the molecular and cellular 
mechanisms involved in mDA development. 
4.8.1 Pluripotent mutant ES cell derivation 
In the experiments to generate ES cells, I have derived 6 lines of transgenic ES cells 
from 54 blastocysts and 10 lines of strain 129 ES cells from 70 blastocysts. Among 
mouse strains, genetic background strongly affects the efficiency of ES cell 
derivation, therefore the 129 strain, the most permissive for ES cell derivation, has 
been used as a control group. Brook et al. have shown that the epiblast is the sole 
source of ES cells in the late blastocysts (Brook and Gardner, 1997). In their 
experiment, ES cell lines could be obtained from all delayed epiblasts of the 129 
strain. They have also suggested that the presence of primitive endoderm impairs the 
ability of epiblasts to produce ES cells. In the literature, primary ES colonies have 
been obtained from 25~30% of whole blastocysts in skilled laboratories (Brook and 
Gardner, 1997; Nichols et al., 1990; Pease et al., 1990). The original derivation 
protocol (Evans and Kaufman, 1981; Martin, 1981) may be modified to be 
performed in feeder-free conditions (Nichols et al., 1990; Pease et al., 1990) and 
even serum-free conditions to produce ES cells without contamination from feeders 
or serum (Ying et al., 2003a), thus providing proof of principle for suitable sources 
for cellular replacement therapy. In my derivation experiment, I have used intact 
delayed blastocysts as the starting material for ES cell production. The ES cell line 
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yield efficiencies from strain 129 and the mutant group was 16.2% and 13.7%, 
respectively. The procedure in this experiment was less complicated and the yield 
acceptable. 
After disaggregation from primary ES cell colonies, differentiation was not been 
completely suppressed for all the lines. In some cases significant numbers of 
differentiated cells persisted during continuous culture and it was difficult to enrich 
the undifferentiated cells. Oct3/4 gene regulation has previously been used to 
overcome the barrier to ES cell production. Since Oct3/4 expression is restricted to 
undifferentiated ES cells, selection against cells in which the gene is downregulated 
may enrich the undifferentiated ES cells (McWhir et al., 1996; Mountford et al., 
1998). By using this strategy, differentiated cells are continuously removed and 
germ-line competent ES cells from non-permissive strain can be derived. In my 
derivation experiment, serum-free ES cell medium has been used to rescue these 
differentiating lines (Pt2A, Pt2C). Based on the report that BMPs supports ES cell 
self-renewal in serum-free N2B27 medium (Ying et al., 2003a), differentiated cells 
did not persist in conditions of serum-deprivation, and the combination of LIF plus 
BMP4 enhanced the self-renewal of the undifferentiated ES cells. Therefore, 
undifferentiated ES cell lines Pt2A and Pt2C have been successfully enriched and 
maintained after being transferred into standard serum-containing medium. However, 
the long-term stability of these rescued ES cells to be maintained in 
serum-containing medium and their potential to differentiate in vitro need to be 
further investigated. 
 
- 203 - 
 
Currently the most practicable way to validate the production of ES cell lines is 
sustained growth with the retention of a characteristic undifferentiated morphology 
or antigen expression. It is debatable whether morphology or marker expression 
provides an adequate basis for identifying genuine ES cells (Gardner and Brook, 
1997; Pera and Trounson, 2004). Cell lines from teratocarcinomas also fulfil some 
ES cell characteristics such as teratoma formation in xenografts in immunodeprived 
mice, and differentiation into various types of cell in vitro. The identity of ES cells is 
definitively established by their ability to participate in embryonic development 
when introduced into early embryos such as morulae or blastocysts. The 
heterozygous line Pt3A and the homozygous line Pt2B have contributed in high 
proportions to resulting chimeras (Chapter 3.2), providing further confirmation of 
their genuine ES characteristics. However, no germ-line competence experiment has 
been performed. 
4.8.2 Midbrain-specific Pitx3-GFP positive neurons 
Marker analysis including β-tubulin III, TH, En1 and Nurr1, at the single cell level, 
has demonstrated that the Pitx3GFP/+ ES cell-derived GFP positive cells show mDA 
neuron characteristics (Figure 4-4, 4-5). In addition to marker expression, previous 
work in our laboratory has shown that ES cell-derived Pitx3-GFP+ mDA neurons are 
sensitive to MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) treatment, and 
GDNF treatment can rescue the neurotoxicity, suggesting that they are biologically 
similar to primary DA neurons in the embryonic and adult midbrain (Zhao et al., 
2004).  
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Many experiments use TH (tyrosine hydroxlase), the rate-limiting enzyme for 
dopamine synthesis, as a marker for DA neurons. However, in addition to the DA 
neurons of SN and VTA in midbrain, TH is also expressed in several other cell 
groups, including DA neurons of hypothalamus and olfactory bulb (Figure 1-3 A), 
the noradrenergic neurons of the locus coeruleus and lateral tegmental system, and 
the adrenergic neurons of the brain. In the periphery, TH is expressed in sympathetic 
ganglia and adrenal chromaffin cells. Therefore, TH alone is not specific enough to 
identify mDA neurons. My differentiation experiments have revealed that only 
13.5% of TH+ cells co-expressed Pitx3-GFP, showing that most ES cell-derived TH+ 
cells did not have mesencephalic characteristics. This agreed with previous work in 
our laboratory that the percentage of GFP+TH+ cells in TH+ population was 13.6%, 
and this result was generated using Pitx3GFP/+ ES cells produced by gene targeting of 
E14TG2a ES cells (Zhao et al., 2004), which were originally derived from the strain 
129 (Hooper et al., 1987). Another laboratory has also reported that 21.1% of ES 
cell-derived TH+ cells express the mDA marker Pitx3 by the EB method of 
differentiation (Chung et al., 2005). Recent studies by other members in our 
laboratory and myself have also revealed that TH+ neurons derived by the monolayer 
differentiation method rarely express midbrain markers including Pitx3-GFP (Parmar 
and Li, in preparation). Since different transcriptional regulatory mechanisms may 
account for regulated expression of the TH gene in different cell populations, a 
system with an mDA specific reporter such as Pitx3-GFP is a more relevant tool with 
which to study mDA neuronal differentiation. 
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4.8.3 Pitx3 null ES cell differentiation 
The purpose of deriving homozygous Pitx3 mutant ES cells lines is to establish a 
model system to investigate mDA development with loss of Pitx3 protein at a cellular 
level. In the data obtained from our Pitx3 null mice, there is a reduction of over 50% 
in the number of TH expressing cells at E14.5, suggesting Pitx3 is required for the 
survival and maintenance of mDA neurons (Maxwell et al., 2005). However, my 
differentiation experiments of Pitx3 null ES cells have not shown a significant 
difference in the number of TH+ DA neurons generated. This might partly due to our 
previous finding that a large percentage of ES cell-derived TH+ neurons are not of 
midbrain identity (Figure 4-8 B). Indeed, by comparing the percentages of TH+ 
population co-expressing Pitx3-GFP, I have found a significant reduction of mDA 
neurons generated by the null cells (Figure 4-8 B), showing an impaired 
differentiation into mDA neurons. 
To further confirm the functional requirement of Pitx3 for mDA neurons during in 
vitro differentiation, a replacement study has been performed by stable transfection 
with a CAG expression vector containing a 1.2-kb full-length Pitx3 cDNA into Pitx3 
null ES cells. This strategy of rescuing by cDNA expression in double knockout ES 
cells has been used previously in genetic studies. Such an example is that of 
Coppolino et al., which show that expression of calreticulin cDNA in homozygous 
mutant ES cells partly rescues integrin-mediated adhesion (Coppolino et al., 1997). 
Replacing Pitx3 in the homozygous Pitx3 null ES cells alleviated the impaired 
potential to differentiate into Pitx3-GFP+TH+ neurons in vitro (Figure 4-8 B). These 
Pitx3-GFP positive neurons, which were derived from rescued Pitx3 null ES cells, 
also co-expressed an independent mDA marker Nurr1 (Figure 4-9 G-I), suggesting 
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that they were true mDA neurons, rather than only being auto-regulated by Pitx3 
forced expression. The overexpression experiment has suggested that Pitx3 might 
promote the acquisition of midbrain characteristics from DA precursors. 
It is worth noting that previous quantitative analysis in our laboratory has revealed 
that the Pitx3 overexpression Pitx3GFP/+ ES cell cultures contain around 3 times more 
Pitx3-GFP+TH+ than in control cultures. Therefore, the nature of mDA differentiation 
of the rescued Pitx3GFP/GFP ES cells is similar to that of Pitx3 overexpression in 
Pitx3GFP/+ ES cells. This is because the Pitx3 transgene is overexpressed 
constitutively by a strong CAG promoter, which does not necessarily mimic the true 
genetic regulation of Pitx3 pathway. An alternative rescue strategy to repair the 
homozygous Pitx3GFP/GFP ES cells is to put Pitx3 cDNA back to its regulatory 
element by another gene targeting event via homologous recombination, as shown in 
the Rag2 study by Rideout et al (Rideout et al., 2002). 
The strict correlation in the timing of expression of Pitx3 and TH during 
development suggests a possible role for the transcription factor Pitx3 as a 
physiological activator of the TH gene. Cazorla et al. have demonstrated the presence 
of an element within the 100 bp proximal region of the rat TH promoter to which 
Pitx3 protein can bind and through which it can modulate TH promoter activity 
(Cazorla et al., 2000). One high-affinity Pitx3 binding site sufficient for Pitx3 
activation of transcription in the mouse TH promoter region has also been shown 
(Lebel et al., 2001). These in vitro promoter studies suggest that Pitx3 protein might 
contribute to the control of TH expression by binding to its promoter. The in vivo 
mouse studies have shown that, at E12.5, the proportion of TH+ cells within the 
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Pitx3-GFP+ population is significantly reduced in the Pitx3 knockout midbrain 
(43.7±5.5%) as compared to their heterozygous littermates (64.8±10.6%, p<= 0.03) 
(Maxwell et al., 2005), providing the first demonstration that Pitx3 is a physiological 
regulator for TH. However, my in vitro differentiation experiments showed no 
difference of TH expression percentage in the ES cell-derived Pitx3-GFP+ neurons 
between heterozygous and homozygous groups (GFP+TH+/GFP+: 92.8±2.2% vs. 
92.2±3.4%, p=0.66). This phenomenon permits several interpretations. Firstly, the 
regulation of TH by Pitx3 might be very complicated and the question could not be 
addressed in a simplified in vitro experiment. Similar phenomenon was also 
observed in En1 overexpression experiments, which will be discussed in the next 
section. Secondly, the reduction of TH expression in Pitx3-GFP+ cells in 
homozygous Pitx3 null mice is restricted in SN, rather than in VTA (Maxwell et al., 
2005). It has been reported that the level of Pitx3 expression is higher in the VTA 
than in the SN (Korotkova et al., 2005). Therefore, it is possible that a larger 
percentage of ES cell-derived GFP+TH+ neurons are of VTA identity. Currently, there 
is no molecular marker that can clearly distinguish SN from VTA DA neurons. 
Further investigation is required to clarify this question. 
In summary, the Pitx3 null ES experiments have provided proof of principle that loss 
of Pitx3 leads to impaired ES cell differentiation into mDA neurons in vitro.  
4.8.4 En1 overexpression experiment 
The spatial and temporal expression pattern of En1 in mid/hindbrain corresponds to 
the developmental functions in mDA neurons. Overexpression of En1 has 
significantly changed the proportion of Pitx3-GFP+ cells in TH  DA population. +
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However, the enhancement by En1 overexpression is much lower than by Pitx3 
overexpression in heterozygous Pitx3-GFP ES cells (Maxwell et al., 2005) or Pitx3 
null ES cells with replacement of Pitx3 (Figure 4-8). 
It has been reported that transduction with a lentiviral expression vector carrying En1 
during in vitro differentiation significantly induces the expression of the late DA 
neuron marker DAT, but not the earlier marker TH (Martinat et al., 2006). En1 is 
associated with survival/maintenance of mDA neurons and the survival effect may 
depend on signals or trophic support provided by other cells (Simon et al., 2001). My 
overexpression experiment has suggested that En1 does not enhance mDA 
development in vitro. Multiple factors may collaborate within a network and En1 
alone is not sufficient to regulate mDA development, at least in the ES cell in vitro 
differentiation system. However, there is still a possibility that En1 regulates 
components of essential signalling pathways including receptors for required trophic 
factors. This can be further investigated by exogenous treatment to evaluate whether 
En1 overexpressing cells are more responsive to neurotrophic factors or more 
resistant to neurotoxic factors. 
4.8.5 Cre-regulated expression system 
The Cre-mediated inducible Pitx3GFP/+ ES cell system developed in our laboratory 
contains two components: the Pitx3GFP/+ ES cells which constitutively express 
CreERT2, and the inducible vector carrying a floxed stop signal (neoPA) between the 
CAG promoter and the transgene. In this chapter the inducible system has been 
characterised by an inducible vector carrying GFP reporter, which is superior to other 
reporter assays because it allows sensitive quantification of the number of induced 
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cells. Before induction, very few cells expressed the GFP reporter. It has also been 
reported that there is 0.04-0.22% of leakage before 4OHT treatment, detected by 
GFP reporter as well (Vallier et al., 2001). There are several explanations for this 
leakage phenomenon. Firstly, the Gfp cDNA is occasionally transcribed in spite of 
the stop signal located in front of it. Therefore it has been suggested to construct 
more than one transcription termination signal before the transgene to prevent 
leakage (Mao et al., 2005; Vallier et al., 2001). Secondly, although theoretically 
CreERT2 can only be activated by the synthetic oestrogen analogue 4OHT, the 
possibility of cross-reacting with certain endogenous ligands cannot be excluded 
completely. The latter explanation is favoured in my observation since GFP 
expressing cells have been found to be in groups, suggesting subsequent cell division 
after unwanted Cre-mediated excision (Figure 4-16 A). Nevertheless, all 4 lines 
tested showed around 1% leakage rate, suggesting very little influence to this system 
before induction. 
Strikingly, the majority of cells expressed the induced GFP reporter after the 
treatment of 4OHT, demonstrating a very efficient induction, which includes 
constitutive expression of CreERT2, the activation of CreERT2 by the inducer 4OHT, 
deletion of the floxed stop signal and activation of the transgene by the CAG 
promoter (Figure 4-14). Further characterisation has also shown high induction 
efficiency during monolayer neural differentiation. Detailed analysis has revealed 
that the Cre-mediated system has a precise temporal control of the recombination 
event during in vitro differentiation although the CAG promoter is less efficient in 
differentiating cells than in ES cells. However, the whole induced expression 
machinery is very powerful and a non-detrimental concentration of 4OHT is required. 
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This inducible system may provide useful research tools for some candidate mDA 
determinants. For example, data from other members in our laboratory have shown 
that Klf4 is a candidate mDA regulator but constitutive expression of Klf4 inhibits 
early ES cell differentiation and complicates an analysis of its function in later 
development (Li et al., 2005; Takahashi and Yamanaka, 2006). I have constructed an 
inducible vector (Appendix V), by which a temporally controlled activation of Klf4 
may be achieved in ES cell gain-of-function experiments for mDA development. 
The conditional transgene approach requires a tight control to avoid unwanted 
expression and to ensure adequate expression of the candidate gene. To date, two 
broad categories of conditional transgenesis used in ES cells are site-specific DNA 
recombination including Cre or Flp recombinase, and transcriptional transactivation 
including the tetracycline-dependent regulatory system (Gossen and Bujard, 2002; 
Lewandoski, 2001). In the tetracycline-based system, the tetracycline-controlled 
transactivator (tTA) is a fusion protein composed of the viral protein VP16 
transactivation domain and the E. Coli tetracycline repressor (TetR), which 
specifically binds both tetracycline and the 19-bp operator sequence (tetO) of the tet 
operon in the target transgene and results in its transactivation. In the original system, 
the tTA cannot bind DNA when the inducer is present (‘tet-off’), whereas in a 
modified version, the ‘reverse tTA’ (rtTA) binds DNA only when the inducer is 
present (‘tet-on’) (Gossen and Bujard, 2002). 
In the Cre-based conditional activation system, leaky control does not generate 
intermediate expression, but will generate a heterogeneous cell population containing 
both induced and non-induced cells (Figure 4-24 A). By using specific antibodies or 
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reporters to distinguish the induced and non-induced cells, it is possible to evaluate 
the cell-autonomous effects of certain candidate regulators on the activated cells and, 
at the same time, the cell-non-autonomous effects of the regulators to the 
non-induced cells in the same culture. In the tetracycline-based transcriptional 
transactivation, or other gene silencing approaches such as RNA interference and 
dominant-negative methods, leakiness will result in a relatively homogeneous cell 
population in which quantitative controlled transgene expression is possible (Figure 
4-24 B). For example, it has been shown in mouse ES cells that by titrating the 
expression of transcription factor Oct3/4 within a small margin, three distinct cell 
fates can be induced (Niwa et al., 2000). 
Additionally, the Cre-based approach is irreversible, therefore in this system a pulse 
of induced Cre activity makes a permanent genomic alteration in a cell and the 
change is inherited by all the cells’ progeny (Guo et al., 2002). This irreversibility 
prevents the requirement of long-term application of the inducer which can itself 
have an effect on the phenotype or affect normal cell biology. On the other hand, it is 
difficult to switch off the activated gene once it has been switched on. 
The Cre-mediated inducible Pitx3-GFP ES cell system developed in our laboratory is 
characterised by very low background; that is, the transcription of the transgene is 
repressed efficiently in the absence of the ligand. The transgene expression in ES 
cells and their differentiated derivatives can be controlled tightly in response to a 
non-detrimental dose of the synthetic hormone 4OHT.  
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4.8.6 The episomal expression system 
I have derived supertransfectable Pitx3GFP/+ ES cells carrying the large T protein. 
When the supercoiled pMGD20neo construct was introduced into Pitx3GFP/+ ES cells, 
not all plasmids were kept episomally. It has been reported that around 15% of G418 
resistant transformants carry the plasmid episomally (Camenisch et al., 1996; 
Gassmann et al., 1995). However, the purpose of this experiment was to generate ES 
cells with high transfection efficiency, which can be obtained by the GFP reporter 
test. Therefore I did not check whether the G418 resistant colonies express the large 
T protein extrachromosomally or intrachromosomally. Theoretically, cells carrying 
pMGD20neo episomally express the large T protein in multiple copies, thus it is 
easier for them to express the second transgene in an efficient way. However, it is 
still possible that some of the lines picked up may carry the large T construct 
integrated intrachromosomally. 
The same observation applied to the GFP expressing cells in the double selection 
condition. Some of the GFP transgene might be expressed intrachromosomally 
(Figure 4-21 C-C’), although cells expressing pCAGGfpIP in multiple episomal 
copies might have a better chance of survival in such a high concentration (2µg/ml) 
of puromycin. In fact, the original aim of Gassmann et al. to develop the 
pMGD20neo construct is to determine whether the efficiency of targeting mutations 
to chromosomal genes in ES cells could be improved by recombination with 
corresponding homologous DNA segments maintained on episomal vectors 
(Gassmann et al., 1995). It has been reported that 85% of the double resistant clones 
contain the second plasmid episomally, suggesting that the pre-existence of large T 
increases the frequency at which the second transfecting ori-containing plasmid can 
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be maintained as an episome. Cells expressing pCAGGfpIP episomally can be 
distinguished because they lose GFP expression once the puromycin selection is 
withdrawn. There are 2 ways to select the GFP negative cells at this point: to pick up 
colonies which have previously expressed GFP highly, or to sort all GFP negative 
cells by FACS. In this experiment, the cells sorted by FACS (3ATP) showed lower 
transfection efficiency than cells selected by colony pick up (0.02% vs. 0.04-0.49%), 
although still higher than the parental line (0.008%). This is because FACS gives a 
mixture of GFP negative cells, among which not all have been successfully 
transfected with pCAGGfpIP. Theoretically, the transfection efficiency can be further 
enhanced by performing the GFP selection procedure again; that is, to transfect 
pCAGGfpIP plasmid again and to sort the GFP negative cells after puromycin 
withdrawal. Another way to get highly transfectable cells is (a) to sort cells highly 
expressing GFP in the double selection by FACS then (b) to sort GFP negative cells 
after withdrawal of puromycin. This may select cells which can highly express the 
transgene efficiently in a quantitative manner. 
There are several advantages of episomal expression vectors in transgene expression 
experiments. Firstly, in stable transgene procedures, the use of episomal vectors 
results in higher transfection efficiency than the use of a chromosome-integrating 
plasmid. This feature allows applications that require to transfect large amount of 
DNA, such as screening of cDNA libraries (Aubert et al., 2002; Chambers et al., 
2003). My supertransfectable Pitx3GFP/+ ES cell study has shown that using 106 cells 
in one well of a 6-well plate for lipofection with a candidate gene, then the number of 
the transformants will be ready for mDA differentiation experiments within 2 weeks. 
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Secondly, episomal expression vectors persist in multiple copies in the nucleus, 
resulting in amplification of the gene of interest. This increases the reliability in 
gain-of-function expression studies in ES cells that are usually hampered by 
transcriptional silencing. In normal lipofection experiments for selecting puromycin 
resistant stable transformants, 0.5~1.0 µg/ml puromycin is added 24~36 hours after 
replating the transfected cells. However, in the experiment for testing the transfection 
efficiency of the supertransfectable Pitx3GFP/+ ES cells, 2 µg/ml puromycin was 
added immediately after replating. The higher dosage and the shorter interval for 
adding the selection drug than ordinary usage indicated that the surviving cells were 
able to express high levels of the resistant gene pac in an efficient manner. 
Thirdly, the inserted gene of interest is not interrupted or subjected to regulatory 
constraints, which often occur upon integration into host DNA. The reverse is also 
true, i.e. the presence of the inserted transgene does not lead to rearrangement or 
interruption of the cell’s own important genomic regions. Integration of foreign DNA 
into the genome of established cells may have some undesired effects, such as 
insertional mutagenesis or silencing by de novo methylation of the introduced 
transgene. Using episomal plasmid vectors may achieve high expression levels 
without affecting the cellular genome (Van Craenenbroeck et al., 2000). This is also 
an important issue in designing optimal delivery and expression systems in the 
applications of gene therapy. 
Furthermore, because episomal vectors utilise cellular enzymes for replication and 
repair, they are also powerful tools for studying DNA replication or mutagenesis. 
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However, there are some drawbacks of the episomal transgene expression system. 
One disadvantage of the episomal expression system is the interference of viral 
proteins in host cellular biology. The large T protein of the polyoma virus is known 
to have a broad spectrum of protein-protein interaction. At the physiological level, 
the large T protein of the BK virus is able to bind to most of the tumour suppressor 
protein p53 in the cell (Harris et al., 1996). Simian virus 40 (SV40) large T protein 
influences cellular gene expression by altering mRNA levels of cellular transcription 
factors, and also by interacting with the DNA-binding or transcriptional activity of 
specific transcription factors. It has also been reported that large T proteins block 
apoptosis induced by growth factor withdrawal in a neural stem cell culture (Harris et 
al., 1996; Slinskey et al., 1999). Further improvement of these vectors has focused on 
the elimination of the large T protein. For example, a newly developed SV40 
ori-based vector, in which the large T antigen is exchanged for the matrix attachment 
region fragment of the human interferon β-globin, indicates that such a vector 
remains as an episome in the cell lines of Chinese hamster ovary (CHO) over more 
than 100 generations without selective pressure (Baiker et al., 2000; Piechaczek et al., 
1999). 
Another concern is whether the high selective pressure used to maintain the episomal 
expression will affect some cellular functions. In my differentiation experiments 
using the GFP reporter, all ES cells kept in puromycin selection on puromycin 
resistant PA6 cells expressed transgene GFP, but the time course of differentiation 
was delayed and rare neural differentiation was observed at day 8 of culture. This 
suggests that puromycin treatment might affect normal ES cell differentiation in 
vitro. 
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The main drawback of the episomal expression system is a gradual loss of transgene 
on the second ori-containing vectors during differentiation in the absence of selection. 
Only around 25% of transgene expression is maintained at day 8 of differentiation 
when neural progenitor cells are derived. Therefore, the episomal expression system 
is more suitable for testing potential early determinants during differentiation. 
Successful examples include the identification of Nanog that maintains ES cell 
self-renewal (Chambers et al., 2003), and the Wnt antagonist Sfrp2 (secreted 
frizzled-related protein-2) that affects early neural differentiation from ES cells 
(Aubert et al., 2002). My own experiment showed that, the transgene expression 
levels at day 2 and day 4 of differentiation are still 67% and 52%, respectively 
(Figure 4-23), which might be applicable for certain candidate analysis. 
It is feasible to deal with the problem of the maintenance of transgene expression by 
engineering a detectable marker, i.e. HA-tag or Flag-tag, or other fluorescence 
protein, to track the transgene expression. It has been reported that 15% of the 
second ori-containing plasmid is integrated intrachromosomally (Camenisch et al., 
1996). In my GFP reporter experiment, around 7% of colonies highly expressed GFP 
after 2 weeks of differentiation in the absence of puromycin. Most of these colonies 
might have the GFP expression vector intrachromosomally. By constructing a 
detectable marker for reporting the transgene expression, the cells or colonies 
maintaining the transgene expression can be distinguished, and the effects of the 
candidate gene on the production of Pitx3-GFP expressing cells can be determined. 
Another alternative is to construct candidate genes into the first plasmid carrying the 
large T protein. High expression of the transgene inserted in the same plasmid 
carrying the large T protein has also been reported in the absence of selection 
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(Camenisch et al., 1996). This is also the main principle in the design of viral-derived 
self-replicating vectors for gene therapy for human genetic disease (Conese et al., 
2004; Van Craenenbroeck et al., 2000) 
 
Figure  4-24 Comparison of the Cre-based induction strategy to the 
tetracycline-based system  
(A) Cre-base site-specific recombination strategy may generate a heterogeneous cell 
population containing both induced and non-induced cells in which the 
cell-autonomous and non-cell-autonomous effects may be evaluated. This approach 
is irreversible thus preventing long term application of the inducer which may itself 
have an effect on the cell biology. 
(B) The tetracycline-based transcriptional transactivation may result in a relatively 
homogeneous cell population in which intermediate transgene expression is possible. 
This system is reversible, so it is possible to switch off the transgene which has been 
activated. 
Circles represent cells expressing normal (dark blue), intermediate (light blue) or no 
(white) transgene products. 
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5.1 Distinct functional roles of Pitx3 in the developing midbrain and lens 
Impaired development of both mDA neurons (Maxwell et al., 2005) and lens in Pitx3 
null mice has been demonstrated. Interestingly, the transcription factor Pitx3 shows 
distinct functional roles between the developing midbrain and the developing lens 
(Figure 5-1). 
In this thesis I have shown that the expression of Pitx3 in the developing lens is 
restricted to the lens epithelial layer and the bow region where cell proliferation 
proceeds. The Pitx3 null lens showed expanded expression of the cell cycle inhibitors 
p27KIP1 and p57KIP2, suggesting that Pitx3 might prevent cell cycle arrest. On the 
other hand, Pitx3 is expressed in post-mitotic mDA neurons. The expression of 
Pitx3-GFP and Sox1, which is a marker of proliferative neural progenitors (Pevny et 
al., 1998), has been found to be mutually exclusive in the E12 midbrain (Zhao et al., 
2004). Additionally, Pitx3-GFP positive mDA neurons do not express Ki67, a 
proliferative marker which labels cells in G1, G2 and M phase (Maxwell et al., 2005). 
These data suggest that Pitx3-GFP expressing cells in the midbrain have withdrawn 
from cell cycle. The reduced number of GFP+TH+ cells in Pitx3GFP/GFP mice suggests 
that Pitx3 is required for generation and maintenance of the post-mitotic mDA 
neurons, while in developing lens Pitx3 is required for the maintenance of the 
proliferative lens epithelial cells. 
Furthermore, the reduced number of midbrain TH expressing cells in the Pitx3-GFP 
positive population in Pitx3GFP/GFP mice provides biological evidence that Pitx3 is 
also involved in the regulation of TH, a key enzyme for the synthesis of dopamine, in 
agreement with the in vitro promoter studies that Pitx3 is able to bind to a response 
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element in the TH promoter and confer a transcriptional effect (Cazorla et al., 2000; 
Lebel et al., 2001). This is in contrast to its function in developing lens where Pitx3 





Figure  5-1 Distinct functions of Pitx3 in developing midbrain and lens 
Pitx3 is expressed and required in proliferative lens epithelial cells before cell cycle 
withdrawal, and in post-mitotic mDA neurons of midbrain. Functionally, it may also 
be a repressor of lens fibre cell-specific crystallin expression. On the other hand, 
Pitx3 regulates the expression of TH in mDA neurons. 
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5.2 Further application of the Pitx3-GFP reporter ES cells 
The homozygous Pitx3GFP/GFP ES cells can differentiate into GFP positive cells with 
neuronal morphology and expression of TH and Nurr1. It is feasible to check other 
expression profiling to see if Pitx3 has regulatory roles for other transcription factors 
or signalling pathways. Additionally, the homozygous Pitx3GFP/GFP ES cells have 
shown impaired differentiation potential into mDA neurons, and can be rescued by 
Pitx3 replacement (Chapter 4.4). Therefore, the Pitx3 candidate downstream targets 
can also be tested in this cellular system by forced expression in Pitx3 null ES cells 
to examine whether the impaired differentiation into mDA neurons is rescued. Thus 
Pitx3 null ES cells provide a platform to screen candidate targets functionally before 
further complicated animal studies.  
One interesting candidate pathway is the regulation of apoptosis in mDA neurons. 
Previously in our laboratory it has been shown that loss of mDA neurons in Pitx3 
null mice is probably due to apoptotic cell death during development (Maxwell et al., 
2005). The TUNEL assay has shown that around double the number of Pitx3-GFP+ 
cells in the Pitx3 null SN are undergoing apoptosis compared to the Pitx3 
heterozygous SN and VTA or the Pitx3 null VTA. The primary culture of E14.5 
midbrain has also revealed that around double the number of Pitx3-GFP+ cells in the 
Pitx3 null culture are undergoing apoptosis as compared to the Pitx3 heterozygous 
culture. However, further molecular mechanisms remain elusive. It will be 
interesting to put caspase-3 inhibitors into these ES cell culture to see if the 
anti-apoptotic treatment rescues the phenotype. Furthermore, it is also applicable to 
introduce an expression vector carrying Bcl-xL, an anti-apoptotic protein of the Bcl-2 
family which is involved in cell survival of SN mDA neurons (Savitt et al., 2005; 
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Shim et al., 2004). 
Lineage-specific reporters provide an opportunity to use purified, molecularly 
defined cell populations from developing midbrain or ES cell-derivatives for testing 
the functional reconstitution in Parkinsonian brain, and for uncovering the molecular 
identity of the desired ‘donor’ cells for developing cell replacement therapy in 
treating PD. For example, GFP reporter driven by Ngn2, which is expressed in DA 
neuron precursors in the developing midbrain, has been used to identify 
transplantable cells from mouse developing ventral midbrain. It has been shown that 
Ngn2-GFP+ cells from mouse midbrain give rise to a higher ratio of TH+ cells in PD 
animal transplantation studies, compared to cells expressing GFP under the control of 
an earlier marker Nestin, demonstrating an enrichment in the progenitor pool in terms 
of the number of survival DA neurons (Thompson et al., 2006). Additionally, glia 
cells in donor ventral midbrain or ES cell-derivatives might also help DA neuron 
development and survival in transplantation animal experiments (Hall et al., 2003). 
FACS-sorted Ngn2-GFP expressing cells from developing ventral midbrain, which 
have committed into neuronal fate, did not show a significant increase in DA neuron 
numbers in grafts compared with the unsorted grafts. It has been suggested by the 
authors that the enrichment of DA progenitors might be countered by the poor 
survival of DA neurons in grafts lacking ventral midbrain glia cells (Thompson et al., 
2006). 
Further transplantation experiments in animal models are needed to establish the type 
and developmental stage of cells that is required for functional repair in Parkinsonian 
brain, with regard to tumourigenicity and developmental plasticity. Pitx3-GFP 
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reporter ES cells may represent a valuable tool for advancing studies in this area. 
Pitx3 expressing cells are post-mitotic mDA neurons (Maxwell et al., 2005; Zhao et 
al., 2004), thus having the lowest tumourigenicity when transplanting into host 
midbrain. On the other hand, they might have the lowest developmental plasticity, 
which is also a significant issue for functional recovery of cell replacement therapy 
in neurodegenerative disease. However, Pitx3-GFP reporter ES cell-derivatives, from 
different differentiation methods or of different stages, may be used in 
transplantation experiments to track the survival of ‘right’ type DA neurons in 
Parkinsonian brain, which has been shown as an important factor for functional 
repair of PD animals (Hudson et al., 1994). 
Instead of the ES cell-based research system, other cells in the Pitx3-GFP reporter 
mice may also be used in cellular and molecular research of mDA development. 
Primary culture of ventral midbrain cells at E11, when Pitx3-GFP is not expressed, 
can be used for testing exogenous factors or signals which can promote development 
of Pitx3-GFP+ neurons. Furthermore, cells from other lineages in Pitx3-GFP reporter 
mice may also be used for testing their potential to trans-differentiate into Pitx3-GFP 
positive mDA neurons, which is of special interest in the search for alternative 
sources to ES cells for cell replacement therapy. 
5.3 Concluding remarks 
The experiments in this thesis provide knowledge in developing lineage-specific 
reporter ES cells. First of all I have derived heterozygous and homozygous 
Pitx3-GFP reporter ES cells from mutant blastocysts. The Pitx3GFP/+ and Pitx3GFP/GFP 
ES cells have been used in chimeric animal experiments and demonstrated a 
cell-autonomous requirement of Pitx3 in developing lens epithelium. These 
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experiments have led to further molecular characterisation of Pitx3 null lens which 
reveals premature activation of fibre cell differentiation programme of lens epithelial 
cells, suggesting that Pitx3 is a key transcription factor for the maintenance of lens 
epithelium, partly via the regulation of the transcription factor Foxe3. Clearly there 
are many factors involved in lens epithelial cell maintenance and fibre cell 
differentiation that are yet to be uncovered. Future studies also need to address the 
relationships and interactions between Pitx3 and other transcription factors or 
signalling pathways involved in lens development. Acquiring this knowledge may 
lead to a better understanding of the role that transcription factors play in mouse and 
human ocular development. 
On the other hand, in vitro differentiation experiments have shown that the 
ES-derived Pitx3-GFP positive cells are DA neurons of mesencephalic identity. I 
have generated supertransfectable Pitx3GFP/+ ES cells to offer a rapid and efficient 
way for introducing and expressing a transgene episomally. The Cre-mediated 
inducible system of Pitx3-GFP reporter ES cells has also been developed in our 
laboratory and I have shown that they have high induction efficiency thus allowing 
transgene activation in a temporally controlled manner. The homozygous Pitx3GFP/GFP 
ES cells showed impaired potential to differentiate into mDA neurons and may 
potentially be used for evaluating candidate Pitx3 downstream targets by 
gain-of-function test. The purpose of developing a Pitx3-GFP reporter ES cell system 
is to identify key determinants governing mDA fate and to investigate mechanisms of 
regulatory genes in mDA neuronal differentiation. Additionally, understanding how 
to generate appropriate cell types robustly and under defined conditions from ES 
cells will be essential for functional applications including the development of cell 
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replacement therapy. 
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Appendix VIII pCAGGfpIP plasmid map 
 
pCAGGfpIP
7295 bps
1000
2000
3000
4000
5000
6000
7000
SpeI
NdeI
SnaBI
BlpI
SgrAI
AgeI
BsrGI
BstXI
Bsu36I
NotI
PmlI
Van91I
BmgBI
Tth111I
BsiWI
AccIII
RsrII
BstEII
BsmBI
SexAI
BfrBI
NsiI
ClaI
EcoICRI
SacI
BclI
SphI
PstI
BsaBI
SfiI
SapI
DrdI
BciVI
BspHI
AhdI
FspI
PvuI
ScaI
AccI
HincII
SalI
CAG promoter
eGFP
IRESPac
SV40 ori/pA
ColE1 Ori
AmpR
ori core
PyF101SV40 pA
 
 
 
